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Résumé 
La peste des petits ruminants (PPR) est une maladie infectieuse, contagieuse des petits ruminants 
domestiques ou sauvages. Elle se caractérise par une hyperthermie élevée (autour de 41°C), du 
jetage, des écoulements oculaires, une stomatite nécrosante, de la diarrhée profuse et 
généralement une forte mortalité. En Afrique, elle peut avoir différentes incidences cliniques sur 
les moutons ou les chèvres, depuis l’infection subclinique jusqu’à une infection aiguë létale. En 
Ethiopie, la PPR clinique est rarement décrite et l’étude de la circulation virale était jusqu’à 
présent peu développée. Dans ce travail, nous montrons la présence d’anticorps contre le virus de 
la PPR sur un grand nombre de moutons, chèvres, vaches et chameaux éthiopiens et nous 
confirmons la transmission naturelle du virus PPR chez ces animaux sans manifestation clinique 
détectable. Cette absence apparente de pathogénicité peut être liée à une résistance génétique 
particulière des races de petits ruminants présentes en Ethiopie ou à une variation de la virulence 
des souches de virus PPR. Afin d’étudier ce dernier point, nous avons entrepris des études in 
vitro sur des souches isolées en Ethiopie et dans différents pays en comparaison avec une souche 
vaccinale obtenue par atténuation par passages en série sur culture cellulaire et d’autres souches 
de morbillivirus. 
Dans un premier temps, nous avons testé la capacité du virus PPR à infecter différents systèmes 
cellulaires. Nous établissons que les cellules VERO (fibroblastes de rein de singe) et 293T 
(cellules épithéliales de rein humain) permettent la réplication du virus PPR comme celle du virus 
de la peste bovine. En revanche, les cellules B95a (cellules lymphoblastoïdes B de singe) ne 
multiplient que le virus de la peste bovine. La capacité d’une cellule à supporter la réplication du 
virus est de nature à influer son pouvoir pathogène et l’épidémiologie de la maladie. La 
différence de sensibilité des cellules au virus PPR peut être lié à l’affinité de la glycoprotéine 
d’enveloppe virale H pour son ou ses récepteurs cellulaires utilisés notamment par le virus de la 
peste bovine. Pour aborder cette question, nous avons entrepris des comparaisons de séquences 
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au niveau de la protéine H du virus PPR, en lien avec ce qui a été déjà décrit sur d'autres 
morbillivirus. 
Pour compléter cette étude sur la virulence, nous avons séquencé les promoteurs de plusieurs 
souches de virus PPR et conduit une analyse des mutations pouvant jouer un rôle dans 
l'atténuation. En effet, les promoteurs viraux des morbillivirus déterminent la transcription des 
ARNm viraux et la réplication du génome viral : la modification de leur séquence peut donc 
affecter leur efficacité et influer sur la virulence de la souche concernée. Nous observons 7 
mutations sur les promoteurs de la souche vaccinale du virus PPR en comparaison avec les autres 
souches virulentes. Certaines mutations sont retrouvées sur les autres morbillivirus, d'autres sont 
spécifiques du virus PPR. De cette approche moléculaire, nous déduisons également l’intérêt 
d’utiliser les séquences des promoteurs du virus, relativement très variables par rapport au reste 
du génome, pour mener des études de phylogéographie et de comparaison entre paramyxovirus. 
Le document de thèse a été organisé en 6 chapitres. Le premier concerne l’histoire naturelle de la 
PPR avec la description du virus, du génome, de l’épidémiologie, de la transmission, des 
symptômes, de la pathologie, de l’immunologie, du diagnostic, de la lutte contre la maladie et des 
aspects économiques en Afrique sub-saharienne. Le deuxième chapitre traite de la biologie 
comparative du virus PPR avec les autres morbillivirus. Le troisième chapitre concerne les 
travaux d’épidémiologie de la PPR effectués en Ethiopie. Le quatrième volet de ce travail reprend 
les études sur la spécificité cellulaire du virus PPR et la comparaison des séquences sur la 
protéine H. Le cinquième chapitre expose les analyses de séquence des promoteurs génomique et 
antigénomique du virus PPR. Enfin, la dernière partie comprend une discussion générale et des 
perspectives. 
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Summary  
 
Peste des petits ruminants (PPR) is an acute and highly contagious viral disease of small 
ruminants, which is characterised by high fever, ocular and nasal discharge, pneumonia, necrosis 
and ulceration of the mucuous membrane and inflammation of the gastro-intestinal tract leading 
to severe diarrhoea and high mortality. In Africa, goats are severely affected while sheep undergo 
a mild form or rarely suffer clinical disease. PPR is one of the most important economical 
diseases in Ethiopia. Clinical PPR is confirmed in Ethiopian goats, however, its circulation in 
other animals has never been described. In the present work, we showed that the antibody 
seroprevalence in camel, cattle, goat and sheep confirmed natural transmission in these animals 
without clinical disease. The apparent absence of pathogenicity in these animals may have been 
due to host resistance or loss of virulence of the virus strain. We have further investigated the 
latter point by in vitro studies on PPRV comparing strains from Ethiopia and other countries with 
the vaccine strain which has been attenuated after several cell culture passages. 
In a first approach, virulence of PPRV was monitored in cell culture system and the use of virus 
specific monoclonal antibodies enabled to detect differences in virulence between PPRV and 
RPV. Vero (primate origin) and 293T (human) cell lines supported virus replication permitting 
the in vitro growth of both PPRV and RPV. In contrast to RPV, B95a (marmoset B) cells infected 
with PPRV were non permissive. The capability of cells to support active virus replication, which 
may result in intercellular spread and induce damages in infected cells, has implications on the 
pathogenesis and epidemiology. Cellular receptors are major determinants of host range and 
tissue tropism of a virus. The difference in infectivity of PPRV and RPV may have depended on 
the H protein epitopes and their cellular receptors. Therefore, we decided to compare the amino 
acid epitope of H protein of PPRV with that of  other morbilliviruses.  
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As part of our investigation of virulence factors, we have sequenced and compared genome and 
antigenome promoters of a vaccine strain with field strains of PPRV. The promoters contain the 
polymerase binding sites to initiate and generate the positive-strand replication and transcription 
of mRNAs. Nucleotide base change differences between vaccine strain and field strains would 
provide molecular basis for  attenuation.  Alignment of the genome promoter sequences revealed 
seven  nucleotide mutations at certain positions. Our finding on nucleotide mutation on PPRV are 
in agreement with the nucleotide changes in rinderpest virus and other morbillivirus promoter 
regions between vaccine strain and wild type virus. Certain mutations were specific to PPRV. 
The promoter sequences were clustered around the geographic origin of the viruses and were 
lineage specific. Phylogenetic analysis of PPRV promoters was used for PPR phylogeograhy, and 
for comparison with other paramyxoviruses. 
The thesis is divided in 6 chapters. The first chapter deals with the natural history of PPR 
including the virus, the genome, epidemiology, transmission, clinical signs, immunology, 
diagnosis, control and its economic cost in the low income subsistence farming systems in sub-
Saharan Africa. The second chapter is about comparative biology of PPRV with regard to other 
groups of morbillivirus genus in the Paramyxoviridae family.  
The third chapter deals with field study and observations on epidemiology of PPR in Ethiopia. In 
chapter four, PPRV virulence was monitored in cell culture system and comparison of H protein 
epitopes. In chapter five, sequence analysis of genome and antigenome promoters of PPRV was 
described In chapter six, general discussion and recommendations were forwarded.  
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Chapter 1. 
Review of Literature 
1.1. Introduction  
For centuries, morbillivirus infections have had a huge impact on both human beings and 
animals. Morbilliviruses are highly contagious pathogens that cause some of the most devastating 
viral diseases of humans and animals worldwide (Murphy et al., 1999). They include measles 
virus (MV), canine distemper virus (CDV), rinderpest virus (RPV), and peste des petits 
ruminants virus (PPRV). Furthermore, new emerging infectious diseases of morbilliviruses with 
significant ecological consequences for marine mammals have been discovered in the past 
decade. Phocid distemper virus (PDV) in seals and the cetacean morbillivirus (CMV) have been 
found in dolphins, whales and porpoises (Barrett et al., 1993, Domingo et al., 1990, McCullough 
et al., 1991). 
The great cattle plagues of the 18th and 19th centuries in Europe were introduced by traders from 
the East (Wilkinson, 1984). Subsequently, rinderpest was introduced into Africa from India 
during colonial wars in Abyssinia in the 1890s, with devastating effects on the susceptible 
domestic and wildlife species (Mack, 1970). International campaigns are under way to eradicate 
globally both MV and RPV. Peste des petits ruminants virus (PPRV), originally endemic in west 
Africa has spread across East Africa, the Middle East and southern Asia as far as Bangladesh 
(Shaila et al., 1996) and Turkey (Ozkul et al., 2002).  
Morbilliviruses are enveloped, nonsegmented negative strand RNA viruses and constitute a genus 
within the family Paramyxoviridae. They cause fever, coryza, conjunctivitis, gastroenteritis, and 
pneumonia in their respective host species. The major sites of viral propagation are lymphoid 
tissues, and acute diseases are usually accompanied by profound lymphopenia and 
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immunosuppression, leading to secondary and opportunistic infections (Appel and Summers, 
1995; Murphy et al., 1999).  
1.2. History 
Peste des petits ruminants (PPR) is a highly contagious and infectious viral disease of domestic 
and wild small ruminants (Furley et al., 1987). It is an economically significant disease of small 
ruminants such as sheep and goats (Dhar et al., 2002). It was first described in Côte d'Ivoire in 
West Africa (Gargadennec and Lalanne, 1942) where it used to be named as Kata, psuedo-
rinderpest, pneumoenteritis complex and stomatitis-pneumenteritis syndrome (Braide, 1981). 
Investigators soon confirmed the existence of the disease in Nigeria, Senegal and Ghana. For 
many years it was thought that it was restricted to that part of the African continent until a disease 
of goats in the Sudan, which was originally diagnosed as rinderpest in 1972, was confirmed to be 
PPR (Diallo, 1988). The realization that many of the cases diagnosed as rinderpest among small 
ruminants in India may, instead, have involved the PPR virus, together with the emergence of the 
disease in other parts of western and South Asia (Shaila et al., 1996), signified its ever-increasing 
importance. It has received a growing attention because of its wide spread, economic impacts 
(Lefèvre and Diallo, 1990) and the role it plays in complication of the ongoing global eradication 
of rinderpest and epidemiosurveillance programmes (Couacy-Hymann et al., 2002). 
1.3. Causative Agent: 
PPR is caused by a virus that was assumed for a long time to be a variant of rinderpest adapted to 
small ruminants. However, studies based on virus cross neutralization and electron microscopy 
showed that it was a morbillivirus that had the physicochemical characteristic of a distinct virus 
though biologically and antigenically related to RPV. It was also shown to be an 
immunologically distinct virus with a separate epizootiology in areas where both viruses were 
enzootic (Taylor, 1979a). The development of specific nucleic acid probes for hybridisation 
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studies and nucleic acid sequencing have proved that PPR virus is quite distinct from rinderpest 
virus (Diallo et al., 1989a). PPRV is in the Morbillivirus genus of the Paramyxoviridae family 
(Gibbs et al., 1979). The Morbillivirus genus also includes other six viruses: measles virus (MV), 
rinderpest virus (RPV), canine distemper virus (CDV), phocine morbillivirus (PMV), porpoise 
distemper virus (PDV) and dolphin morbillivirus (DMV) (Barrett et al., 1993a, Barrett, 2001).  
1.3.1. Virus structure and genome organization 
When viewed through electronmicroscope, morbilliviruses display the typical structure of 
Paramyxoviridae: a pleomorphic particle with a lipid envelope which encloses a helical 
nucleocapsid (Gibbs et al., 1979). The nucleocapsids have a characteristic herring-bone 
appearance. Morbilliviruses are linear, non-segmented, single stranded, negative sense RNA 
viruses with genomes approximately 15–16 kb in size and 200 nm diameter (Norrby and Oxman, 
1990). Full length genome sequences are available for MV (Cattaneo et al., 1989), RPV (Baron 
and Barrett, 1995), CDV (Barrett et al., 1987), PPRV (Bailey et al., 2005) and the dolphin 
morbillivirus (DMV) (Rima et al., 2003). These data have been used to establish reverse genetics, 
a technology critical for negative sense RNA virus research (Nagai, 1999; Neumann et al., 2002). 
The sequence data show striking similarities and it is believed that the morbilliviruses have an 
identical genome organization (Barrett et al., 1991; Banyard et al., 2005). The genome is divided 
into six transcriptional units (Fig. 1-1, Fig. 1-2) encoding two non structural (V and C protein) 
and six structural proteins (Barrett, 1999; Baron and Barrett, 1995; Diallo, 1990). The gene order 
has been established as follows 3’-N-P/C/V-M-F-H-L-5’ (Barrett, 1999; Barrett et al., 1991; 
Diallo, 1990). The genome sequence was divisible by six, a feature shared with other 
Paramyxoviridae (Calain and Roux, 1993). The exact length of morbillivirus genomes differs 
owing to a variable size of the junction between the M and F genes, but not because of varied 
protein lengths. This junction has a particularly high GC content (65%) but no obvious role in 
replication has been shown (Liermann et al., 1998; Radecke et al., 1995).  
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The nucleocapsid (N) protein: The N protein is the most abundant viral protein both in the virion 
and in infected cells (Diallo et al., 1987). It directly associates with the RNA genome to form the 
typical herring bone structure of morbillivirus nucleocapsids. There is a single transcription 
promoter at the 3’ end, upstream to the first codon of the N gene, including the non coding part of 
the N gene and a 52-56 bases leader sequence (Billeter et al., 1984, Crowley et al., 1988, Ray et 
al., 1991). Various roles have been proposed for the leader RNA, including RNA binding site for 
the polymerase to initiate and generate positive strand RNA replication (Fig. 1-3) (Norrby and 
Oxman, 1990; Walpita, 2004), and down regulation of host cell transcription (Ray et al., 1991). 
Transcription and replication of morbilliviruses are controlled by untranslated regions (UTRs) at 
the 3’ and 5’ ends of the genome, known as the genome (GP) and antigenome (AGP) promoters 
(Lamb and Kolakofsky, 2001). In PPRV, these are represented by nucleotides 1–107 and 15840–
15948, respectively. A conserved stretch of 23–31 nucleotides at the 3’ terminus of both the GP 
and the AGP has been shown to be an essential domain required for promoter activity. The 
sequence of the promoters was highly conserved in PPRV (Mioulet et al., 2001). Conserved 
sequences at the junction between the GP and the N gene start, which includes the intergenic 
triplet, are also required for transcription (Mioulet et al., 2001). The intergenic regions are made 
up of four elements: a semi conseved polyadenylation signal, a highly conserved GAA sequence, 
a semi conserved start signal for the next gene and variable length of 5’ and 3’ untranslated 
regions (UTRs) (Barrett et al., 1991). 
A poly U tract which, is responsible for polyadenylation of the positive sense transcripts 
produced by the viral RNA-dependent RNA polymerase, was located 52 bases downstream of the 
N ORF stop. This sequence is highly conserved in the morbilliviruses and acts as part of a gene 
stop and polyadenylation signal. Reduction in size of the poly U tract of the paramyxovirus 
simian virus 5 (SV5) from six residues to four was shown to diminish downstream initiation to 
20–30% of wild-type levels indicating a possible role as a critical spacer region between gene 
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stops and starts (Rassa et al., 2000). This sequence was maintained throughout the genome of 
PPRV except at the M/F, and F/H junctions where the U tract is interrupted by a G residue. It is 
unknown if this G insertion has any modulating effect on the polymerase stuttering mechanism 
employed to polyadenylate nascent mRNAs, or on the transcription of the downstream mRNA(s). 
Immediately following the poly U tract was a conserved triplet (GAA) that has been shown to be 
an intergenic region which is not transcribed during mRNA synthesis but which is an essential 
signal for the activity of the viral polymerase since mutations or deletions in this region can 
reduce or abrogate viral replication (Kolakofsky et al., 1998). Deletion mutagenesis studies 
indicate that the 5’ UTRs for CDV and RPV F genes may serve to direct translation initiation 
from a particular AUG, thus ensuring efficient translation of F protein. (Evans et al., 1990). The 
rate of transcription of mRNAs from each gene is proportional to its distance from the genome 
promoter, since there is a chance that at each intergenic junction the polymerase may detach from 
the template and reinitiate transcription from the 3’ end (Barrett et al., 1991). 
The second transcription unit encodes the P, C and V proteins. The P protein of morbilliviruses 
interacts with both the N and L proteins to form the viral polymerase. The N terminus of V is 
identical to P but polymerase slipping at the editing site can result in a frame shift whereby an 
inserted G residue in the mRNA directs the production of an alternative C terminus (Cattaneo et 
al., 1989; Wardrop and Briedis, 1991, Mahapatra et al., 2003). The hexamer phasing of the P 
gene editing site is also thought to play a critical role in this process (Kolakofsky et al., 1998). 
The alternative C terminus of PPRV has seven conserved cysteine residues that are thought to 
interact to form a motif for binding metal ions (especially zinc). This was shown experimentally 
for both Sendai virus-5 (SV5) and MV V proteins (Paterson et al., 1995). The C and V proteins 
of paramyxoviruses, although essentially non-structural, have been shown to have critical roles in 
infection. In RPV they were shown to be important for replication (Baron and Barrett, 2000). C-
minus mutants showed growth defects in vitro, this being related to a reduced level of mRNA 
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transcription. In contrast V-minus mutants were not defective in vitro, but had an altered 
cytopathic effect and increased genome/antigenome RNA production. The C and V proteins of 
paramyxoviruses also act as interferon antagonists, modifying the cellular immune response to 
infection (Gotoh et al., 2001; Horvath, 2004).  
The Matrix (M) proteins are basic membrane associated molecules that interact with surface 
glycoproteins in the lipid envelope as well as the virion RNP. They are the most highly conserved 
proteins in the Paramyxovirus family and this was reflected in the conservation of the PPRV M 
protein when compared to that of other morbilliviruses. This high conservation is probably due to 
the pivotal role the M protein plays in virion morphogenesis. A small protein with such a critical 
role is likely to be intolerant to variation, especially within a genus whose members are 
antigenically so similar. It is a non-glycosylated envelope protein thought to be involved in 
nucleocapsid-envelope recognition and envelope formation during the budding process of virions 
from the host cell membrane (Kingsbury, 1990). M interacts with both the nucleocapsid and the 
cytoplasmic tails of the F and H glycoproteins. 
The F protein is also highly conserved. Paramyxoviruses generate an inactive precursor (F0) 
which is cleaved by host cell enzymes to yield an active di-sulphide linked protein F1–F2 and the 
cleavage site was also conserved (Lamb and Kolakofsky, 2001). The F protein is one of two 
glycosylated envelope proteins that constitute the peplomers or surface projections. Synthesized 
as a precursor, F0 is subsequently cleaved by cellular proteases into two disulfide-linked 
polypeptides, F1  and F2  (Sato et al., 1988). Proteolytic cleavage is believed to be essential for F 
protein biologic activity. 
The H protein is responsible for attachment of the virus to the host cell (Choppin and Scheid, 
1980, Lamb and Kolakofsky, 2001). The biological activity of the H protein is one of the criteria 
for classification of Paramyxoviridae. H proteins are highly variable (Blixenkrone- Moller et al., 
1996). Indeed, along with the P, the H is the least conserved of the morbillivirus proteins. The H 
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protein is the least conserved among CDV, RPV and MV (37% identity between CDV and MV) 
(Blixenkrone-Moller et al., 1996) and 37% amino acid homology between MV and CDV (Wild 
et al., 1995). Members of the Paramyxovirus genus (e.g. Newcastle disease virus) have H protein 
with both hemagglutinating and neuraminidase activities (Scheid and Choppin, 1974); the 
Morbillivirus H protein exhibits only hemagglutinating activity, and the H protein of members of 
Pneumovirus genus (Respiratory syncytial viruses) has neither hemagglutinating nor 
neuraminidase activities (Kingsbury et al., 1978).   
The large (L) protein is the enzymatic component of the viral transcriptase and replicase. The L 
proteins are multi-functional and, in addition to their polymerase activity, have methylation, 
capping and polyadenylation activities (Lamb and Kolakofsky, 2001). Morbillivirus L proteins 
have three highly conserved domains (designated A, B and C), separated by two hinge regions 
which vary greatly between morbilliviruses (McIlhatton et al., 1997). The conservation of the D 
and N residue in this motif is known to be an absolute requirement for polymerase activity 
(Chattopadhyay et al., 2004). Specifically, the GD residues of this motif constitute part of a turn 
structure that is predicted to be the core polymerase motif (Poch et al., 1990). This protein region 
is involved in nucleic acid binding and is formed when leucine residues, from adjacent alpha-
helices, interdigitate to stabilise the L protein (Ramji and Foka, 2002; Vinson et al., 1989). 
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Fig. 1-1 Genome of Morbilliviruses. ( image, anonym ) 
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Fig. 1-2. Genes and promoters of Morbillivirus (from Parks et al, 2001): the protein coding 
regions (N, P, V, C, M, F, H, and L), noncoding intergenic regions and the leader and trailer 
regions along with specialized sequence motifs are shown. The genome promoter includes the 
leader sequence and the non coding regions N at the 3' end of the genomic RNA. The antigenome 
promoter includes the trailer sequence and the untranslated regions of the L gene at 5’ end. Gene 
start (GS) and gene end (GE), enclosing the intergenic trinucleotide motifs are also shown. 
 
 
 
Fig. 1-3. Morbillivirus replication pathway. Full-length genome copies are made via replication 
intermediate strands of the minigenome. (image, anonym, unpublished) 
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1.4. Geographical Distribution:  
PPR is known to be present in a broad belt of sub-Saharan Africa, Arabia, the Middle East and 
Southern Asia. Major outbreaks in Turkey and India in recent years have indicated a marked rise 
in the global incidence of PPR (Nanda et al., 1996; Ozkul et al., 2002; Shaila et al., 1996).  
The virus was isolated in Nigeria (Taylor and Abegunde, 1979), Sudan (ElHag and Taylor, 
1984), Saudia Arabia (Abu Elzein et al., 1990), India (Shaila et al., 1989, Nanda et al., 1996) and 
Turkey (Ozkul et al., 2002).  Serological evidences were detected in Syria, Niger and Jordan, 
while the virus presence was confirmed with cDNA probe in Ethiopia (Roeder et al., 1994) and 
Eritrea (Sumption et al., 1998), respectively. Genetic relationship between PPR viruses isolated 
from different geographical regions was studied by sequence comparison of the F-protein gene. 
Four lineages were revealed (Shaila et al., 1996, Dhar et al., 2002) (Fig. 1-4, Fig. 1-5). Lineage 1 
is represented by viruses isolated in Africa in 1970s (Nigeria/1975/1, Nigeria/1975/2, 
Nigeria1975/3, Nigeria/1976/1 and Senegalese strain). Lineage 2 which includes viruses isolated 
in the late 1980s in West Africa (Ivory Coast and Guinea) is the only African lineage that did not 
cross the Red Sea to the Asian countries. Lineage 3 is a combination of isolates from Sudan 
(Meilig /1972) (Diallo, 1988), Ethiopia (Roeder et al., 1994). Lineage 4 of PPR virus isolates 
which includes the Asian isolates from Israel/1994, Iran/1994, Nepal/1995, Bangeldesch/1993 
and India (Shaila et al., 1996), is confined to Asia. Recently, it was reported in Turkey (Ozkul et 
al., 2002). The presence of the two African lineages in Asia beside a distinct Asian lineage may 
be taken as indication of the trade route of spread of the disease.  
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Fig. 1-4 Geographic distribution of PPRV lineages (Dhar et al., 2002) 
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Fig. (1-5) Phylogenetic relationships of the Peste des petits ruminants virus isolates based on (F) 
protein gene (Ozkul et al., 2002) 
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1.5. Epidemiology 
1.5.1. Transmission: 
Transmission requires close contact between infected animals in the febrile stage and susceptible 
animals (Braide, 1981) because of the lability of the virus outside the living host. The discharges 
from eyes, nose and mouth, as well as the loose faeces, contain large amounts of the virus. Fine 
infective droplets are released into the air from these secretions and excretions, particularly when 
affected animals cough and sneeze (Bundza et al., 1988; Taylor, 1984). Animals in close contact 
inhale the droplets and are likely to become infected. Although close contact is the most 
important way of transmitting the disease, it is suspected that infectious materials can also 
contaminate water and feed troughs and bedding, turning them into additional sources of 
infection. These particular hazards are, however, probably fairly short-term since the PPRV, like 
rinderpest, would not be expected to survive for long outside the host. Indirect transmission 
seems to be unlikely in view of the low resistance of the virus in the environment and its 
sensitivity to lipid solvent (Lefèvre and Diallo, 1990). There is no known carrier state for PPRV. 
Trade in small ruminants, at markets where animals from different sources are brought into close 
contact with one another, affords increased opportunities for PPR transmission, as does the 
development of intensive fattening units. 
1.5.2. Host Range and pathogenicity: 
PPR is mainly a disease of small ruminants. It affects goats and sheep. PPR virus exhibits 
different levels of virulence between sheep and goats. Goats are severely affected while sheep 
generally undergo a mild form (Lefèvre and Diallo, 1990). Although infected, sheep rarely suffer 
clinical disease (El Hag Ali and Taylor, 1988; Roeder et al., 1994). An outbreak with a high 
mortality in sheep was reported by Taylor (1984) who hypothesised that sheep possessed an 
innate resistance to the clinical effects of disease, but occasional field strains could overcome this 
resistance and produce high mortality (Taylor, 1984). Breed may affect the outcome of PPR virus 
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infection and its epidemiology, the Guinean breeds (West African dwarf, Iogoon, kindi and 
Djallonke) are known to be highly susceptible (Lefèvre and Diallo, 1990). This is in agreement 
with the finding that British breed exhibited severe clinical reaction when infected experimentally 
while the Sudanese breeds failed to develop a characteristic clinical response (El Hag and Taylor, 
1984). A more recent observation detected variations in breed susceptibility within goats in West 
Africa. The acute form of the disease was observed in WAD goats while WALL breed developed 
only mild form (Diop et al., 2005). (Fig. 1-6 and Fig. 1-7).  
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Fig. 1-6  PPR resistance goat breeds in sahelian region (Photo by Dr V. Martin) 
 
 
Fig. 1-7  PPR resistance sheep in West Africa (Photo, anonym, Dakar, Senegal) 
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In India and the Middle East both goats and sheep are affected with equally devastating 
consequences. In India, morbidity and case fatality reach 10 and 25% respectively in flocks of 
indigenous sheep (Shaila et al., 1989). The outbreak will not involve cattle, whether rinderpest 
vaccinated or not, even if they are in contact with affected goats and sheep. Cattle and pigs are 
known to be a dead end host and all attempt to induce clinical disease in adult cattle 
experimentally failed; they undergo a silent or subclinical infection that protect them against 
subsequent challenge with virulent strain of RP (Gibbs et al., 1979; Taylor, 1984). Sero-
neutralization test for the presence of PPR antibodies detected 4.2% in 142 camels (Ismail et al., 
1995). PPR affect wildlife animals both under field condition and experimentally. The disease 
was induced experimentally in American white deer (Odocoileus virginianus) which was found 
to be susceptible (Hamdy et al., 1976) and a field outbreak was reported from a zoological 
collection in Alain (Furley et al., 1987). It caused a high mortality and severe disease in Dorcas 
Gazelles (Gazella dorcas), Nubian Ibex (Capra ibex nubiana), Laristan sheep (Ovis orientalis 
laristani) and gemsbok (Oryx gazellaa). Subclinical involvement of Nigale (Tragelaphinae) was 
suspected. In another report from Saudi Arabia, PPR was suspected on clinical and serological 
base in Gazaelle and deer (Abu Elzein et al., 1990). Antelope and other small wild ruminant 
species can also be severely affected (Abu Elzein et al., 2004). 
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1.5.3. Pattern of the disease: 
In general, a morbidity is common, particularly in fully susceptible goat populations. Milder 
forms of the disease may occur in sheep and partially immune goat populations. There are 
considerable differences in the epidemiological pattern of the disease in the different ecological 
systems and geographical areas. In the humid Guinean zone where PPR occurs in an epizootic 
form, it may have dramatic consequences with morbidity of 80%-90% accompanied with a 
mortality between 50 and 80% (Lefèvre and Diallo, 1990). While in arid and semi-arid regions, 
PPR is seldomly fatal but usually occurs as a subclinical or inapparent infection opening the door 
for other infections such as Pasteurellosis (Lefèvre and Diallo, 1990). Though outbreaks in West 
Africa coincide with the wet rainy season, Opasina and Putt (1985) observed outbreaks during 
the dry season in two different ecological zones. A high morbidity of 90% accompanied with 
70% case fatality was reported from Saudi Arabia (Abu Elzein et al., 1990).  
Serological data from Nigeria revealed that antibodies occur in all age groups from 4-24 months 
indicating a constant circulation of the virus (Taylor, 1979b). In Oman the disease persisted on a 
year round basis maintaining itself in the susceptible yearling population (Taylor et al., 1990). 
Therefore, an increase in incidence reflects an increase in number of susceptible young goats 
recruited into the flocks rather than seasonal upsurge in the virus activity, since its upsurge pend 
on the peak of kidding seasons (Taylor et al., 1990). Moreover, the susceptibility of young 
animals aged 3 to 18 months was proved to be very high, being more severely affected than 
adults or unweaned animals (Taylor et al., 1990). 
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1.6. Clinical Signs 
Clinical signs of PPR have been well documented (Hamdy et al., 1976; Obi, 1984; Lefèvre, 
1987; Taylor, 1984; Bundza et al., 1988; Roeder et al., 1994; Roeder and Obi, 1999). 
Introduction of PPR into a flock may be associated with any of the following:  
• history of recent movement or gathering together of sheep and/or goats of different ages 
with or without associated changes in housing and feeding;  
• introduction of recently purchased animals; contact in a closed/village flock with sheep 
and/or goats that had been sent to market but returned unsold; 
• change in weather such as the onset of the rainy season (hot and humid) or dry, cold 
periods, contact with trade or nomadic animals through shared grazing, water and/or 
housing;  
• a change in husbandry (e.g. towards increased intensification) and trading practices. 
Following infection there is a 3–4 day incubation period during which the virus replicates in the 
draining lymph nodes of the oro-pharynx before spreading via the blood and lymph to other 
tissues and organs including the lungs causing a primary viral pneumonia. The predominant 
form of the disease is the acute form. The salient clinical signs start with sudden rise in body 
temperature to 39.5 - 41°C. Affected animals breathe fast, sometimes so fast that they exhibit 
rocking movements with both the chest and abdominal walls moving as the animal breathes. 
Severely affected cases show difficult and noisy breathing marked by extension of the head and 
neck, dilation of the nostrils, protrusion of the tongue and soft painful coughs. They have 
obvious signs of pneumonia. A clear watery discharge starts to issue from the eyes, nose and 
mouth, later becoming thick and yellow as a result of secondary bacterial infection. Appearance 
of a serous to mucopurulent nasal discharge which may crust over and occlude the nostril, 
sneezing, ocular discharge resulting in matting of the eyelids. The discharges wet the chin and 
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the hair below the eye; they tend to dry, causing matting together of the eyelids, obstruction of 
the nose and difficulty in breathing (Fig. 1-8). Unlike RP, there is a definite but inconstant, 
respiratory system component (Brown et al., 1991; Bundza et al., 1988). One to two days after 
fever has set in, the mucous membranes of the mouth and eyes become very reddened. Then, 
epithelial necrosis causes small pin-point greyish areas on the gums, dental pad, palate, lips, 
inner aspects of the cheeks and upper surface of the tongue. These areas increase in number and 
size and join together. The lining of the mouth is changed in appearance. It becomes pale and 
coated with dying cells and, in some cases, the normal membrane may be completely obscured 
by a thick cheesy material. Underneath the dead surface cells, there are shallow erosions. Gentle 
rubbing across the gum and palate with a finger may yield a foul-smelling material containing 
shreds of epithelial tissue (Braide, 1981) (Fig. 1-9). Body temperature usually remains high for 
about 5-8 days, and then slowly returns to normal prior to recovery or drops below normal 
before death (Fig. 1-10).  
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Fig. 1-8 Clinical signs, discharges (Photo, Abraham and Roeder, Ethiopia)  
 
Fig. 1-9 Mouth lesions (Photo, Abraham and Roeder, Ethiopia)   
 
Fig. 1-10 Body temperature fluctuation and phases of clinical disease (Scott et al., 1986) 
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Diarrhoea commonly appears about two to three days after the onset of fever although, in early 
or mild cases, it may not be obvious. The faeces are initially soft and then watery, foul-smelling 
and may contain blood streaks and pieces of dead gut tissue. Where diarrhoea is not an obvious 
presenting sign, the insertion of a cotton wool swab into the rectum may reveal evidence of soft 
faeces which may be stained with blood. Such victims may eventually become dehydrated with 
sunken eyeballs, and death often follows within seven to ten days from onset of the clinical 
reaction. Other animals will recover after a protracted convalescence.  
The affected animals had lymphocytopenia, elevated PCV (above 60% while normal 35-45%), 
very high RBCs count while the level of hemoglobin and the white blood cells was normal 
(Furley et al., 1987). A common feature in later stages of the sub-acute disease is the formation 
of small nodular lesions in the skin on the outside of the lips around the muzzle. The exact cause 
of this is not known. 
1.7. Pathology  
Pathogenesis: PPR virus, like other morbilliviruses, is lymphotropic and epitheliotropic (Scott, 
1981). Consequently, it induces the most severe lesions in organ systems rich in lymphoid and 
epithelial tissues. The respiratory route is the likely portal to entry. After the entry of the virus 
through the respiratory tract system, it localizes first replicating in the pharyngeal and 
mandibular lymph nodes as well as tonsil. Viremia may develop 2-3 days after infection and 1-2 
days before the first clinical sign appears. Subsequently viremia results in dissemination of the 
virus to spleen, bone marrow and mucosa of the gastro-intestinal tract and the respiratory system 
(Scott, 1981). 
Post mortem findings: The carcass of an affected animal is usually emaciated, the hindquarters 
soiled with soft/watery faeces and the eyeballs sunken. The eyes and nose contain dried-up 
discharges. Lips may be swollen; erosions and possibly scabs or nodules in late cases. The nasal 
cavity is congested (reddened) lining with clear or creamy yellow exudates and erosions. They 
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may be dry with erosions on the gums, soft and hard palates, tongue and cheeks and into the 
oesophagus. The lung is dark red or purple with areas firm to the touch, mainly in the anterior 
and cardiac lobes (evidence of pneumonia). Lymph nodes (associated with the lungs and the 
intestines) are soft and swollen. Abomasum congested with lining haemorrhages. 
The pathology caused by PPR is dominated by necrotizing and ulcerative lesions in the mouth 
and the gastro-intestinal tract (Roeder et al., 1994). Erosion in the oral cavity is a constant 
feature. The rumen reticulum and omasum rarely exhibit lesions. Occasionally, there may be 
erosions on the pillars of the rumen. The omasum is a common site of regularly outlined 
erosions often with oozing blood. Lesions in the small intestine are generally moderate, being 
limited to small streaks of hemorrhages and, occasionally, erosions in the first portions of the 
duodenum and the terminal ileum. The large intestine is usually more severely affected, with 
congestion around the ileo-cecal valve, at the ceco-colic junction and in the rectum. In the 
posterior part of the colon and the rectum, discontinuous streaks of congestion “zebra stripes” 
form on the crests of the mucosal folds.  
In the respiratory system, small erosion and petechiae may be visible on the nasal mucosa, 
turbinates, larynx and trachea. Bronchopneumonia may be present, usually confined to the 
anteroventral areas, and is characterized by consolidation and atelectasis. 
Histopathology: PPR virus causes epithelial necrosis of the mucosa of the alimentary and 
respiratory tracts marked by the presence of eosinophilic intracytoplasmic and intranuclear 
inclusion bodies. Multinucleated giant cells (syncytia) can be observed in all affected epithelia 
as well as in the lymph nodes (Brown et al., 1991). In the spleen, tonsil and lymph nodes, the 
virus causes necrosis of lymphocytes evidenced by pyknotic nuclei and karyorrhexis (Rowland 
et al., 1971). Brown and others (1991) using immunohistochemical methods detected viral 
antigen in both cytoplasm and nuclei of tracheal, bronchial and bronchio-epithelial cell, type II 
pneumocytes, syncytial cells and alveolar macrophages. 
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Small intestines are congested with lining haemorrhages and some erosions. Large intestines 
(caecum, colon and rectum) have small red haemorrhages along the folds of the lining, joining 
together as time passes and becoming darker, even green/black in stale carcasses.  
1.8. Immunity: 
The surface glycoproteins hemagglutinin (H) and fusion protein (F) of morbilliviruses are highly 
immunogenic and confer protective immunity. PPRV is antigenically closely related to rinderpest 
virus (RPV) and antibodies against PPRV are both cross-neutralizing and cross protective 
(Taylor, 1979a). A vaccinia virus double recombinant expressing H and F glycoproteins of RPV 
has been shown to protect goats against PPR disease (Jones et al., 1993) though the animals 
developed virus-neutralizing antibodies only against RPV and not against PPRV. Capripox 
recombinants expressing the H protein or the F protein of RPV or the F protein of PPRV 
conferred protection against PPR disease in goats, but without production of PPRV-neutralizing 
antibodies (Romero et al., 1995) or PPRV antibodies detectable by ELISA (Berhe et al, 2003). 
These results suggested that cell-mediated immune responses could play a crucial role in 
protection. Goats immunized with a recombinant baculovirus expressing the H glycoprotein 
generated both humoral and cell-mediated immune responses (Sinnathamby et al., 2001). The 
responses generated against PPRV-H protein in the experimental goats are also RPV cross-
reactive suggesting that the H protein presented by the baculovirus recombinant ‘resembles’ the 
native protein present on PPRV (Sinnathamby et al., 2001). Lymphoproliferative responses were 
demonstrated in these animals against PPRV-H and RPV-H antigens (Sinnathamby et al., 2001). 
N-terminal T cell determinant and a C-terminal domain harboring potential T cell determinant(s) 
in goats was mapped (Sinnathamby et al., 2001). Though the sub-set of T cells (CD4+ and CD8+ 
T cells) in PBMC that responded to the recombinant protein fragments and the synthetic peptide 
could not be determined, this could potentially be a CD4+ helper T cell epitope, which has been 
shown to harbor an immunodominant H restricted epitope in mice (Sinnathamby et al., 2001). 
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Identification of B- and T-cell epitopes on the protective antigens of PPRV would open up 
avenues to design novel epitope based vaccines against PPR. 
Sheep and goats are unlikely to be infected more than once in their economic life (Taylor, 1984). 
Lambs or kids receiving colostrum from previously exposed or vaccinated with RP tissue culture 
vaccine were found to acquire a high level of maternal antibodies that persist for 3-4 months. The 
maternal antibodies were detectable up to 4 months using virus neutralization test compared to 3 
month with competitive ELISA (Libeau et al., 1992). Measles vaccine did not protect against 
PPR, but a degree of cross protection existed between PPR and canine distemper (Gibbs et al., 
1979). 
Though PPR disease can be effectively controlled by RPV vaccine, rinderpest eradication 
programmes have been launched in many countries and if these campaigns are successful, Office 
International des Epizooties (OIE) recommends the cessation of vaccination of all the animals 
with RPV vaccine so that any residual foci of RPV could be identified. Under these 
circumstances, small ruminants could only be protected against PPR by using homologous 
attenuated vaccine. In addition, the successful use of an attenuated PPRV vaccine against RPV 
has been reported in goats, opening the possibility to use it as a differentiable vaccine for cattle 
(Couacy-Hymann et al., 1995). 
1.9. Diagnosis 
Goats and sheep can be infected with RP and PPR as well. Clinical differential diagnosis is not 
possible as similar disease is produced by both viruses in small ruminants. Therefore, tentative 
clinical diagnosis may have to be confirmed by laboratory analysis. Diagnosis of PPR may be 
performed by virus isolation, detection of viral antigens, and nucleic acid sequencing and 
detection of specific antibody in serum.  
1.9.1. Virus isolation  
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Samples for virus isolation include heparinized blood, eye and nasal swabs (from live animals), 
tonsil, mesenteric lymph nodes, spleen, section of colon and lung. For successful isolation, 
samples must be collected during the hyperthermic phase (Lefevre, 1987) and submitted to the 
testing laboratory in cold ice. The most widely used cell culture systems are primary lamb kidney 
and ovine skin (Gilbert and Monnier, 1962; Laurent, 1968, Taylor and Abegune, 1979) and Vero 
cells (Hamdy et al., 1976).  
The sensitivity of virus isolation technique could be increased when the virus is grown in lamb 
and goats kidney cells (Taylor, 1984). Vero cells are however widely used for their continuity 
and low liability of contamination. PPRV has also been adapted to grow in other continuous cell 
lines including MDBK and BHK-21 (Lefèvre, 1987). Vero cells, derived from African green 
monkey kidney are currently the most widely used cell line for PPRV and RPV. A culture of 
Vero cells from American type cell culture (ATCC # CCL81) was found to yield very high titres 
and is currently used in many laboratories working on PPRV and RPV. Appearance of cytopathic 
effects (CPE) may require at least 8-10 days or several blind passages. In Vero cells, the 
cytopathic effects (CPE) produced by PPRV consist of cell rounding, clumping into typical 
grape-like clusters, formation of small syncytia and appearance of long fine often anastomosing 
“spindle cells” (Hamdy et al., 1976). Like other morbilliviruses, PPRV produces eosinophilic 
intracytoplasmic and intranuclear inclusion bodies both in primary cells (Laurent, 1968) and 
continuous cell lines (Hamdy et al., 1976). 
T-lymphoblast cell line transformed by Theileria parva proved to be more sensitive when 
compared to other cell culture and gave a result within 24 hours (at least 6 days for other cell 
culture) for both PPRV and RPV (Rossiter, 1994).  
Once isolated in cell culture, a candidate PPRV may be identified by one of the three procedures: 
• animal inoculation: PPR causes clinical disease in goats and sheep but not in cattle (Gibbs 
et al., 1979);  
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• reciprocal cross neutralization (differential neutralization): PPRV is neutralized by both 
PPR and RPV reference sera, but is neutralized at greater titre with the homologous serum 
(Taylor and Abegunde and, 1979, Taylor, 1979a);  
• molecular techniques: cDNA probe, (Diallo et al., 1989a, Pandey et al., 1992), 
electrophoretic profile in polyacrylamide gel (PAGE) (Diallo et al., 1987) and PCR, 
(Barret et al., 1993, Forsyth et al., 1995, Couacy-Hymann et al., 2002).  
1.9.2. Antigen detecting methods:  
1.9.2.1. Agar Gel Immunodiffusion Test 
Agar gel immunodiffusion test (AGID) is widely used and can detect 42.6% of antemortem 
specimens and necropsy specimens (Obi, 1984; Abraham and Berhan, 2001). It can be used to 
test the presence of both antigen and antibodies and can give results within 2-4 hours when RP 
hyperimmune serum is used while it needs 4-6 hours with PPR hyperimmune serum (Obi, 1984). 
One of the important advantages of this test that it is highly specific (92%), though it can not 
differentiate between PPR and RP.  
1.9.2.2. Hyperimmune serum: 
Standard antiserum is made by immunising sheep with 5 ml of PPR virus with a titre of 104 
TCID50 (50% tissue culture infective dose) per ml given at weekly intervals for 4 weeks. The 
animals are bled 5-7 days after the last injection. Standard RP hyperimmune antiserum is also 
effective in detecting PPR antigen.  
1.9.2.3. Counter immunoelectrophoresis 
Counter immunoelectrophoresis (CIEP) is in the same principle as the AGID except that the gel 
is electrically charged to improve the sensitivity of the test.  
1.9.2.4. ELISA for antigen detection: 
A monoclonal antibody-based sandwich ELISA was found to be highly sensitive in detection of 
antigen in tissues and secretions of infected goats (Saliki et al., 1994). Another format of antigen 
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ELISA which is more widely used is immunocapture ELISA (Fig. 1-11). It utilizes MAb directed 
against the nucleocapsid protein (Libeau et al., 1994). It can give a reliable result within two 
hours in precoated plates and from samples maintained at room temperature for a period of seven 
days with no more than 50% reduction in response (Libeau et al., 1994). The immunocapture 
ELISA allows a rapid differential diagnosis of PPR or rinderpest viruses, and this is of great 
importance as the two diseases have a similar geographical distribution and may affect the same 
animal species. The detecting MAbs used in immunocapture ELISA are directed against two non 
overlapping domain of the N-protein of PPR and RP, but the capture antibody detects an epitope 
common to both RP and PPR (Libeau et al., 1994). The test is very specific and sensitive, it can 
detect 100.6 TCID50/well for the PPR virus and 102.2 TCID50 for the rinderpest virus. This 
discrepancy between the two viruses in the assay may be due to a difference in the affinity of the 
detection antibody for the different N proteins. The main advantages of this assay are: 
• Rapidity, it can be performed in a precoated plate in less than 2 hours; 
• Specificity ; 
• Robustness, it can be carried out on samples which have not been kept under ideal 
conditions and where no viable virus is present; 
• Simplicity. 
The immunocapture ELISA is suitable for routine diagnosis of rinderpest and PPR from field 
samples such as ocular and nasal swabs. 
1.9.2.5. cDNA probes: 
For the differentiation between PPR and RP, the use of [P³²]-labelled cDNA probes derived from 
the N-protein gene of the two viruses had been described (Diallo et al., 1989a). It could 
differentiate between the two viruses without need for virus isolation. cDNA directed against the 
matrix protein, fusion protein and phosphoprotein gene were found to cross hybridise to a much 
greater extent and were not suitable for use as discriminating probes (Diallo et al.,1989a). 
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Unfortunately, this hybridization cannot be used widely because it requires fresh specimens and 
in addition to the short half life of [P³²], there is constraints with the handling of isotopes. 
Therefore, probes using non radioactive labels such as biotin (Pandey et al., 1992) or dioxin 
(Diallo et al., 1995) were developed. The biotin labeled cDNA was found to be as specific as the 
one using the radioactive label and more rapid in differentiation between PPR and RP (Pandey et 
al., 1992). However, it was reported elsewhere, that the expected sensitivity had never been 
obtained using non-radioactive labels (Diallo et al., 1995). 
1.9.2.6. Reverse transcription polymerase chain reaction (RT-PCR) 
Conventional serological techniques and virus isolation are normally used to diagnose 
morbillivirus infection in samples submitted for laboratory diagnosis. However, such techniques 
are not suitable for use on decomposed tissue samples, the polymerase chain reaction (PCR), has 
proved invaluable for analysis of such poorly preserved field samples.  
Saiki and others (1988) first demonstrated the efficiency of amplifying in vitro a selected 
sequence flanked by two oligonucleotide primers of opposite orientation. The method consists of 
repetitive cycles of DNA denaturation, primer annealing and extension by a DNA polymerase 
effectively doubling the target with each cycle leading, theoretically, to an exponential rise in 
DNA product. The replacement of the polymerase Klenow fragment by thermostable polymerase 
derived from Thermus aquaticus (Taq) has greatly improved the usefulness of PCR. Using this 
system, a rate of amplification up to 107  to 109 times has been reported. The efficiency achieved 
actually can vary enormously, however, since it is dependent on factors such as the number of 
cycles, the quantity of the starting material, the length of the target DNA, the temperature 
conditions of annealing and priming, and the polymerase used. When the starting material is 
DNA, high purification of the nucleic acid is not necessary so the procedure is greatly simplified. 
These qualities have made the PCR one of the essential techniques in molecular biology today 
and it is starting to have a wide use in laboratory disease diagnosis. 
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Since the genome of all morbilliviruses consists of a single strand of RNA, it must be first copied 
into DNA, using reverse transcriptase, in a two-step reaction known as reverse 
transcription/polymerase chain reaction (RT-PCR). RT-PCR has been shown to be useful for the 
rapid detection of morbillivirus-specific RNA in samples submitted for laboratory diagnosis 
(Shaila et al., 1996). It has proved especially useful in identifying the new morbilliviruses found 
in marine mammals (Barrett et al., 1993b). Both genus-specific and universal morbillivirus 
primer sets have been produced that can be used to distinguish all known morbilliviruses (Forsyth 
and Barrett, 1995). 
Two sets of primers have been made, based on sequences in the 3’ end of N genes (messenger 
sense), which are least conserved regions between the two viruses. They enable specific 
amplification of 300 base pair (bp) fragments for RPV and PPRV (Couacy-Hymann et al., 2002). 
Reverse transcription-polymerase chain reaction tests (RT-PCR) using phosphoprotein (P) 
universal primer and fusion (F) protein gene specific primer sets to detect and differentiate 
between PPR and RP were described (Barrett et al., 1993b; Forsyth and Barret, 1995; Couacy-
Hymann et al., 2002).  
1.9.3. Serology: 
Many tests have been used for the demonstration of PPR antibodies in serum: virus neutralization 
test, agar gel diffusion test, immunoelectrophoresis and recently blocking and competitive 
ELISA. 
1.9.3.1. Virus neutralisation: 
The virus neutralisation test (VNT) is sensitive and specific, but time-consuming and expensive. 
The standard neutralisation test is carried out in roller-tube cultures of primary lamb kidney cells 
or Vero cells when primary cells are not available. VNT is the most reliable test for detection of 
morbillivirus antibodies (Rossitter, 1994). Serum against either PPR or RP may neutralise both 
 30
viruses, but would neutralize the homologous virus at a higher titre than the heterologous virus. 
Therefore for differentiation purpose reciprocal cross neutralization is used (Taylor and 
Abegunde, 1979).  
1.9.3.2. cELISA 
Competitive and blocking ELISA based on monoclonal antibodies specific for N-protein (Libeau 
et al., 1995) and H-protein (Anderson and Mckay, 1994; Saliki et al., 1993; Singh et al., 2004) 
were developed for detection of antibodies in animal sera. These tests either used gradient 
purified virus or expressed antigens. In the N-protein cELISA, the serum antibodies and the MAb 
compete on specific epitope on nucleoprotein obtained from recombinant baculovirus. Though no 
cross reaction in N-protein cELISA was reported, a high level of competition up to 45% was 
observed among the negative (Libeau et al., 1995). Despite the fact that neutralizing antibodies 
are not directed against the N-protein, but the H-protein (Diallo et al., 1995), a correlation of 0.94 
between VNT and cELISA was observed suggesting that the former was more sensitive (Libeau 
et al., 1995). The relative sensitivity of this cELISA to VNT was 94.5, while the specificity was 
99.4%. Both blocking ELISA and cELISA detecting anti-H antibodies are based on competition 
between an anti-H monoclonal antibody (MAb) and serum antibodies, but in case of blocking 
ELISA the test sera are preincubated with antigen and then incubated with the MAb (Saliki et al., 
1993). The sensitivity and specificity of the H-blocking ELISA were found to be 90.4% and 
98.9% respectively (Saliki et al., 1993). PPR cELISA using MAb directed against the H-protein 
cross reacted to some extent with rinderpest, while RP cELISA is specific, therefore an animal 
was assumed to have experienced RP if it is positive in both PPR and RP ELISA (Anderson and 
McKay, 1994). The protocol of cELISA is illustrated in Fig. 1-13. The absorbance in PPR ELISA 
is converted to percentage of inhibition (PI) using the formula: 
PI=100-(absorbance of the test wells/ absorbance of the mAb control wells) x 100. Sera showing 
PI greater than 50% are scored positive. The overall specificity of c-ELISA test was 98.4% with a 
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sensitivity of 92.2% when compared with VNT. The diagnostic efficacy of the assay in terms of 
sensitivity and specificity was calculated using two-sided contingency table (Singh et al., 2004). 
Sensitivity of the assay was taken as proportion of positive samples out of actual positive 
samples. Specificity was calculated as proportion of negative samples out of total negative 
samples. The anti-H RP cELISA has been successfully used for serological monitoring of post 
vaccination herd immunity in the Pan African Rinderpest Campaign (PARC) project to control 
and eradicate rinderpest from the African continent and which later became part of the FAO 
Global Rinderpest Eradication Project (GREP). Its wide spread use in (OIE) rinderpest 
serological surveillance run into controversial difficulties as apparent missing of antibody 
detection in rinderpest lineage II.  
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Fig. 1-11 Immunocapture ELISA  (Image, Dr G. Libeau)
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Fig. 1-12 PCR reaction steps (Image, anonym, unpublished) 
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Fig. 1-13. Indirect and  Competitive ELISA for antibody detection (Dr G. Libeau) 
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1.10.Control and prophylaxis:  
There is no specific treatment against the disease. Control of PPR in non infected countries may 
be achieved using classical measures such as restriction of importation of sheep and goats from 
affected areas, quarantine, slaughter and proper disposal of carcasses and contact fomites and 
decontamination of affected premises in case of introduction. Control of PPR outbreaks can also 
rely on movement control (quarantine) combined with the use of focused ("ring") vaccination and 
prophylactic immunization in high-risk populations. Immunization of small ruminants with 
lymph node and spleen materials containing virulent virus inactivated with 1.5-5% chloroform 
was tried and the animals were immune to subsequent challenge 18 months latter (Braide, 1981). 
Until recently, the most practical vaccination against PPR was based on the use of tissue culture 
adapted rinderpest vaccine. Vaccination of animals with RP attenuated virus has been practiced 
for a long time. The tissue culture rinderpest vaccine (TCRV) at a dose of 102.5 TCID50  protected 
goats against PPR for 12 months and the animals were not able to transmit the infection 
following challenge with PPR virus (Taylor, 1979a), although the antigen was detected in 
lachrymal swabs from vaccinated animals after challenge with virulent virus (Gibbs et al., 1979). 
However, it was reported previously that considerable residues of virulence were detected after 
32, 42, even 65 serial passages in embryonic lamb kidney cells (Taylor, 1979a). This vaccine was 
successfully used to control PPR in some countries in west Africa (Bourdin, 1973) and is widely 
used in many African countries (Lefèvre and Diallo, 1990). It has been withheld from being used 
because of its interference with the Pan-African Rinderpest Campaign (PARC), since it is 
impossible to determine if seropositive small ruminants have been vaccinated or naturally 
infected with RPV. Sera from animals vaccinated with RP vaccine contain substantial level of RP 
antibodies with little or no cross neutralising antibodies to PPR but after challenge with PPR, 
neutralizing antibodies to PPR increase sharply. RP thermostable vaccine was developed for 
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protection of goats against PPR (Stem, 1993). Homologous PPR vaccine attenuated after 63 
passages in vero cell (Diallo et al., 1989b) was used and produced a solid immunity for 3 years 
(Diallo et al., 1995). The PPRV homologous vaccine was found to be safe under field conditions 
even for pregnant animals and it induced immunity in 98% of the vaccinated animals (Diallo et 
al., 1995). The PPRV vaccine has been tried for protection of cattle against RP and it was found 
very effective (Couacy-Hymann et al., 1995). PPR vaccine seed is available through the Pan 
African Veterinary Vaccine Centre (PANVAC) at Debre Zeit, Ethiopia, for Africa, or CIRAD-
EMVT at Montpellier, France, for other areas.  
1.11. Disease Economy: 
The PPR epidemics can cause mortality rates of 50–80% in naive sheep and goats populations 
(Kitching, 1988). Due to the confusion with other diseases, the economic impacts of PPR are 
probably underestimated, but it is believed that PPR is one of the major constraints of small 
ruminant farming in the tropic (Taylor, 1984). Based on assumption that goats experience an 
outbreak every 5 years, Opasina and Putt (1985) estimated an annual sum ranging from 2.47£ per 
goat at high loss and 0.36 £ per goat at lowest. The loss due to PPR in Nigeria was estimated to 
be 1.5 million dollars annually (Hamdy et al., 1976). The economic losses due to PPR alone in 
India have been estimated annually to 1,800 millions Indian Rupees (39 millions US$) 
(Bandyopadhyay, 2002). An economic analysis for assessing benefits of vaccination against PPR 
in Niger revealed that such a programme was highly beneficial with an anticipated net present 
value (NPV) return in five years of 24 millions USD following an investment of two millions 
USD.   
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Chapter 2 
Comparative biology of PPRV among other morbilliviruses 
2.1 Introduction 
Peste des petits ruminants virus (PPRV) is a very recent addition to the Morbillivirus genus in 
comparison to measles virus (MV), canine distemper virus (CDV) and rinderpest virus (RPV). 
The disease PPR was described as a clinical entity only in 1942 (Gargadennec and Lalanne, 
1942). Measles, canine distemper and rinderpest have been known to exist for several centuries 
(Appel et al., 1981). PPRV was isolated in cell culture (Gilbert and Monnier, 1962) at least 10 
years after the three other morbilliviruses were cultured in the early 1950s. For a long time after 
the description of PPR and even after the agent was isolated, it was thought to be a variant of RP 
that was adapted to goats and sheep and had lost its virulence for cattle (Laurent, 1968).  
PPR is an important disease in its own right, but it has also created problems because of its 
apparent similarity to rinderpest. The clinical signs of rinderpest in small ruminants closely 
resemble those of PPR, making differential diagnosis difficult. It should, however, be kept in 
mind that clinical disease caused by rinderpest in small ruminants is a relatively rare event, even 
in Asia. 
2.2 Pathogenicity and host range 
Since morbilliviruses do not persist in an infectious form following an acute infection, and 
infection results in life-long immunity in recovered hosts, the virus relies on a constant supply of 
new susceptible hosts for its maintenance. It has been estimated that a population of at least 
300,000 individuals is required to maintain MV in circulation (Black, 1991). Each of the 
morbilliviruses has its different natural host ranges (Appel et al., 1981). MV causes disease only 
in primates. Non-human primates are highly susceptible to MV, but their numbers are too small 
to maintain the virus in circulation and infection occurs through contact with humans. Canine 
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distemper virus is naturally pathogenic in the Canidae (dog, wolf, fox), Mustilidae (ferret, mink, 
weasel), Tayassuidae (javelins) (Appel et al., 1991) and Procyonidae (raccoon) families. The 
recent outbreaks of distemper in seals in Lake Baikal (Visser et al., 1993), in lions in the 
Serengeti National Park (Roelke-Parker et al., 1996), and in leopards and other large cats in zoos 
(Appel et al., 1994) have underscored the ability of CDV to invade new host species. Phocine 
distemper virus, the most recently described member of the Morbillivirus genus can infect many 
species of seal (Duignan et al., 1995; Osterhaus, 1992). Little is known of the host range of the 
cetacean morbillivirus, but serological evidence for its presence in many species of cetacean has 
been obtained (Duignan et al., 1995). Rinderpest virus is primarily a pathogen of cattle and water 
buffaloes but also could cause disease in goats, sheep, and rarely in pigs (Murphy et al., 1999) 
and most species belonging to other Artiodactyla. Dogs fed infected meat can develop antibodies 
to RPV, indicating a subclinical infection (Rossiter, 1994). Peste des petits ruminants virus 
occurs in goats and sheep but it has been described in captive wild small ruminants belonging to 
three families: Gazellinae (dorcas gazelle), Caprinae (Nubian ibex) and Hippotraginae (gemsbok) 
(Furley et al., 1987).  
Another difference among morbilliviruses is the ability of some members to establish persistent 
infections in their natural hosts. Acute MV infection occurs mainly in childhood and is 
characterized by fever, cough, coryza, conjunctivitis and skin rash. In about 1/ 106 cases, a fatal 
degenerative neurological condition known as subacute sclerosing panencephalitis (SSPE) may 
occur 4-10 years after the acute clinical disease of measles (Appel et al., 1981). A related 
condition designated measles inclusion body encephalitis (MIBE) has also been described 
(Norrby and Oxman, 1990). Similarly, a very rare but fatal progressive motor and mental 
deteriorating condition known as old dog encephalitis (ODE) has been described in dogs many 
years after acute CDV infection (Appel et al., 1981). No carrier state or persistent infections have 
been described for the RPV, PPR or CDV. 
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Cellular receptors and tropism: Cellular receptors are one of the major determinants of the host 
range and tissue tropism of a virus. Human signaling lymphocyte activation molecule (SLAM; 
also known as CD150), a membrane glycoprotein expressed on some lymphocytes and dendritic 
cells (Cocks et al., 1995), is a cellular receptor for MV (Tatsuo et al., 2000). The tissue 
distribution of human SLAM can explain the pathology of measles. Selective infection and 
destruction of SLAM positive cells may be the principal mechanism underlining the 
immunosuppressive effect of morbilliviruses in general (Tatsuo et al., 2000). The target cells for 
RPV are epithelial cells, activated lymphocytes, and macrophages (Rey Nores et al., 1995). Field 
isolates of CDV also replicate in dog or ferret macrophages (Brugger et al. 1992) as well as in 
primary dog brain cell cultures (Zurbriggen et al., 1987). Cell lines such as Vero (African green 
monkey kidney) which use mainly CD46 receptors do not allow the propagation of field isolates, 
whereas cell culture adapted CDV strains such as the Onderstepoort vaccine strain are able to 
replicate in many cell lines (Appel and Gillespie, 1972). It is known that virulence for the natural 
host may be lost when CDV is adapted to cell culture (Harrison et al., 1968). Furthermore, the 
marmoset B cell line B95a, which is commonly used to isolate MV from clinical specimens 
(Kobune et al., 1990) expresses a high level of SLAM on the cell surface (Tatsuo et al., 2000). 
B95a cells have been shown to be very sensitive to CDV and RPV (Kai et al., 1993, Kobune et 
al., 1991). Vero, 293T (human kidney), and L (mouse fibroblast) cells developed syncytia after 
transfection with the H and F genes of the RPV Kabete O strain. Thus, SLAMs appeared to act 
most efficiently as receptors for MV, CDV, and RPV, respectively (Castro et al., 1999). 
Morbilliviruses use SLAMs of their respective host species as cellular receptors (Tatsuo et al., 
2001). However, MV, CDV, and RPV strains could use SLAMs of non host species as receptors, 
albeit at reduced efficiencies (Tatsuo et al., 2001). Thus, the finding that these three 
morbilliviruses use SLAMs as cellular receptors suggests that the usage of SLAM as a receptor 
has been maintained from the ancestral virus, accounting for an essential part of the pathogenesis 
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of morbillivirus infections. Recently, B95a was commonly used to isolate morbilliviruses from 
clinical specimens (Kai et al., 1993). A high level of SLAM expression on B95a cells (Tatsuo et 
al., 2000) appears to be a reason for its usefulness. B95a has been shown to be very sensitive to 
both virulent field virus and vaccine strains of RPV (Lund and Barrett, 2000). Despite sequence 
differences, the structure required for the interaction with morbillivirus H proteins may be well 
conserved among SLAMs of many different species. Therefore, the use of SLAM as a cellular 
receptor may be included in their characteristic properties (Tatsuo et al., 2001). 
2.3. Serologic relationships 
A possible relationship between CDV and RPV was first suspected from the observation that 
dogs fed on rinderpest infected meat became immune to CDV (Polding and Simpson, 1957). For 
a long time after PPR was first described, and even the virus was isolated (Gilbert and Monnier, 
1962), the causal virus was believed to be a variant of RPV partly because sera against the two 
agents cross-neutralized and vaccination with RPV vaccine protected against PPR (Bourdin, 
1973). Initial studies on the relationship among the morbilliviruses were done using classical 
serological tests (agar gel precipitation, complement fixation, hemagglutination and virus 
neutralization) and cross protection studies (Orvell and Norrby, 1974).  
Cross neutralization has been adopted as a means for differentiating between PPRV and RPV 
whose host ranges overlap in small ruminants, serum raised against one virus neutralizing the 
homologous virus at a higher titre than the heterologous one (Gibbs et al., 1979). A practical 
consequence of serologic cross reactivity between morbilliviruses is that diagnostic tests based on 
polyclonal antibody with notable exception of VNT, are incapable of distinguishing between 
PPRV and RPV. 
2.4 Cross protection studies 
Several investigators have examined one sided and or reciprocal cross protection between various 
morbillivirus pairs: MV/CDV (Appel et al., 1984), MV/RPV (Provost et al., 1971), RPV/PPRV 
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(Gibbs et al., 1979), and CDV/PDV (Osterhaus et al., 1990). Although the results from various 
studies may differ because of differences in virus strains, type of vaccine, size of inoculum and 
experimental methods, it can be stated that any two morbilliviruses show some degree of cross 
protection. The tissue culture rinderpest vaccine TCRV (Plowright and Ferris, 1962) has been 
shown to provide complete protection against PPR in goats for at least one year (Taylor, 1979a). 
TCRV had been used in many countries in control of PPR (Lefèvre and Diallo, 1990). Its use, 
however, complicated global efforts to eradicate RP. 
Indeed, after RP is eradicated in cattle, small ruminants may serve as a reservoir from which RPV 
could re-emerge. Since there is presently no test for distinguishing between vaccine and wild-
type RPV, one cannot determine the origin (vaccinal or natural infection) of RPV antibodies in 
goats and sheep. A homologous attenuated PPR vaccine has been developed (Diallo et al., 
1989b), but the problem of differentiating between vaccine and wild-type PPRV may still be 
posed. This may be the stimulating force for developing marked vaccines for both rinderpest and 
PPR. 
2.5 Antigenic relationships  
Panels of monoclonal antibodies (MAbs) have been generated to study antigenic relationships 
among the morbilliviruses (Harder et al., 1991, Libeau and Lefèvre, 1990). Two studies (Norrby 
et al., 1985, Sheshberadaran et al, 1986) used anti–CDV and anti-MV MAbs to study the 
antigenic relationships among CDV, MV and RP by virus neutralization and or direct 
immunofluorescence. It could be concluded: 
• Most MAbs specific for the nucleoprotein (N) and fusion (F) proteins reacted with all 
three viruses, CDV, RPV or MV; 
• MAbs to the phosphoprotein (P) and matrix (M) proteins showed only partial cross 
reactivity with the greatest variation occurring between CDV and MV; 
• The H protein MAbs cross reacted at a low level and only between RPV and MV.  
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Based on the systematic observation of epitopes shared between RPV and either CDV or MV, 
never between MV and CDV alone, it has been proposed that RPV may be the archevirus of 
the Morbillivirus genus from which the other viruses evolved, CDV having branched off 
earlier than MV (Norrby et al., 1985). Genetic evidence tends to support this proposal. 
Further more studies with RPV MAbs though more limited in scope, also indicate that, more 
MAbs cross react between the MV/RPV pair than the CDV/RPV pair (Libeau and Lefèvre, 
1990; Sugiyama et al., 1991). The two studies that have included PPRV or anti-PPRV MAbs 
concluded that PPRV was more closely related to RPV than to MV (McCullough et al., 
1986). However, the results of Libeau and Lefèvre (1990) using anti-RPV MAbs indicate that 
PPRV may be also as distant from RPV as it is from MV. 
Monoclonal antibodies have also been instrumental in the characterization of morbilliviruses 
recently isolated from wild aquatic mammals: phocine distemper, dolphin morbillivirus 
(DMV) and porpoise morbillivirus. The available data suggest that: 
• Phocine distemper virus (PDV) isolated from seals in Lake Baikal in Siberia is 
closely related to CDV to be considered a strain of that virus (Visser et al., 1990). 
• Phocine distemper virus isolated from seals in the North Sea, while being a distinct 
morbillivirus, is more closely related antigenically to CDV (Harder et al., 1991). 
• DMV and PMV isolated respectively from dolphin and porpoises in the 
Mediterranean Sea, are similar but distinct morbilliviruses, more closely related to 
PPRV and RPV than to CDV or MV (Visser et al., 1993). 
2.6. The Comparison of proteins of Morbilliviruses  
Eight distinct proteins have been described in morbilliviruses (Tables 2-1, 2-2, 2-3). 
Properties and biological functions of these proteins include three viral structural proteins 
(N,P and L) which are internal polypeptides complexed with the viral genome to form the 
nucleocapsid, while the other three (M,F,H) form the virus envelope (Norrby and 
 43
Oxmann, 1990). Comparison using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) techniques of the structural proteins for MV (Cattaneo et 
al., 1989), CDV (Orvell, 1980), RPV and PPRV (Diallo et al., 1987) detected variability 
in electrophoretic mobility. Variability in mobility has been detected in the N (Campbell 
et al., 1980), P, M, and H proteins (Rima, 1983; Saito et al., 1992). The N, M, F and L 
proteins appeared to be the most conserved proteins (Table 2-1). The M, F and P proteins 
of the vaccine strain of PPRV are most closely related to those of DMV (Diallo et al., 
1994; Haffar et al., 1999; Meyer and Diallo, 1995).  
Nucleocapsid (N) Protein: The N protein is phosphorylated in at least some strains of 
MV (Campbell et al., 1980), CDV (Campbell et al., 1980) and RPV (Grubman et al., 
1988). It is very susceptible to non specific intracellular proteolysis resulting in the 
appearance of extra bands on SDS-PAGE gels (Rima, 1983). Its breakdown may be 
prevented by addition of protease inhibitors. Apart from its physical role of protecting the 
viral RNA genome, the N protein has been shown to play a role in the immune response 
to MV. Vaccinia virus (VV) recombinants expressing the N protein (VV-N) of MV have 
been shown to induce partial protection in mice (Wild et al., 1992) and full protection in 
rats (Brinckmann et al., 1991) against MV challenge. Since N protein immunized 
individuals do not produce any neutralizing antibody, the mechanism of protection is 
most likely a cell mediated response. CD4+ T-cell response has recently been obtained 
using lymphocytes from MV N proteins immunized mice (Giraudon et al., 1991). The N 
protein of MV may play a critical role in viral assembly since it has been shown that 
vaccinia virus (VV) expressing the N gene of MV could assemble into nucleocapsid like 
structures (Spehner et al., 1991).  
Mobility differences have been detected in the N and M proteins of RPV (Anderson et 
al., 1990; Diallo et al., 1987) and the N protein of PPRV (Taylor et al., 1990). In RPV 
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the N protein from strains of low virulence migrate faster than the N protein from more 
virulent strains (Diallo et al., 1987). This difference, however, is not useable as a 
virulence marker since the highly attenuated RBOK vaccine strain has an N protein of 
intermediate mobility similar to its virulent ancestor, the RBOK wild-type. In PPRV, all 
isolates from the African continent have N protein that migrates at a slightly faster rate 
than the N proteins of isolates from the Arabian Peninsula (Taylor et al., 1990). This 
difference has been proposed as a biochemical marker for differentiation of the two 
groups of PPRV isolates (Lefèvre and Diallo, 1990). 
Phosphoprotein: The polymerase associated (P) protein is a minor component of virions. 
It is phosphorylated (hence the acronym phosphoprotein) in at least some strains of all 
morbilliviruses (Diallo et al., 1987). Phosphorylation may be partly responsible for 
observed variations in the electrophoretic mobility of the P proteins of various CDV and 
MV strains (Orvell, 1980). Because of its association with the nucleocapsid, the P protein 
is thought to be required for formation of an active transcription complex (Norrby and 
Oxman, 1990). A similar role has been shown for the P protein of Newcastle disease 
virus, another Paramyxoviridae (Hamaguchi et al., 1983). The P protein of MV may also 
play a role in the immune response, since VV expressed protein partially protected rats 
against MV challenge (Brinckmann et al., 1991). Finally, the P protein of MV is required 
for retention of N protein in the cytoplasm, where the latter is needed for encapsidation of 
replicating genome (Huber et al., 1991). 
Non structural proteins: The C protein or its putative mRNA has been identified in cells 
infected by MV (Bellini et al., 1985), CDV (Hall et al., 1980), RPV (Grubman et al., 
1988) and PDV (Blixenkrone-Moller et al., 1992; Curran and Rima, 1992). It is 
transcribed independently of the full length P from a second reading frame on the 
functionally bicistronic P gene. The V protein or its putative mRNA have so far been 
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described in cells infected by MV (Cattaneo et al., 1989; Wardrop and Briedis, 1991) and 
PDV (Curran and Rima, 1992). The roles of C and V proteins remain unknown (C 
increased mRNA transcription in vitro and is an interferon antagonist; V has a putative 
regulatory role on transcription and replication and is also an inhibitor of interferon 
response).  
The Matrix (M) protein is the smallest in size but it is one of the most abundant of the six 
structural proteins (Rima, 1983). The M protein may play a role in the immune response 
as indicated by partial protection of rats against MV using a VV expressed protein 
(Brinckmann et al., 1991). In recent years, research on the M proteins of MV has 
intensified following the findings that SSPE viruses had a non-expressed M proteins 
(Hall and Choppin, 1981) and that sera from SSPE patients had high levels of antibodies 
against all MV structural proteins except M protein (Hall and Choppin, 1981). 
Subsequently, it was shown that differences between wild-type MV and SSPE viruses 
involved abnormalities in the expression, structure or stability of not only the M protein 
(Cattaneo et al., 1988) but also the F and H proteins (Baczko et al., 1986). Such changes 
are thought to be responsible for the lack of budding viral particles, infectious virus or 
cell fusion in the presence of detectable nucleocapsids in SSPE infected brain tissue (Ter 
Meulen and Carter, 1984). Abnormalities in protein structure and function particularly 
the M protein, may thus be responsible for establishment or maintenance of MV 
persistence. Indeed it has recently been shown that normal MV M protein is associated 
with intracellular viral nucleocapsids whereas M protein from an SSPE strain of the same 
lineage is localized mainly in the cytosol of infected cells (Hirano et al., 1992).  
The fusion (F) protein mediates fusion between the virus envelope and cell membrane or 
between the infected cell and adjacent cells, thereby playing a major role in viral 
penetration and spread within the host (Norrby and Oxman, 1990). The comparison of 
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the nucleic acid sequences of different morbillivirus fusion (F) protein genes revealed 
that the 5'-end sequence of the mRNA is specific to each virus. The F protein plays an 
important role in the immune response. Purified VV- expressed or ISCOM (immune 
stimulating complexes) incorporated F proteins have been successfully used to protect 
rabbits and cattle against RPV (Barrett et al., 1989). Dogs against CDV (De vries et al., 
1988) and rats and mice against MV (Wild et al., 1992). Although animals immunized 
with F protein may generate neutralizing antibodies which are protective, other 
mechanisms such as inhibition of cell fusion may be important in protection, since non-
neutralizing MAbs induced protection of mice against lethal CDV challenge (Hirayama 
et al., 1991). Recent sequencing data on SSPE viruses indicate that alterations in the F 
protein cytoplasmic domain may also play a role in establishment of MV persistence 
(Schmid et al., 1992). 
The hemagglutinin (H) protein is responsible for the virus-cell membrane interaction for 
binding the cellular  receptors. Among morbilliviruses, only MV has an H protein with 
hemagglutinating properties, although sera against CDV and RPV inhibit 
hemagglutination by MV (Orvell and Norrby, 1974). The H protein may also play a role 
in cell to cell fusion as indicated by the capacity of anti-H MAbs to inhibit cell to cell 
fusion in vitro (Wild et al., 1991). The role of the H protein in protection has been 
extensively investigated. Vaccinia virus-expressed or ISCOM incorporated H proteins 
induce complete protection against RPV in cattle (Giavedoni et al., 1991) and CDV in 
mice (Hirayama et al., 1991). Virus neutralization is an important protection mechanism, 
since passively administered anti-H neutralizing MAbs induce full protection in mice 
(Varsanyi et al., 1987). Inhibition of cell to cell fusion may also be a protection 
mechanism. Furthermore, MAbs against the H proteins of MV have been shown to 
decrease the expression of the P, F, and M proteins a phenomenon called (antibody-
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induced antigenic modulation) which may also play a role in protection (Fujinami et al., 
1984).  
The polymerase (L) protein is the largest polypeptide of morbilliviruses (Rima,1983). 
The L protein is a very minor viral component, its gene being the last to be transcribed. 
In association with the N and P proteins, it forms the nucleocapsid. The L protein is also 
necessary to the transcription or ribonucleoprotein complex (Hamaguchi et al., 1983). 
Because of its large size the L protein is believed to exhibit the major RNA dependent 
RNA polymerase activities (nucleotide polymerization, capping and polyadenylation) of 
viral mRNA (Kingsbury, 1990). 
2.7 Genetic relationships 
2.7.1. Nucleotide and amino acid sequence homologies 
Full length genome sequences are available for MV (Cattaneo et al., 1989), RPV (Baron 
and Barrett, 1995), CDV (Barrett et al., 1987), PPRV (Bailey et al., 2005) and the 
dolphin morbillivirus (DMV) (Rima et al., 2003). The MV-RPV and CDV-PDV pairs 
exhibit the closest relationship. The nucleotides or amino acid sequence may be a good 
indicator of the degree of relatedness. A graphical representation of the similarity 
between PPRV and other members of the Morbillivirus genus showed regions of high 
and low nucleotide conservation. Regions of high conservation include the L and M 
genes. Non-coding regions show very little similarity (Bailey et al., 2005). The PPRV 
genome encoded the same eight proteins as the type virus (MV), also its length was 
divisible by six, a feature shared with other Paramyxoviridae (Calain and Roux, 1993). 
The genome was most similar at the nucleotide (nt) level to that of RPV. The full length 
genome sequence shows that the N, V and H proteins of PPRV had close similarity with 
DMV, indicating a close antigenic relationship between the two viruses (Bailey et al., 
2005).  
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Table 2-1 Comparative electrophoretic mobilities of Morbillivirus proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular weights are expressed in kilodaltons (Kd). (Diallo et 1987) 
 
Table 2-2 Homology at amino acid sequence level in percentage 
Virus pair N P M F H 
MV-CDV 67 45 76 66 37 
MV-RPV 74 - 78 77 60 
MV-PDV 69 45 77 57 38 
CDV-RPV - - 77 66 38 
CDV-PDV 76 76 90 83 74 
RPV-PDV - - 73 56 37 
 
Table 2-3 Protein homology of morbilliviruses 
Protein compared CDV MV RPV PPRV 
N 77 64 66 69 
P 75 43 47 na 
M 91 78 76 77 
F 83 57 56 68 
H 75 33 32 36 
L 90 72 73 na 
Barrett, 1999        *na = data not available  
 
 
 
Estimated molecular weight 
Postanslational 
modification 
 CDV MV RP PPRV  
Polymerase (L) 180-200 180-200 200-212 200 Glycosylated 
Hemagglutinin (H) 76-85 79-80 74-81 78 Phosphorylated 
Phosphoprotein (P) 66-73 70-72 71-92 82-86 Phosphorylated 
Nucleocapsid (N) 58-60 59-60 65-68 60-62 Glycosylated 
Fusion (F0) 59-62 59-62 62 -  
F1  subunit 40-41 40-41 49.5 -  
F2  subunit 16-23 16-23 - - Glycosylated 
Matrix (M) 34-35 34-35 38 39  
Non structural (C) 15 18-20 19 19.5  
Non structural (V) - 40 - -  
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2.8. Phylogenetic relationships 
On the basis of phylogenetic analysis of morbilliviruses, it is thought that when cattle 
were domesticated, they passed a morbillivirus, a progenitor of modern RPV, to humans, 
which eventually evolved into MV. Similarly, carnivores could have contracted a 
morbillivirus infection from their ruminant prey, which then evolved into CDV (Barrett 
and Rossiter, 1999). MV and RPV are closely related, and CDV and phocine distemper 
virus are the most distantly related to MV and RPV among morbilliviruses (Barret and 
Rossiter, 1999). Furthermore, among all viral proteins, the H protein is the least 
conserved among CDV, RPV, and MV (37% identity between CDV and MV) 
(Blixenkrone-Moller, 1993). PDV antibodies, were found in sera obtained from Arctic 
seals (Barrett, 1999). Arctic seals may have been infected with CDV by contact with 
terrestrial carnivores that can carry the virus (wolves, foxes, dogs, polar bears) and have 
evolved into the phocid virus (Barrett, 1999). 
2.9. Conclusions 
PPRV exhibits the typical characteristics of the Morbillivirus genus in the 
Paramyxoviridae family. PPRV is not only a distinct virus but may be less closely related 
to RPV than MV to RPV. Data from the three members of the Morbillivirus genus (MV, 
CDV, and RPV) indicate that strains of varying pathogenicity may occur naturally. In 
RPV for example strains of low virulence have been identified (e.g. RBT/1 and 
Reedbuck). Such strains distinguish themselves from virulent strains by having a faster 
migrating N protein (Diallo et al., 1987) or by their MAb reactivity spectrum (Libeau and 
Lefèvre, 1990). The available PPR isolates have been the subject of only a few studies 
and there is no indication that they differ in pathogenicity. Variations in clinical disease 
of PPR in Africa may have resulted from breed resistance or a default in appropriate 
cellular receptors rather than of variations in virulence of the PPRV. Therefore, the 
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epidemiology, pathogenicity and host resistance of PPR is more complex than thought 
earlier. It is hoped that marked RP and PPR vaccines and diagnostic tests capable of 
differentiating infected and vaccinated animals will improve the diagnostic and 
epidemiosurveillance capability. Control of PPR using tissue culture PPR homologous 
vaccine is currently underway in endemic countries. However, the predominant 
husbandry system in Africa where most households keep a few free ranging goats or 
sheep, means that vaccination coverage of the population will be difficult to attain in 
small ruminants. 
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Scope of the thesis 
The ability of PPRV to infect and produce disease (pathogenicity) in a range of animals 
appears to be variable based on breed and species of animals, endemic situation and eco-
climatic (environmental) or field conditions. The hypothesis was that infection with 
PPRV does not always result in clinical disease. Field serosurveillance was conducted to 
determine the probability of infection in several species of animals in Ethiopia. From the 
observation that the virus could circulate without inducing clinical signs in some 
susceptible species, it was decided to carry out in vitro studies on the virulence of PPRV. 
Virulence of PPRV was first monitored by measuring the severity of infectivity in 
different cell culture systems. Three cell lines, which are frequently used for morbillivirus 
replication in vitro, were infected with a defined MOI of virus and monitored for a period 
of time sequence. Infectivity of PPRV was compared with RPV using virus specific 
monoclonal antibodies.  
The infectivity of the virus varied and indicated differences in cell permissivenes and 
cellular tropism. Cellular receptors are one of the major determinants of the host range 
and tissue tropism of a virus. However, virus and cellular interaction is a complex process 
involving attachment and fusion genes, cellular environment and immune status of 
animals. This approach was completed by a molecular analysis of the H protein, the virus 
ligand of the cell receptor and of the virus promoters, comparing strains of different 
virulence. The objective was to identify molecular determinants for virulence. 
OBJECTIVES  
The objectives of the study were to: 
1. Undertake studies on epidemiology of PPR in Ethiopia: In Africa, goats are severely 
affected while sheep undergo a mild form or rarely suffer clinical disease. PPR is one of 
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the most important economical diseases in Ethiopia. Clinical PPR is confirmed in 
Ethiopian goats, however, its circulation in other animals has never been described. The 
apparent absence of pathogenicity in these animals may have been due to host resistance 
or loss of virulence of the virus strain. The objective of the present work is to detect the 
antibody seroprevalence in camel, cattle, goat and sheep, which may confirm natural 
transmission in these animals without clinical disease.  
2. Monitor PPR virulence in cell culture and analyse the H protein: PPRV exhibited different 
levels of virulence between sheep and goats. Goats were severely affected while sheep 
generally underwent a mild form. However, the virus circulation in both species was the 
same level, suggesting a difference in host susceptibility. In addition, other species, the 
camel, was infected by the virus but without showing clear disease. This difference may 
result from a difference in cell susceptibility to the virus. The cell susceptibility can be 
affected by the rate of infection, the affinity of the virus for its cell membrane receptor, 
the attachement (H) protein, the efficiency of intercellular spreading of the virus and 
capacity to induce damages in infected cells. However, the factors which determine the 
virulence remain largely unknown and have not been related to a single event. Low 
virulence outcome may result from a lesser infection of the cells or a lower replication of 
the virus in the cells, both resulting in a lower viral antigen distribution through different 
organs and tissues. Such characteristics may account for the milder clinical disease and 
lower mortality. The capability of cells to be infected and support active virus replication 
has important implications on the pathogenesis of the disease. The second objective was 
designed to monitor sensitivity of different cell lines to PPRV.  
3. Sequence analysis of genome and antigenome promoters of wild-type and vaccine strains 
of PPRV: molecular basis for attenuation of the virus vaccine strain was sought with 
comparative sequence analysis of the genome and antigenome promoters (GP and AGP). 
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As demonstrated by Banyard et al. (2005) in the case of RPV, the virus genome 
promoters play a role in the pathogenicity of morbilliviruses. Thus, GP and AGP of the 
peste des petits ruminants (PPR) virus, amplified from different pathological samples of 
sheep and goat origins, were sequenced and compared with corresponding sequences of 
PPR vaccine strain and other morbilliviruses. 
 54
Chapter 3 
PPR occurrence in Ethiopia 
3.1. Introduction  
Ethiopia, is 471,776 sq miles (1,221,900 sq km) which is located in the Horn of  Africa (Fig. 3-
1). It borders with Eritrea in the north,  Djibouti in the northeast, Somalia in the east and 
southeast, Kenya in the south, and the Sudan in the west. The capital city is Addis Ababa, which 
is located in the center of the country.   
3.1.1 Population 
The population of Ethiopia in 2004 is estimated at 71.066 million comprising 59.867 million 
rural (84 percent) and 11.199 million urban (16 percent), respectively. The male female ratio is 
approximately 50%. The overall annual population growth rate is estimated at 2.8 percent.  
3.1.2.  The Agricultural Sector 
Ethiopia is comprised of several major ecological zones leading to extreme variations in agro-
climatic conditions and diverse genetic resource bases. Agriculture is the cornerstone of the 
economy, where small-holder farmers are responsible for 96% of the cropped area. The crops 
grown varied according with soil types ranging from vertisol to sand, and cropping altitudes 
ranging from less than 600 m to more than 3,000 m above sea level. The main cereal staples are 
wheat, barley, teff (Eragrostis abyssinica), finger millet, maize and sorghum. Cash crops include 
coffee, oilseeds and spices. 
Rainfall has two distinct seasons: the belg, a minor season that usually begins in January – 
February and ends in April–May and the meher or kiremt, the main rainy season, which starts in 
June–July and ends in September–October.  
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3.1. 3. The Livestock Sub-Sector 
Livestock production is an integral part of the country's agricultural system and is determined by 
ecology, climate, and it’s economic importance for the farmer. Common grasslands provide 
extensive pasture and browse in Afar, Somali, the southern zones of Bale, Borena and South 
Omo, and in the western lowlands that reach from Gambella to Tigray.  
Livestock are significant components of small scale and pastoralist farming systems and are 
reserves for family emergency needs. Manure is the cheapest and easily available fertilizer to 
increase soil fertility. Draft oxen are used for ploughing the land for crop production. Sheep and 
goats supply more than 30% of the domestic meat consumption. Animals and their products 
including hides and skins are major export commodity, which is estimated to be 50 million USD 
per annum. Pastoralists and semi-pastoralists sustain their culture, life style and pride on their 
livestock.  
The livestock population is estimated at 35 million tropical livestock units (TLU) which includes 
30 million cattle, 21 million sheep, 24 million goats, 7 million equids, one million camels and 
over 53 million chicken. The main cattle breeds include the Arsi (highland zebu), Boran, Fogera, 
Horo, Sheko (Gimira), Abigar (Nuer), and the Adal. The Fogera and Horo, well known for their 
milk, are reared around lake Tana and Eastern Welega regions, respectively. The Boran, a beef 
breed, is found in the southern and eastern parts of the country, while the Gimira and Abigar 
breeds in the south-west are considered to have tolerance to high tse-tse challenge. European 
breeds, especially Friesian and Jersey, have been imported and used for cross breeding with the 
indigenous animals. 
Sheep and goat breeds include the Horro, Menz, Adal (Afar) Arsi and Black-Head Ogaden 
Sheep, and the Adal (Afar) goat. Few exotic breeds of sheep and goats have been introduced for 
cross breeding. Awassi and Corriedale sheep have been used in the highlands while the Anglo-
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Nubians are kept for milk and meat production in the lower altitude of the mixed farming 
systems.  
3.1. 4. Animal Health 
  Animal diseases have a significant impact on household food security. Some of these diseases 
wipe out the entire herds and threaten the livelihoods of the farmers. They contribute to a general 
decline in the productivity and have been determinant factors for poverty in rural communities. 
Animal diseases affect productivity by 50 to 60% a year by reducing production potentials of the 
indigenous stock and restricting the introduction of more productive exotic breeds.  
The major causes of economic loss and poor productivity in livestock is the prevalences of a wide 
ranges of diseases (CBPP, FMD, CCPP, PPR, AHS and HS among others) and parasites 
(Trypanosomiasis, Anaplasmosis, other external and internal parasites). The direct losses due to 
mortality is estimated 8-10% of cattle, 14-16% of sheep flock and 11-13% of goat per annum. 
Indirect economic losses occur through slow growth, low fertility and decreased work output. 
Three major impacts of diseases were: socio-economic 85% (primarily production losses and 
control costs incurred by the poor), zoonotic (for those diseases transmissible from animals to 
humans) and national average of 15% a combination of marketing impacts on the poor with 
public-sector expenditures on disease control. Therefore, impact of animal diseases on the 
economy is that, they impede investment in the sector, and are sanitary barriers of export 
markets. Therefore, improving health and productivity would provide an important opportunity 
for increasing food security and could be a promising and cost effective way of stimulating the 
national economy. 
While recognising the extent of the animal health challenges, it is important to note the success of 
recent efforts to eradicate rinderpest. Ethiopia has formally declared itself provisionally free of 
rinderpest to the Office International des Epizooties.  
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3.2. PPR in Ethiopia 
PPR was suspected on clinical grounds to be present in goat herds in Afar region of Eastern 
Ethiopia in 1977 (Pegram et al., 1981). Moreover, serological and clinical evidences were 
reported by Taylor (1984). However, the presence of the virus was only confirmed in 1991 with 
cDNA probe in lymph nodes and spleen specimens collected from an outbreak in a holding land 
near Addis Ababa. PPR was characterized by ocular and nasal discharges, mouth lesions, 
pneumonia, gastro enteritis and diarrhoea (Figs. 1-8, 1-9). The disease in this outbreak caused 
more than 60% mortality (Fig. 3-2). ). The disease probably was introduced into Ethiopia in 1989 
in the Southern Omo river valley from where it moved eastward to Borena region and then 
northwards along the Rift valley to Awash (Gopilo et al., 1991, Roeder et al., 1994). The disease 
became endemic in goats (Abraham and Berhan, 2001).  
Small ruminants in this country mainly thrive on free-range pasture land, shrubs and forest 
cover. Due to the shrinkage in pasture land and forest area, these animals move to long distance 
in search of fodder and water during dry season. This phenomenon is common due to different 
summer and winter grazing grounds depending upon the altitude. PPR is transmitted through 
direct contact between infected animal and susceptible population. During nomadism, animals 
come in contact with local sheep and goat population from where they pick up the infection or 
spread disease if nomadic flock is pre-exposed. Therefore, migratory flocks play an important 
role in transmission epidemiology of PPR. Movement of animals and introduction of newly 
purchased animals from the market also play an important role in transmission and maintenance 
of the virus. This could be one of the possible reasons for higher frequency of PPR outbreaks 
between March to June (Fig. 3-3), which also correspond to lean period of kidding. Although 
seasonal occurrence of PPR virus outbreaks is disputed, disease transmission is certainly 
affected by animal movement for which socioeconomic factors and variations in agro climatic 
conditions are responsible. Large group of animals move to large areas and even between 
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different districts. With the start of rains, the movement of animals is restricted due to the easy 
availability of local fodder. Nutritional status of the animals also gets improved during the rains. 
This may reduce disease transmission after the start of rains and during the period of easy 
availability of fodder. Similar observations were also recorded in tropical humid zone of 
Southern Nigeria during a period of 5 years of observations (Taylor, 1984).  
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Fig 3-1 Map of  Ethiopia 
 
Fig. 3-2 PPR point epidemic in goats in one gathering site for marketing. (Roeder et al., 1994) 
 
 
Fig. 3-3 PPR has seasonal disease pattern in endemic areas. (Animal health reports, 2001) 
Months of the year 
No. outbreaks 
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In Ethiopia, PPR in goats was described and confirmed by the laboratory. However, there was 
always a question if other species of animals (camel, cattle and sheep) could be infected in the 
absence of detectable clinical signs. Our first work was to address this question. The following 
published article describes the antibody seroprevalence which was carried out in these animals. 
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From this study, we confirmed that PPRV exhibited different levels of virulence between sheep 
and goats. Goats were severely affected while sheep generally underwent a mild form. However, 
the virus circulation in both species was the same level, suggesting a difference in host 
susceptibility. In addition, another species, the camel, was infected by the virus but without 
showing clear disease. This difference may result from a difference in cell susceptibility to the 
virus. The cell susceptibility can be affected by the rate of infection, the affinity of the virus for 
its cell membrane receptor, the efficiency of intercellular spreading of the virus and capacity to 
induce damages in infected cells. However, the factors which determine the virulence remain 
largely unknown and have not been related to a single event. Low virulence outcome may result 
from a lesser infection of the cells or a lower replication of the virus in the cells, both resulting in 
a lower viral antigen distribution through different organs and tissues. Such characteristics may 
account for the milder clinical disease and lower mortality. The capability of cells to be infected 
and support active virus replication has important implications on the pathogenesis of the disease. 
Rinderpest virus is primarily a pathogen of cattle and water buffaloes but also could cause disease 
in goats, sheep, and rarely in pigs (Murphy et al., 1999) and most species belonging to other 
Artiodactyla. Dogs fed infected meat can develop antibodies to RPV, indicating a subclinical 
infection (Rossiter, 1994). Morbilliviruses use SLAMs of their respective host species as cellular 
receptors (Tatsuo et al., 2001). However, MV, CDV, and RPV strains could use SLAMs of 
nonhost species as receptors, albeit at reduced efficiencies (Tatsuo et al., 2001). Thus, the finding 
that these three morbilliviruses use SLAMs as cellular receptors suggests that the usage of SLAM 
as a receptor has been maintained from the ancestral virus, accounting for an essential part of the 
pathogenesis of morbillivirus infections. Genetically, it was assumed that when cattle were 
domesticated, they passed a morbillivirus, a progenitor of modern RPV, to humans, which 
eventually evolved into MV. Similarly, carnivores could have contracted a morbillivirus infection 
from their ruminant prey, which then evolved into CDV (Barrett and Rossiter, 1999). PPRV has 
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also probably arisen from a RPV ancestor through adaptation to small ruminants. Interestingly, 
adaptation of RPV to another species seems to have resulted in a reduction of the host range 
(basically primates for MV, carnivores for CDV and small ruminants for PPRV). In this context, 
we were interested to check if PPRV may have different cell affinity than the one already 
described for other morbilliviruses. The second article was about comparing PPRV and 
rinderpest (RPV) vis-à-vis three different cell lines.  
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Chapter 4 
 
Article 2.  Submitted to Virus Research 
Differences in sensitivity of B95a, MOCL-5, 293T and Vero cells to peste des petits 
ruminants virus (PPRV)  
G. Abraham, G. Libeau, C. Minet, C. Grillet, Catherine Cetre-Sossah, and E. Albina* 
CIRAD- EMVT, TA30/G, Campus International de Baillarguet, 34398 Montpellier, Cedex 5, 
France. 
Abstract 
A panel of cells infected with  peste des petits ruminants virus (PPRV) and rinderpest virus 
(RPV) and harvested at different times post infection, were stained with virus specific 
monoclonal antibodies and with specific mouse antisera (IgG) conjugated with fluorescein 
isothiocyanate. After fixation they were analysed using  flow cytometry and the results were later 
compared with the cell culture titration. Vero and 293T cell lines supported virus replication of 
PPRV and RPV. However, antigen was not detected in B95a cells infected with PPRV. Further 
efforts to adapt PPRV in B95a cells by six blind passages failed to result in productive infection. 
Differences in sensitivity of B95a cells between PPRV and RPV may reflect differences in the 
interaction of viral protein with the SLAM (CD150) receptor. Comparative amino-acid sequence 
analysis of the H proteins of PPRV, RPV, measles virus (MV) and canine distemper virus (CDV) 
showed conserved critical residues for the interaction with the SLAM. Three point mutations 
were detected specific for PPRV and hypothetical 3D structural model of globular head of H 
protein confirmed these modifications at positions 508, 525 and 526. Whether these 
modifications may account for a defective interaction of the PPRV with B95a cells will need 
further analysis.  
Key words: B95a, H protein, peste des petits ruminants, rinderpest, SLAM, receptor 
* Corresponding author: Dr Emmanuel Albina Tel:(33)467593705 or (33)467593724  
Fax : (33) 4 67 59 37 98. Email : emmanuel.albina@cirad.fr 
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1. Introduction 
Peste des petits ruminants (PPR) is an acute and highly contagious viral disease of domestic and 
wild small ruminants, which is characterised by high fever, ocular and nasal discharge, 
pneumonia, necrosis and ulceration of the mucuous membrane and inflammation of the gastro-
intestinal tract leading to severe diarrhoea and death (Gibbs et al., 1979). PPRV exhibits different 
levels of virulence between sheep and goats (Lefèvre and Diallo, 1990, Roeder et al., 1994 ). 
However, the factors which determine the virulence remain unknown and have not been related 
to a single event (Brown and Torres, 1994; Rey Nores and McCullough, 1996). Low virulence 
outcome may result from a lower replication of the virus, resulting in a lower viral antigen 
distribution through different organs and tissues. Such characteristics may account for the milder 
clinical disease and lower mortality (Wohlsein et al., 1995). The capability of cells to be infected 
and support active virus replication has important implications on the pathogenesis and 
epidemiology of the disease.   
PPR and RP viruses are classified in the genus Morbillivirus of the family Paramyxoviridae. 
They are genetically and antigenically very closely related to other viruses in the genus. 
Morbilliviruses are enveloped viruses with non segmented negative-strand RNA genomes. They 
have two envelope glycoproteins, the hemagglutinin (H) and fusion (F) proteins, mediating 
receptor binding and membrane fusion, respectively. The H (attachment) glycoproteins of 
Morbilliviruses are more divergent (Blixenkrone-Müller et al., 1996) and may play a role in host 
cell specificity. Cellular receptors are one of the major determinants of the host range and tissue 
tropism of a virus (Baron et al., 1996). B95a lymphoblastoid cells are a good host for rinderpest 
virus, but they did not support replication of PPRV unless the virus was adapted through five or 
six blind passages (Das et al., 2000). This appeared to be in contradiction with results obtained 
with other morbilliviruses in the same cells. RPV (Kobune et al., 1991), MV (Kobune et al., 
1990) and canine distemper virus (Seki et al., 2003) replicated and were isolated successfully in 
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this cell line. SLAM receptors have been used by CDV, MV and RPV and H gene sequences 
interacted with this receptor in B95a cell infections.  
The present work was designed to monitor sensitivity of different cell lines with PPRV and RPV 
was used as positive control of the assay.   
2. Materials and methods 
2.1. Cells and  virus: Vero (African green monkey), 293T (transformed human embryo kidney) 
and B95a (marmoset B cell lines) from American Type Culture Collection and MOCL-5 (sheep 
monocyte derived cell line) (Olivier et al., 2001), were grown in Eagles minimum essential 
medium (Gibco, UK), Dulbecco’s modified medium with L glutamine (Gibco, UK) and RPMI 
1640 (Gibco, UK), respectively and supplemented with 10% fetal bovine serum and 1% 
Glutamine. All cultures were maintained in 5% CO2 incubator at  37°C. 
2.2. In vitro infection: The above cultured cells were infected with vaccine strain of PPR virus 
(Diallo et al., 1989b) and  Rinderpest virus vaccine strain (Pirbright, UK). For negative controls, 
an inoculum of uninfected cell lysate prepared in the same manner that for the virus was used. 
After an adsorption period of 30 minutes at 37°C, the cell cultures were incubated and harvested 
at different times post infection (0 – 144 hours). 
2.3. Monoclonal antibody (MAb): PPRV anti-N monoclonal antibody (Libeau et al., 1992) and 
the PPRV anti-H, RPV (anti-H and N)  monoclonal antibodies (Pirbright, UK) were used for 
immuno labelling. The fluorescein conjugated isotype was anti mouse IgG (H+L) (Sigma, USA). 
2.4. Flow cytometry: Non-adherent cells were removed by shaking of culture flasks followed by 
pipetting to dislodge loosely adherent cells. Adherent cells were removed from the tissue culture 
flasks by incubation with EDTA/trypsin for 5 minutes at 37°C. After being harvested, cells were 
washed with washing buffer (0.1% PBS-azide, 5% horse serum and 0.1% saponin (w/v) 
solution). Immunolabelling was achieved in a two step procedure: (I) incubation with 
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predetermined optimal concentrations of anti-N or anti-H monoclonals  at 4°C for 30 minutes and 
(II) staining with isotype specific mouse antisera (IgG) conjugated with fluorescein 
isothiocyanate. Each step was followed by two washings with washing buffer, after which  the 
cells were  fixed with 1% PFA. 
Fluorescence staining was determined by flow cytometry using a FACScan flow cytometer 
(Becton Dickinson, USA) and the Lysis II software program (CellQuest, UK). Forward scatter 
and side-scatter profiles were used to place gates on live cells and excluding cell debris. At least 
5,000 live cells were acquired. 
2.5. Virus infectivity assay: Cell and supernatant fractions from PPR infected and non-infected 
cultures were harvested at different times post infection (0 – 144 hours) and stored at –70°C until 
titration. The virus titre was determined by titration of serial 10 fold  dilutions on semi-confluent 
monolayers of cells in tissue culture micro-plates. The virus titre was calculated by the method of 
Reed and Muench (1938). 
2.6.  Adaptation of  PPRV to B95a cells :  Two strains, the Vero-adapted Nigeria 75/1 vaccine 
strain and the wild type virulent Nigeria 75/1 strain, were serially passaged to six times. The 
cytopathic effect was regularly checked over the period of 7-10 days for each passage. 
2.7. Comparative analysis of H gene amino-acid sequences: The amino-acid sequences of the 
hemagglutinin protein of PPRV and other vaccine cell-adapted and wild type strains of 
Morbillivirus were aligned using CLUSTAL W included in the Vector NTI-9 package (Informax 
Inc., USA). Critical residues for H-MV/SLAM (CD150) interaction, identified so far, were 
placed on the multiple alignments. Specific amino-acid mutations on the H-PPRV in highly 
conserved positions for other morbillivirus were also identified.  
2.8. Modelling : The sequence of the H globular head of the vaccine strain PPRV (Nig75/1, was 
compared other morbilliviruses : Accession numbers used are PPRV (vac: X74443, wt: 
AJ512718 and NC_006383), RPV (vac: Z30697, wt: X98291), MV (vac: AF266286 and 
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AF266289, wt: AF266288 and AB012948), CDV (vac: AF305419 and AF378705, wt: 
AF164967 and AY466011). 
 The sequences were then introduced in a 3D model building and visualization using SwissModel 
(Peitsch, 2005, Guex et Peitsch, 1997, Schwede et al, 2003) and DeepView version 3.7 (Swiss-
PdbViewer) and the H-MV model from Massé et al (2004) as molecule template. 
3. Results 
At times indicated, cells were harvested and stained with anti-N and anti-H monoclonal 
antibodies specific for PPRV or RPV. After staining and acquisition, data were plotted on gated 
live cells using a 3D histogram (fluorescence intensity (x-axis), number of cells (y-axis) and 
incubation time (z-axis). The maximum antigen expression was measured at 120 hours post 
infection (Fig. 1 and 2). The flow cytometry detected viral N antigen in 293T cells earlier, while 
in Vero cells the N antigen was detected only after 72 hours post infection. Peak fluorescence on 
both cell populations was achieved between 120 and 144 hours (Fig. 3). The B95a, 293T and 
Vero cell lines supported rinderpest virus replication and expression. However, B95a cells did 
not support replication of PPR virus and so PPR virus antigen was not detected in these cells. 
Further efforts to adapt PPRV in B95a cells by six blind passages failed to result in productive 
infection. Antigen was not detected in the sheep MOCL 5 cells infected with both PPRV and 
RPV (data not shown).  
In cell culture titration assay CPE was detected in 293T earlier than in Vero cells. Peak titres 
were detected at 120 hours post infection (Fig. 4). The titres varied with cell type, but clearly 
both cells were able to support the growth of PPRV and RPV. Results of cell culture titration and 
flow cytometry analysis were comparable and fairly confirmed the sensitivity of the test.  
H gene sequences of PPRV, RPV, CDV and MV retrieved from gene bank database were aligned 
and sequences were compared.  
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Amino-acid sequence multiple alignment of the H-protein of different morbilliviruses is shown 
on Fig. 5. Highly conserved positions are indicated in red letters and critical residues for SLAM 
(CD150) interaction are in black boxes, within the 501-555 positions. From this alignment, we 
were interested to identify unique and conserved mutations in H-PPRV compared to the other 
morbillivirus. Twenty seven positions were thus detected (amino-acids in blue). Interestingly, one 
mutation V525 Æ I525 is on a position identified in H-MV as critical for interaction with the 
SLAM of B95a cells (Massé et al, 2004). However, the non polar, hydrophobic aliphatic valine 
was mutated for an amino-acid sharing the same properties, thus, suggesting a moderate impact 
on the protein functions. Two other mutations were located in the region of the H protein that is 
critical for SLAM interaction: V508 Æ I508 and F555 Æ V555. Furthermore, we submitted to 
SwissModel, the amino-acid sequence of the globular head of the H protein of our vaccine strain 
Nig75/1. Surface modelling was established using as template, the hypothetical 3D structural 
model of H-MV. The results are shown in Fig. 6. Overall, the critical sight for SLAM interaction 
is conserved with a part located on the top of the globular head and the second part on one lateral 
side. However, two differences could be identified between the H-MV and H-PPRV molecules. 
First, on top side, the surface of critical residues was slightly modified, may be as a consequence 
of the mutation V508 Æ I508. In addition, the critical residue L526 on H-MV was buried in our 
H-PPRV model and replaced by amino-acids Y540 and I542. 
4. Discussion 
The objective of the current investigation was to determine if there had been any difference in 
replication and subsequent antigen detection between PPR and rinderpest viruses with cell type. 
Comparison of the infections showed that the kinetics of replication were variable. Thus the 
antigen titre at the earlier time points post infection was lower in Vero compared to 293T cells. 
These results would suggest that replication in 293T cells was initially more efficient. The reason 
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may relate to the difference levels of cytoplasmic, particularly lysosomal, activity in the cell 
types. Nevertheless, these differences did not prevent the virus from eventually spreading to all 
cells in the culture.  Moreover, vaccine strains of both PPR and rinderpest viruses are well 
adapted to Vero cells. 
B95a and MOCL5 cells did not support active PPR virus replication. It may be that these cells 
lack or are deficient in specific attachment protein sequence or an intercellular host protein 
necessary for efficient virus replication. This may also reflect the use of a different cell receptor 
(Wild et al., 1991). Cellular receptors are one of the major determinants of the host range and 
tissue tropism of a virus. The H (attachment) glycoproteins of morbilliviruses are variable 
(Blixenkrone-Müller et al., 1996) and this may play a role in host cell specificity. B95a 
lymphoblastoid cells are a good host for rinderpest virus, but they did not support replication of 
PPRV. Further efforts to adapt PPRV in B95a cells by six blind passages failed to result in 
productive infection, contrary to the reports of Das and others (2000). Differences in sensitivity 
of B95a cells between PPRV and RPV may reflect the use of a different cell receptor, which is 
believed to be determinant in the host range and tissue tropism. This appeared to be in 
contradiction with results obtained with other morbilliviruses in the same cells. RPV (Kobune et 
al., 1991), MV (Kobune et al., 1990) and canine distemper virus (Seki et al., 2003) replicate and 
can be isolated successfully in B95a cell line. MV uses CD46 receptor for Vero but SLAM for 
B95a (Takeuchui et al., 2002 ).  
Amino-acid sequence analysis of the H protein of several vaccine and wild type strains of PPRV, 
RPV, measles virus (MV) and canine distemper virus (CDV) showed that the critical residues 
identified on the H-MV protein for the interaction with the SLAM (CD150 receptor) are 
conserved in all morbillivirus H sequences we have analysed and surface modelling using 
hypothetical 3D structural model of H-MV identified one mutation as critical for interaction with 
the SLAM of B95a cells (Massé et al, 2004). Thus, the hydrophobic non polar aliphatic H-MV 
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residue V525 was replaced by the hydrophobic non polar aliphatic I525. The effect of this 
conservative mutation on the H-SLAM interaction is probably limited but requires further 
investigation. In addition, the SwissModel (Schwede et al., 2003), using the amino-acid sequence 
of the globular head of the H protein detected two differences between the H-MV and H-PPRV 
molecules. First, on top side, the surface of critical residues was slightly modified, may be as a 
consequence of the mutation V508 Æ I508. Second, the critical residue L526 on H-MV was 
replaced by amino-acids Y540 and I542. Whether these modifications may account for a 
defective interaction of the H-PPRV with the B95a SLAM receptor will need further analysis, as 
the non-susceptibility of B95a cells to PPRV cannot be explained simply by sequence 
modification of the H protein. 
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Fig. 1 Flow cytometry analysis of cells infected with peste des petits ruminants  virus. The 
relative cell number (in %) is plotted on the Y-axis(0, 20, 40, 60), fluorescence intensity is 
plotted on the X-axis (101 , 102 , 103, 104 of each square) and time is plotted on the Z – axis 
(starting from 0, 24, 48, 72, 96, 120, 144 hours post infection for each square). 
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Fig. 2 Flow cytometry analysis of cells infected with rinderpest virus. The relative cell number 
(in %) is plotted on the Y-axis(0, 20, 40, 60), fluorescence intensity is plotted on the X-axis (101 , 
102 , 103, 104 of each square) and time is plotted on the Z – axis (starting from 0, 24, 48, 72, 96, 
120, 144 hours post infection for each square). 
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Fig. 3. Percentage of cells indicating positive fluorescence. 
 
Fig. 4. Titration of Both PPRV and RPV in B95a, 293T and Vero cell lines.  
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PPRV (NC_006383)    (1) MSAQRERINAFYKDNPHNKNHRVILDRERLVIERPYILLGVLLVMFLSLI 
   PPRV (X74443)    (1) MSAQRERINAFYKDNLHNKTHRVILDRERLTIERPYILLGVLLVMFLSLI 
    RPV (X98291)    (1) MSPPRDRVDAYYKDNFQFKNTRVVLNKEQLLIERPCMLLTVLFVMFLSLV 
    RPV (Z30697)    (1) MSPPRDRVDAYYKDNFQFKNTRVVLNKEQLLIERPCMLLTVLFVMFLSLV 
   MV (AB012948)    (1) MSPQRDRINAFYKDNPHPKGSRIVINREHLMIDRPYVLLAVLFVMFLSLI 
   MV (AF266288)    (1) MSPQRDRINAFYKDNPHPKGSRIVINREHLMIDRPYVLLAVLFVMSLSLI 
   MV (AF266286)    (1) MSPQRDRINAFYKDNPHPKGSRIVINREHLMIDRPYVLLAVLFVMFLSLI 
   MV (AF266289)    (1) MSPQRDRINAFYKDNPHPKGSRIVINREHLMIDRPYVLLAVLFVMFLSLI 
  CDV (AF164967)    (1) MLSYQDKVSAFYKDNARANSSKLSLVTEEQGGRRPPYLLFVLLILLVGIM 
  CDV (AY466011)    (1) MLSYQDKVGAFYKDNARANPSKLSLVTEEHGGRRPPYLLFVLLILLVGIL 
  CDV (AF378705)    (1) MLSYQDKVGAFYKDNARANSTKLSLVTEEHGGRRPPYLLFVLLILLVGIL 
  CDV (AF305419)    (1) MLPYQDKVGAFYKDNARANSTKLSLVTEGHGGRRPPYLLFVLLILLVGIL 
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   PPRV (X74443)   (51) GLLAIAGIRLHRATVGTAEIQSRLNTNIELTESIDHQTKDVLTPLFKIIG 
    RPV (X98291)   (51) GLLAIAGIRLHRAAVNTAKINNDLTTSIDITKSIEYQVKDVLTPLFKIIG 
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   MV (AB012948)   (51) GLLAIAGIRLHRAAIYTAEIHKSLSTNLDVTNSIEHQVKDVLTPLFKIIG 
   MV (AF266288)   (51) GLLAIAGIRLHRAAIYTAEIHKSLSTNLDVTNSIEHQVKDVLTPLFKIIG 
   MV (AF266286)   (51) GLLAIAGIRLHRAAIYTAEIHKSLSTNLDVTNSIEHQVKDVLTPLFKIIG 
   MV (AF266289)   (51) GLLAIAGIRLHRAAIYTAEIHKSLSTNLDVTNSIEHQVKDVLTPLFKIIG 
  CDV (AF164967)   (51) ALLAITGVRFHQVSTSNMEFSRLLKEDMEKSEAVHHQVIDVLTPLFKIIG 
  CDV (AY466011)   (51) ALLSITGIRFHKVSTSNMEFSRLLKEDMEKSEAVHHQVIDVLTPLFKIIG 
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    RPV (Z30697)  (101) DEVGLRTPQRFTDLTKFISDKIKFLNPDKEYDFRDINWCINPPERIKIDY 
   MV (AB012948)  (101) DEVGLRTPQRFTDLVKFISDKIKFLNPDREYDFRDLTWCINPPERIKLDY 
   MV (AF266288)  (101) DEVGLRTPQRFTDLVKFISDKIKFLNPDREYDFRDLTWCINPPERIKLDY 
   MV (AF266286)  (101) DEVGLRTPQRFTDLVKFISDKIKFLNPDREYDFRDLTWCINPPERIKLDY 
   MV (AF266289)  (101) DEVGLRTPQRFTDLVKFISDKIKFLNPDREYDFRDLTWCINPPERIKLDY 
  CDV (AF164967)  (101) DEIGLRLPQKLNEIKQFILQKTNFFNPNREFDFRDLHWCINPPSKIKVNF 
  CDV (AY466011)  (101) DEIGLRLPQKLNEIKQFILQKTNFFNPNREFDFRDLHWCINPPSKVKVNF 
  CDV (AF378705)  (101) DEIGLRLPQKLNEIKQFILQKTNFFNPNREFDFRDLHWCINPPSKVKVNF 
  CDV (AF305419)  (101) DEIGLRLPQKLNEIKQFILQKTNFFNPNREFDFRDLHWCINPPSTVKVNF 
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 PPRV (AJ512718)  (151) DQFCEYKAAVKSIEHIFESPLNKSKKLQSLTLGPGTGCQGRTVTRAHFSE 
PPRV (NC_006383)  (151) DQFCEYKAAVKSIEHIFESPLNKSKKLQSLTLGPGTGCLGRTVTRAHFSE 
   PPRV (X74443)  (151) DQFCEYKAAVKSVEHIFESSLNRSERLRLLTLGPGTGCLGRTVTRAQFSE 
    RPV (X98291)  (151) DQYCAHTAAEDLITMLVNSSLTGTTVLRTSLVNLGRNCTGPTTTKGQFSN 
    RPV (Z30697)  (151) DQYCAHTAAEDLITMLVNSSLTGTTVPRTSLVNLGRNCTGPTTTKGQFSN 
   MV (AB012948)  (151) DQYCADVAAEELMNALVNATLLEARATNQFLAVSKGNCSGPTTIRGQFSN 
   MV (AF266288)  (151) DQYCADVAAEELMNALVNSTLLETRTTNQFLAVSKGNCSGPTTIRGQFSN 
   MV (AF266286)  (151) DQYCADVAAEELMNALVNSTLLETRTTNQFLAVSKGNCSGPTTIRGQFSN 
   MV (AF266289)  (151) DQYCADVAAEELMNALVNSTLLETRTTNQFLAVSKGNCSGPTTIRGQFSN 
  CDV (AF164967)  (151) TNYCDTIGIRKSIASAANPILLSALSGGRGDIFPPYRCSGATTSVGRVFP 
  CDV (AY466011)  (151) TNYCDTIGIRKSIASAANPILLSALSGSRSDIFPPYRCSGATTSVGKVFP 
  CDV (AF378705)  (151) TNYCESIGIRKAIASAANPILLSALSGGRSDIFPPHRCSGATTSVGKVFP 
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 85
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 PPRV (AJ512718)  (201) LTLTLMDLDLEMKHNVSSVFTVVEEGLFGRTYTVWRSDARDPSTDPGIGH 
PPRV (NC_006383)  (201) LTLTLMDLDLEMKHNVSSVFTVVEEGLFGRTYTVWRSDARDPSTDLGIGH 
   PPRV (X74443)  (201) LTLTLMDLDLEIKHNVSSVFTVVEEGLFGRTYTVWRSDTGKPSTSPGIGH 
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    RPV (Z30697)  (201) ISLTLSGIYSGRGYNISSMITITGKGMYGSTYLVGKYNQRARRPSKVWHQ 
   MV (AB012948)  (201) MSLSLLDLYLSRGYNVSSIVTMTSQGMYGGTYLVEKPNLSSKGSELSQLS 
   MV (AF266288)  (201) MSLSLLDLYLSRGYNVSSIVTMTSQGMYGGTYLVEKPNLSSKRSELSQLS 
   MV (AF266286)  (201) MSLSLLDLYLGRGYNVSSIVTMTSQGMYGGTYLVEKPNLSSKRSELSQLS 
   MV (AF266289)  (201) MSLSLLDLYLGRGYNVSSIVTMTSQGMYGGTYLVEKPNLSSKRSELSQLS 
  CDV (AF164967)  (201) LSVSLSMSLISRTSEIINMLTAISDGVYGKTYLLVPDYIEGGFDT----Q 
  CDV (AY466011)  (201) LSVSLSMSLISRTSVIINMLTAISDGVYGKTYLLVPDDIEREFDT----Q 
  CDV (AF378705)  (201) LSVSLSMSLISRTSEIINMLTAISDGVYGKTYLLVPDDIEREFDT----Q 
  CDV (AF305419)  (201) LSVSLSMSLISRTSEVINMLTAISDGVYGKTYLLVPDDIEREFDT----R 
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  CDV (AY466011)  (247) EIRVFEIGFIKRWLNDMPLLQTTNYMVLPENSKAKVCTIAVGELTLASLC 
  CDV (AF378705)  (247) EIRVFEIGFIKRWLNDMPLLQTTNYMVLPENSKAKVCTIAVGELTLASLC 
  CDV (AF305419)  (247) EIRVFEIGFIKRWLNDMPLLQTTNYMVLPKNSKAKVCTIAVGELTLASLC 
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 PPRV (AJ512718)  (301) TSSETVTLSERGVPKRKPLVVVILNLAGPTLGGELYSVLPTSDLMVEKLY 
PPRV (NC_006383)  (301) SSSETVTLGERGVPKREPLVVVILNLAGPTLGGELYSVLPTSDLMVEKLY 
   PPRV (X74443)  (301) TPSETVTLSESGVPKREPLVVVILNLAGPTLGGELYSVLPTTDPTVEKLY 
    RPV (X98291)  (301) LADSPVALHYGRVGDDNKIRFVKLGVWASPADRDTLATLSAIDPTLDGLY 
    RPV (Z30697)  (301) LADSPVALHYGRVGDDNKIRFVKLGVWASPADRDTLATLSAIDPTLDGLY 
   MV (AB012948)  (301) HREDSITIPYQGSGKGVSFQLVKLGVWKSPTDMQSWVPLSTDDPVIDRLY 
   MV (AF266288)  (301) HGEDSITIPYQGSGKGVSFQLVKLGVWKSPTDMQSWVPLSTDDPVIDRLY 
   MV (AF266286)  (301) HREDSITIPYQGSGKGVSFQLVKLGVWKSPTDMQSWVTLSTDDPVIDRLY 
   MV (AF266289)  (301) HGEDSITIPYQGSGKGVSFQLVKLGVWKSPTDMQSWVPLSTDDPVIDRLY 
  CDV (AF164967)  (297) VDESTVLLYHDSDGSQDGILVVTLGIFGATPMDQVEEVIPVAHPSVEKIH 
  CDV (AY466011)  (297) VDESTVLLYHDSRGSQDGILVVTLGIFGATPMDHIEEVIPVAHPSMEKIH 
  CDV (AF378705)  (297) VEESTVLLYHDSSGSQDGILVVTLGIFWATPMDHIEEVIPVAHPSMEKIH 
  CDV (AF305419)  (297) VEESTVLLYHDSSGSQDGILVVTLGIFWATPMDHIEEVIPVAHPSMKKIH 
 
                        351                                            400 
 PPRV (AJ512718)  (351) LSSHRGIIKDNEANWVVPSTDVRDLQNKGECLVEACKTRPPSFCNGTGSG 
PPRV (NC_006383)  (351) LSSHRGIIKDDEANWVVPSTDVRDLQNKGECLVEACKTRPPSFCNGTGSG 
   PPRV (X74443)  (351) LSSHRGIIKDNEANWVVPSTDVRDLQNKGECLVEACKTRPPSFCNGTGIG 
    RPV (X98291)  (351) ITTHRGIIAAGTAIWAVPVTRTDDQVKMGKCRLEACRDRPPPFCNSTDWE 
    RPV (Z30697)  (351) ITTHRGIIAAGTAIWAVPVTRTDDQVKMGKCRLEACRDRPPPFCNSTDWE 
   MV (AB012948)  (351) LSSHRGVIADNQAKWAVPTTRTDDKLRMETCFQQACKGKIQALCENPEWA 
   MV (AF266288)  (351) LSSHRGVIADNQAKWAVPTTRTDDKLRMETCFQQACKGKIQALCENPEWA 
   MV (AF266286)  (351) LSSHRGVIADNQAKWAVPTTRTDDKLRMETCFQQACKGKIQALCENPEWA 
   MV (AF266289)  (351) LSSHRGVIADNQAKWAVPTTRTDDKLRMETCFQQACKGKIQALCENPEWA 
  CDV (AF164967)  (347) ITNHRGFIKDSIATWMVPALVSEKQEEQKNCLESACQRKSYPMCNQTSWE 
  CDV (AY466011)  (347) ITNHRGFIKDSIATWMVPALASEKQEEQKGCLESACQRKTYPMCNQTSWE 
  CDV (AF378705)  (347) ITNHRGFIKDSIATWMVPALASEKQEEQKGCLESACQRKTYPMCNQTSWE 
  CDV (AF305419)  (347) ITNHRGFIKDSIATWMVPALASEKQEEQKGCLESACQRKTYPMCNQASWE 
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                        401                                            450 
 PPRV (AJ512718)  (401) PWSEGRIPAYGVIRVSLDLASDPGVVITSVFGPLIPHLSGMDLYNNPFSR 
PPRV (NC_006383)  (401) PWSEGRIPAYGVIRVSLDLASDPGVVITSVFGPLIPHLSGMDLYNNPFSR 
   PPRV (X74443)  (401) PWSEGRIPAYGVIRVSLDLASDPGVVITSVFGPLIPHLSGMDLYNNPFSR 
    RPV (X98291)  (401) PLEAGRIPAYGVLTIKLGLADEPKVDIISEFGPLITHDSGMDLYTSFDGT 
    RPV (Z30697)  (401) PLEAGRIPAYGVLTIKLGLADEPKVDIISEFGPLITHDSGMDLYTSFDGT 
   MV (AB012948)  (401) PLKDNRIPSYGVLSVNLSLTVELKIKIASGFGPLITHGSGMDLYKSNHNN 
   MV (AF266288)  (401) PLKDNRIPSYGVLSVDLSLTVELKIKIASGFGPLITHGSGMDLYKSNHNN 
   MV (AF266286)  (401) PLKDNRIPSYGVLSVDLSLTVELKIKIASGFGPLITHGSGMDLYKSNHNN 
   MV (AF266289)  (401) PLKDNRIPSYGVLSVDLSLTVELKIKIASGFGPLITHGSGMDLYKSNHNN 
  CDV (AF164967)  (397) PFGGGQLPSYGRLTLPLDPSIDLQLNISFTYGPVILNGDGMDYYESPLLD 
  CDV (AY466011)  (397) PFGGGQLPSYGRLTLPLDASVDLQLNISFTYGPVILNGDGMVYYESPLLN 
  CDV (AF378705)  (397) PFGGRQLPSYGRLTLPLDASVDLQLNISFTYGPVILNGDGMDYYESPLLN 
  CDV (AF305419)  (397) PFGGRQLPSYGRLTLPLDASVDLQLNISFTYGPVILNGDGMDYYESPLLN 
 
                        451                                            500 
 PPRV (AJ512718)  (451) AVWLAVPPYEQSFLGMINTIGFPNRAEVMPHILTTEIRGPRGRCHVPIEL 
PPRV (NC_006383)  (451) AVWLAVPPYEQSFLGMIYTIGFPYRAEVMPHILTTEIRGPRGRCHVPIEL 
   PPRV (X74443)  (451) AAWLAVPPYEQSFLGMINTIGFPDRAEVMPHILTTEIRGPRGRCHVPIEL 
    RPV (X98291)  (451) KYWLTTPPLQNSALGTVNTLVLEPSLKISPNILTLPIRSGGGDCYTPTYL 
    RPV (Z30697)  (451) KYWLTTPPLQNSALGTVNTLVLEPSLKISPNILTLPIRSGGGDCYIPTYL 
   MV (AB012948)  (451) VYWLTIPPMKNLALGVINTLEWIPRFKVSPNLFTVPIKEAGEDCHAPTYL 
   MV (AF266288)  (451) VYWLTIPPMKNLALGVINTLEWIPRFKVSPNLFTVPIKEAGEDCHAPTYL 
   MV (AF266286)  (451) VYWLTIPPMKNLALGVINTLEWIPRFKVSPYLFNVPIKEAGEDCHAPTYL 
   MV (AF266289)  (451) VYWLTIPPMKNLALGVINTLEWIPRFKVSPYLFTVPIKEAGEDCHAPTYL 
  CDV (AF164967)  (447) SGWLTIPPKNGTVLGLINKASRGDQFTVIPHVLTFAPRESSGNCYLPIQT 
  CDV (AY466011)  (447) SGWLTIPPKNGTILGLINKAGRGDQFTVIPHVLTFAPRESGGNCYLPIQT 
  CDV (AF378705)  (447) SGWLTIPPKNGTIVGLINKAGRGDQFTVLPHVLTFAPWESSGNCYLPIQT 
  CDV (AF305419)  (447) SGWLTIPPKDGTISGLINKAGRGDQFTVLPHVLTFAPRESSGNCYLPIQT 
 
                        501                                            550 
 PPRV (AJ512718)  (501) SRRVDDDIKIGSNMVILPTMDLRYITATYDVSRREHAIVCYIYDTGLSSS 
PPRV (NC_006383)  (501) SRRVDDDIKIGSYMVILPTIDLRYITATYDVSRSEHAIVYYIYDTGRSSS 
   PPRV (X74443)  (501) SSRIDDDIKIGSNMVVLPTKDLRYITATYDVSRSEHAIVYYIYDTGRSSS 
    RPV (X98291)  (501) SDRADDDVKLSSNLVILPSRDLQYVSATYDISRVEHAIVYHIYSTGRLSS 
    RPV (Z30697)  (501) SDRADDDVKLSSNLVILPSRDLQYVSATYDISRVEHAIVYHIYSTGRLSS 
   MV (AB012948)  (501) PAEVDGDVKLSSNLVILPGQDLQYVLATYDTSRVEHAVVYYVYSPSRSFS 
   MV (AF266288)  (501) PAEVDGDVKLSSNLVILPGQDLQYVLATYDTSRVEHAVVYYVYSPGRSFS 
   MV (AF266286)  (501) PAEVDGDVKLSSNLVILPGQDLQYVLATYDTSRVEHAVVYYVYSPSRSFS 
   MV (AF266289)  (501) PAEVDGDVKLSSNLVILPGQDLQYVLATYDTSRVEHAVVYYVYSPSRSFS 
  CDV (AF164967)  (497) SQIMDKDVLTESNLVVLPTQNFRYVIATYDISRGDHAIVYYVYDPIRAIS 
  CDV (AY466011)  (497) SQIIDRDVLIESNLVVLPTQSFRYVIATYDISRNDHAIVYYVYDPFRTIF 
  CDV (AF378705)  (497) SQIIDRDVLIESNIVVLPTQSFRYVIATYDISRSDHAIVYYVYDPIRTIS 
  CDV (AF305419)  (497) SQIRDRDVLIESNIVVLPTQSIRYVIATYDISRSDHAIVYYVYDPIRTIS 
 
                        551                                            600 
 PPRV (AJ512718)  (551) YYYPVRLNFKGNPLSLRIECFPWRHKVWCYHDCLIYNTITDEEVHTRGLT 
PPRV (NC_006383)  (551) YFYPVRLNFKGNPLSLRIECFPWRHKVWCYHDCLIYNTITDEEVHTRGLT 
   PPRV (X74443)  (551) YFYPVRLNFRGNPLSLRIECFPWYHKVWCYHDCLIYNTITNEEVHTRGLT 
    RPV (X98291)  (551) YYYPFKLPIKGDPVSLQIECFPWDRKLWCHHFCSVIDSGTGEQVTHIGVV 
    RPV (Z30697)  (551) YYYPFKLPIKGDPVSLQIECFPWDRKLWCHHFCSVVDSGTGEQVTHIGVV 
   MV (AB012948)  (551) YFYPFRLPIKGVPIELQVECFTWDQKLWCRHFCVLADSESGGHITHSGMV 
   MV (AF266288)  (551) YFYPFRLPIKGVPIELQVECFTWDQKLWCRHFCVLADSESGGHITHSGMV 
   MV (AF266286)  (551) YFYPFRLPIKGVPIELQVECFTWDQKLWCRHFCVLADSESGGHITHSGMV 
   MV (AF266289)  (551) YFYPFRLPIKGVPIELQVECFTWDQKLWCRHFCVLADSESGGHITHSGMV 
  CDV (AF164967)  (547) YTYPFRLTTKGRPDFLRIECFVWDDDLWCHQFYRFEADSTNSTTSVENLV 
  CDV (AY466011)  (547) YTYPFRLTTKGRPDFLRIECFVWDDNLWCHQFYRYEANIANSTTSVENLV 
  CDV (AF378705)  (547) YTHPFRLTTKGRPDFLRIECFVWDDNLWCHQFYRFEADIANSTTSVENLV 
  CDV (AF305419)  (547) YTHPFRLTTKGRPDFLRIECFVWDDNLWCHQFYRFEADIANSTTSVENLV 
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                        601            618 
 PPRV (AJ512718)  (601) GIEVTCNPV--------- 
PPRV (NC_006383)  (601) GIEVTCNPV--------- 
   PPRV (X74443)  (601) GIEVTCNPV--------- 
    RPV (X98291)  (601) GIEITCNGK--------- 
    RPV (Z30697)  (601) GIKITCNGK--------- 
   MV (AB012948)  (601) GMGVSCTVTREDGTNSR- 
   MV (AF266288)  (601) GMGVSCTVTREDGTNRR- 
   MV (AF266286)  (601) GMGVSCTVTREDGTNRR- 
   MV (AF266289)  (601) GMGVSCTVTREDGTNRR- 
  CDV (AF164967)  (597) RIRFSCNRSKP------- 
  CDV (AY466011)  (597) RIRFSCNRSNP------- 
  CDV (AF378705)  (597) RIRFSCNR---------- 
  CDV (AF305419)  (597) RIRFSCNR---------- 
 
 
 
 
Fig. 5  Analysis of H amino-acid sequence of PPRV strains and comparison with other vaccine 
(vac) and wild type (wt) strains of Morbillivirus. Red letters in grey boxes display the identical 
amino-acid residues. Black boxes identify critical residues for H-MV/SLAM interaction 
(positions 505, 507, 521-523, 525-527, 529-533, 536-537, 547-548, 552-554). Blue letters 
indicate PPRV specific mutations compared to other morbilliviruses (27 positions). Accession 
numbers used in this figure are PPRV (vac: X74443, wt: AJ512718 and NC_006383), RPV (vac: 
Z30697, wt: X98291), MV (vac: AF266286 and AF266289, wt: AF266288 and AB012948), 
CDV (vac: AF305419 and AF378705, wt: AF164967 and AY466011). 
 
 
  88
  
552 
196 
547 
531 
532 
533 507 
505 
508 
279 314 
413 
507 
554 
552 
553 
555 
548 
547 
537 
533 
532 
531 
531 
525 523 
521 
508 
507 
505 
196 
202 
399 
577 
413 
540 542 
(a) 
(b) 
  89
 
554 
552 
553 
555 
548 
547 
537 
533 
532 
531 
526 
525 
523 
521 
508 
507 
505 
196 
202 
399 
577 
555 
196 
547 
531 
532 
533 
507 
505 
508 
279 
314 
413 
(c) 
(d) 
  90
Fig. 6  3D surface models of the globular head of the H protein of PPRV (a and b) in comparison 
with MV (c and d). Top views are shown on (a) and (c), while (b) and (d) are side views rotated by 
about 315° around the x axis. Red surfaces display the critical residues identified on the H-MV 
protein for its interaction with the SLAM (CD150) receptor of B95a (Masse et al, 2004). Blue 
surfaces show the amino-acids specifically mutated on the H-PPRV compared to the other 
morbillivirus. The black surface is a critical residue for SLAM receptor interaction that was found 
only mutated on the H-PPRV. Green surfaces represent two amino-acids in the H-PPRV that land in 
place of the amino-acid 225 in the H-MV. 
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Difference in virulence may not result exclusively on the host or cell susceptibility. Once 
entered in the cells, the virus may not necessarily find the necessary environment for an 
efficient replication. This could explain a diffence in the clinical outcome. Inside the cells, 
the major biological processes on which relies the virus replication, involve three proteins 
tighly associated with the nucleic acid to form the ribonucleic complex. The function of this 
complex is dependent on the presence of particular inverted terminal sequences at the 
genome extremities. These sequences are named genome promoter (3’ – 5’, genome sens) 
and antigenome promoter (5’ – 3’ genome antisens). The first one is responsible for the 
mRNA transcription and the production of the positive full genome RNA that serves as a 
template for genome replication. The antigenome promoter is responsible for the production 
of new genome molecule. Promoter sequences are conserved regions of the gene because of 
the essential role they play in transcription and replication. Nucleotide mutations in these 
regions may result in a loss of virulence, at least between wild type virus and cell culture 
adapted vaccine strain. We were also interested to see if differences in these sequences 
could be seen between strains producing disease in goats and strains producing disease in 
sheep. In this study, base changes that may contribute to viral attenuation were investigated 
by comparative analysis of the GP and AGP from field strains affecting sheep or goats and a 
vaccinal. The promoter sequences were also compared with those from other members of 
the Morbillivirus genus and the family Paramyxoviridae to assess possible shared critical 
residues for virulence and the phylogenetic relationships between all these viruses.  
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Abstract 
Genome and antigenome promoters (GP and AGP) of the peste des petits ruminants (PPR) virus, 
amplified from different pathological samples of sheep and goat origins, were sequenced and 
compared with corresponding sequences of PPR vaccine strain and other morbilliviruses. 
Alignment of GP sequences revealed six nucleotide changes at positions 5, 12, 26, 36, 42 and 81, 
and one nucleotide mutation in AGP at position 15842 between PPR vaccine and field strains. 
Mutation 26 was clearly linked with the attenuated phenotype of the vaccine strains of PPRV, 
rinderpest virus (RPV), measles virus (MV) and canine distemper virus (CDV) as well. Mutations 5 
and 12 were only seen on the PPRV and RPV vaccine strains and 4 other mutations, 36, 42, 81 and 
15842 were seen only on the PPRV vaccine strain sequence. Interestingly, the field strains of PPRV 
were the only ones showing a residue U at position 36 instead of C for other morbilliviruses and the 
PPR vaccine strain. These nucleotide mutations, or some of them, may influence gene expression 
by changing the interaction of the leader with the viral polymerase or with a cellular protein 
involved in the modulation of the gene replication/transcription. As such they may be some of the 
candidates involved in the attenuation of PPRV. In spite of differences in virulence between goats 
and sheep reported in the field, there had been 100% homology of sequences in clinical samples of 
nasal swabs, lung and lymph nodes from both species. However, a higher heterogeneity within 
strains isolated from different areas was evidenced and accounted for a relevant phylogenetic 
clustering according to the geographic origin. It was also shown that the promoter sequences, 
although very short compared to the full genome, could make relevant phylogenetic tree of 
Paramyxoviridae. 
Key words: leader, morbillivirus, peste des petits ruminants (PPR), promoter, rinderpest (RP),   
trailer 
*Corresponding author: Dr Genevieve Libeau; Genevieve.libeau@cirad.fr  
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Introduction 
 
Peste des petits ruminants (PPR) is an acute and highly contagious viral disease of domestic and 
wild small ruminants, which is characterised by high fever, ocular and nasal discharge, pneumonia, 
necrosis and ulceration of the mucous membrane and inflammation of the gastro-intestinal tract 
leading to severe diarrhoea and death (Gibbs et al., 1979). PPR is caused by a single strand non-
segmented negative RNA virus which belongs to the family Paramyxoviridae, genus Morbillivirus 
which also includes measles virus, rinderpest virus (RPV), canine-distemper virus, phocine-
distemper virus, and dolphin and porpoise morbilliviruses (Barrett et al., 1993a). All morbilliviruses 
are related serologically, and sequence data shows that there is a high degree of homology at the 
sequence level. The genome contains six tandemly arranged transcription units encoding six 
structural proteins, the surface glycoproteins F and H, the nucleocapsid (N), the matrix (M), the 
polymerase or large (L) and the polymerase-associated (P) proteins. The cistron directing the 
synthesis of this later protein is encoding the virus non-structural proteins C and V by the use of two 
other open reading frames (ORF) of the messengers. The gene order is 3’N-P-M-F-H-L5’, as 
determined by transcriptional mapping (Dowling et al., 1986). The genome is flanked by extragenic 
sequences at the 3’ and 5’ ends, referred to as the leader (52 nucleotides) and trailer (37 
nucleotides), respectively. For viruses of the family Paramyxoviridae, the genome promoter (GP) 
includes 107 nucleotides comprising the leader sequence and the adjacent non-coding region of the 
N gene at the 3’ end of the negative-strand. The antigenome promoter (AGP) includes 109 
nucleotides that encompass the trailer sequence and the proximal untranslated region of the L gene. 
Both the GP and the AGP contains the polymerase binding sites and the RNA encapsidation signals 
for the replication of the full genome while the production of messengers RNA is a function of the 
GP (Murphy et al., 1998; Murphy and Parks 1999; Tapparel et al., 1998; Walpita, 2004). Therefore 
nucleotide changes in the GP and AGP of the genome which affect the replication/transcription of 
the RNA may have an impact on the virulence of the virus. Comparison of sequence data from 
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vaccinal and virulent strains of rinderpest and measles viruses identified nucleotide changes 
throughout the genome. Those located in the GP and AGP are among the potential attenuation of 
the virus (Parks et al., 2001; Baron et al., 1996; Banyard et al, 2005). In this paper, evidence of base 
changes between an attenuated vaccine strain and virulent PPRV strains from the field was obtained 
by the comparative analysis of the GP and AGP sequences. We used also those sequences to 
identify the relationship between the different samples we analysed and compared these data with 
those previously reported for the F protein gene sequence  (Shaila et al, 1996; Dhar et al., 2002). 
The promoter sequences were also compared with those from other members of the Morbillivirus 
genus for the identification of shared attenuation genetic markers, and of the Paramyxoviridae 
family for their phylogenetic  relationships. 
Materials and Methods 
The samples 
The samples were obtained either as nasal swabs or as post-mortem tissues submitted for 
confirmatory diagnosis from clinical diseases in goats and sheep (Table 1). A set of samples from 
goats and sheep collected in Israel and covering several years of collection was included in order to 
assess the molecular variation of the promoters within a given region. All samples were processed 
using standard methods (Couacy-Hymann et al., 2002) and one hundred microlitres of the sample 
solution were used for the RNA extraction. Vaccine strain of PPR virus (Diallo et al,. 1989) was 
grown in Vero cells. Cell growth medium was Eagles MEM supplemented with 10% fœtal bovine 
serum (FBS) and 1% of a mixed antibiotic solution (Gibco, Life Technologies, UK). Infected cells 
and the supernatant were harvested at 75% of the cytopathic effect (CPE), and frozen at -70°C until 
RNA extraction.  
RNA extraction 
RNA was extracted as described by Couacy-Hymann and others (2002). Briefly, nine hundred µl 
lysis solution (containing guanidine isothiocyanate, β-mercaptoethanol, sarcosyl and sodium citrate) 
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and 100 µl sample suspension were mixed. The tube was then centrifuged for 3 minutes at 10,000 
rpm. The supernatant was used in subsequent steps. One volume of 70% ethanol was mixed by 
pipetting and the mixed solution was extracted by rapid spinning at 10,000 rpm through RNeasy 
mini spin column (Qiagen, USA). The supernatant was discarded and the pellet was washed three 
times with washing solution (Ethanol 50%, Tris-Hcl 10mM pH7.4-7.6, EDTA 1mM, NaCl 50mM). 
The pellet was eluted in 50 µl of DEPC-treated water. One µl of RNase inhibitor (10U/µl) 
(Amersham,UK) was added to the RNA solution and frozen at –70°C until used. 
Single stranded cDNA synthesis and PCR for virus detection and sequencing 
For the detection of PPRV in pathological samples, the RNA was denatured at 65°C for ten 
minutes. Reverse transcription (RT) reaction was carried out in a 250 µl PCR tube as follows : 8 µl 
of the extracted RNA was mixed with 1µl of DTT, 1µl of random primer pd(N)6 and 5 µl of First 
strand cDNA bulk (Amersham, UK). The mixture was incubated at 37°C for 1h. PCR was 
conducted using primers designed by Couacy-Hymann et al. (2002) to amplify fragments of the 
PPRV N gene. The forward (5’-CAAGCCAAGGATTGCAGAAATGA-3’) and reverse 
(5’-AATTGAGTTCTCTAGAATCACCAT-3’) primers were universal Morbillivirus, while the 
forward (5’-GTCTCGGAAATCGCCTCACAG-3’) and reverse (5’-CCTCCTCCTG 
GTCCTCCAGAA-3’) primers were PPR specific. In a 250µl PCR microtube, cDNA was mixed 
with the following reagents: 5 µl of dNTP mixture (200mM), 5µl of 10X Taq buffer, 5 µl of 
primers (5 pmol/µl), 36 µl of water and 1 µl of Taq polymerase (1.25U/µl) (Qiagen, USA). Once all 
the reagents were mixed, the tube was placed into the Gene Amp PCR system 2400 (Applied 
Biosystem, USA). The amplification was carried out according to the following programme: an 
initial heating step 95°C for 5 min followed by denaturation at 94°C for 2 min and 35 cycles of 
94°C for 30s, annealing at 55°C for 30 s, extension at 72 °C for 2 minutes. 
The full genome sequence of PPRV vaccine strain Nigeria 75/1 was determined in our laboratory 
(accession numbers: X74443, Z37017, Z47977, Z81358).The 3’ and 5’ ends of the PPRV vaccine 
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strain was amplified from the virus infected cell total RNA using the 5´ RACE System for Rapid 
Amplification of cDNA Ends kit following instructions of the supplier (Invitrogen, USA). Primers 
used in those reactions were designed based on the N gene 
(5’-ATCATCTGTGATCCGCTGTATCAAT-3’) for the genome 3’ end cloning and the L gene 
(5’-TCCACCATGATGTTGCCTCAGG-3’) for the genome 5’. For the amplification of the genome 
and antigenome promoters of other PPRV strains, the same primers were used in conjunction with 
new primers which were designed at the genome extremities based on the vaccine strain leader and 
trailer sequences previously determined, 5’-ACCAGACAAAGCTGGGTAAGGATA-3’ and 
5’-ACCAGACAAAGCTGGGTAAGGATA-3’, respectively. Two hundred pmol of each primer 
were used in a 50 µl PCR reaction mixture. The amplification conditions were the same as indicated 
previously with exception of changes in annealing temperature of 52°C for 30 seconds in the trailer 
PCR cycle.  
Analysis of PCR- amplified products 
Ten microlitres of the amplicon were analysed by electrophoresis on a gel which was made of 1.5% 
agarose in Tris-borate-EDTA (TBE) buffer (0.089M Tris base, 0.089M boric acid and 0.002M 
EDTA, pH 8.3). The gel was stained with ethidium bromide and the DNA was visualised by UV 
fluorescence and photographed.  
Determination of GP and AGP sequences 
PCR products were purified on columns (Qiaquick PCR Purification kit, Qiagen, USA) and directly 
sequenced. Cycle sequencing was performed using dye-labeled terminators and Taq DNA 
polymerase (Applied Biosystems, USA), followed by analysis on an ABI Prism 377 automatic 
sequencer (Applied Biosystems, USA). Analysis of sequence results was performed using Vector 
NTI-9 package (Informax Inc., USA). Sequence alignments were done using CLUSTAL W 
included in this package. For the analysis of nucleotide changes, 6 PPRV sequences from Genbank 
(Table 2), including one vaccine strain sequence, were first considered because the 5’end of their 
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GP and the 3’end of their AGP have been completed. Subsequently, interesting positions identified 
previously were confirmed on partial promoter sequences (primers excluded) of our 12 additional 
virulent strains detected in field samples (coded strains in Table 1). All Israeli strains were 
sequenced but only one from each collection year and the divergent ones within a given year were 
used. Phylogenetic analysis was then carried out using a criterion of neighbourhood based on the 
principle of parsimony (Saitou and Nei, 1987). Dissimilarities and distances between the sequences 
were first determined using the Darwin 5 software (Perrier et al., 2003). Trees were then generated 
with the TreeCon MATRIXW program (Van de peer and De Watchter, 1993) included in Darwin5. 
Tree construction was based on the unweighted Neighbor-Joining method proposed by Gascuel 
(1997). Bootstraps were determined on 1000 replicates. 
Results and Discussion 
Base substitutions on the GP and AGP between the virulent strains of PPRV and the vaccine 
strain 
In the cycle of infection, the RNA dependant RNA polymerase (RdRp) of non-segmented negative 
viruses as morbilliviruses uses the GP to synthesize the messengers RNA and later full-length 
genome copies are made via replication intermediate strands of the genome from both GP and AGP 
(Fig. 1a). Therefore changes in these regions may have a significant effect on the rate of 
transcription of viral mRNA or full-length genome replication (Mioulet et al., 2001). As a first step 
for looking into the molecular basis of PPR pathogenesis, we decided to compare the GP and AGP 
of different PPRV strains. We started by determining the leader and trailer sequences of the PPRV 
vaccine strain. As demonstrated for the Sendai virus (SeV) (Tapparel et al., 1998, Vuillermoz and  
Roux, 2001), the promoters of morbilliviruses are bipartite and are composed of the leader plus the 
untranslated 5’ end of the N gene for the GP, the 3’ untranslated gene of the L gene plus the trailer 
for AGP (Fig. 1b). In Fig. 2, is presented the alignment of the different morbillivirus promoter 
sequences. It can be seen that while the 3’ ends of the genomes are completely uniform in size, they 
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are two gaps in the alignment of morbillivirus AGP alignment. Indeed, for CDV and PDV, one 
nucleotide is missing in the 3’ end of the L gene and is compensated by the presence of an extra 
nucleotide in the trailer making the figures for both viruses of 71 and 38 nucleotides, respectively, 
instead of 72 and 37 for the other morbilliviruses. Except this minor difference, the sequence 
alignment generated for GP and AGP of the Morbillivirus genus revealed a high degree of 
conservation. For example, the first four nucleotides of the 3’ terminus, UGGU (Fig 1b), are shared 
between all viruses. It is believed that these four nucleotides contain the landing site for the viral 
RdRp. However, if the intergenic sequence is conserved among all morbilliviruses, being GAA, the 
intergenic L-trailer sequence is more variable and is GAU for PPRV, GUU for CDV and marine 
mammal morbilliviruses. In Fig. 2, are indicated the two important regions constituting each 
promoter according to what was proposed by Vuillermoz and Roux (2001) for the SeV. Both GP 
and AGP complement each other on about the first 16 nucleotides for each virus. The promoter 
region I is probably involved both in the encapsidation of the genome within the helical structure 
made by the N protein and in the interaction between the encapsidated genome and the RNA-
dependant RNA polymerase (Tapparel et al, 1998). The second essential element, promoter region 
II, is composed of a series of three hexamer motifs present at position 79-84, 85-90 and 91-96 on 
the GP sequence. Here, the existence of the conserved discontinuous elements has been 
substantiated by studies with the SeV (Tapparel et al., 1998) and Simian virus (Murphy and Parks, 
1999) showing that the three sequences can significantly influence paramyxovirus RNA replication. 
In this region, conserved critical C residues are found at positions 79, 85 and 91 and conserved U 
residues are found at positions 83 and 89, thus forming a 3’-(CNNNUN)2-CNNNNN-5’ conserved 
hexamer motif on the GP sequence and its AGP counterpart 5’-(GNNNAN)2-CNNNNN-3’ 
(Tapparel et al, 1998, Walpita, 2004). This motif is playing a major role in the promoter activities 
and is expected to contain important signals for encapsidation and transcription. The hexamer phase 
of this conserved motif is though to be stacked close to the three hexamers of the promoter region I 
  99
and to expose the conserved nucleotide residues on the same face of the helical nucleocapsid to 
form a RNA-dependent RNA polymerase binding site (Tapparel et al, 1998; Mioulet et al, 2001). In 
addition to these two conserved promoter regions, a third conserved region is found at position 52-
71 in GP and 59-71 on AGP.  
To identify possible attenuation nucleotides in the promoters of PPRV, we have amplified and 
sequenced the GP and AGP from 12 virulent strains recovered from field samples and compared the 
data with those of the vaccine strain. This later is derived from the virulent Nigeria 75/1 strain and 
is known to be highly attenuated for all animals into which it has been inoculated so far (Diallo et 
al., 1989). PPRV in field samples was initially detected by a RT-PCR using Morbillivirus universal 
primers targeting a highly conserved region of the N gene (positions 790-812 and 988-1012) as 
reported by Couacy-Hymann et al. (2002). Virus specific RNA was detected in nasal and eye 
swabs, mouth and gum erosions (Table 3). Amplification using universal primers produced 250 bp 
fragments from PPRV and also from RPV. PPRV specific primers, targeting the 3’ terminal of the 
N gene, detected 390 bp fragments but did not amplify RPV (Fig. 3). Half of the samples positive 
with the PPR specific primers were however negative with universal primers thus indicating that the 
current Morbillivirus universal N gene based primers have limitations in detecting all strains of 
PPRV at the conditions of amplification we used (Table 3). Similar results were obtained by 
Forsyth and Barrett (1995) who used P gene primers as Morbillivirus universal primers. Even 
though the primers were designed in a zone where the gene sequence is well conserved between 
different morbilliviruses, a single base change at the 3’ end of a primer as a result of virus strain 
variation can abolish the amplification. The negative results reported by Forsyth and Barrett (1995) 
and by us here with primers designed in conserved target sequences indicate again the necessity of 
using at least two sets of primers for the diagnosis of pathogens such as RNA viruses known to have 
high rate of mutations. Specimens which were positive with the PPRV specific primers were then 
submitted to two other PCR tests to amplify both GP and AGP fragments as indicated in Materials 
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and Methods. The amplified products were sequenced. The sequence analysis was first done by 
including also the sequences from 2 RPV, 2 MV, 2 CDV and that of the original strain PPRV 75/1 
from which derives our vaccine strain, all being available from Genbank. Sequence alignment of the 
GP (107 base pairs) of virulent strains of PPRV and the vaccine strain revealed six unique 
nucleotide changes at positions 5 (transition U Æ C), 12 (transition A Æ G), 26 (transversion U Æ 
A), 36 (transition U Æ C), 42 (transition C Æ U) and 81 (transition C Æ U) in the vaccine strain 
(Fig. 4). Nucleotide changes on positions 5 and 12 could not be identified in our 12 field strains 
because they were included in the forward primer used for GP amplification. However, positions 
26, 36, 42 and 81 were all confirmed to be U, U, C, and C, respectively, thus strengthening the 
importance of these mutations in link with the virulent/attenuated phenotype. The original virus 
Nigeria 75/1 wild type (Nig75/1*) and its derived vaccine strain (63 passages on cell culture) have 
only 2 nt changes in GP. Their AGP sequences are identical. In Nig75/1* one nucleotide change is 
on position 12 (transition Awt → Gvac) in link with the virulent genotype. The other change at 
position 83 is C which is specific to the Nig75/1* since all other PPR strains and other 
morbilliviruses have a U residue at this position. Preliminary results of experimental works on live 
animals indicated that, although virulent, PPR Nigeria 75/1 wild type has a much lower virulence 
than other PPR strains (Couacy-Hymann, personal communication). This observation would be in 
agreement with the conservation of promoter sequences between this low virulent strain and its 
attenuated progeny. It also suggests that other genetic determinants for PPRV virulence are 
probably present outside the viral promoters as already shown for RPV (Banyard et al, 2005). Non-
segmented negative strand viruses have sequence elements at their genomic RNA ends which 
complement to each other (see Fig. 2 for morbillivirus 5’ and 3’ ends). For the SeV, it was 
demonstrated that the trailer is a stronger promoter than the leader and that all the 31 first 
nucleotides are important (Calain and Roux, 1995; Tapparel and Roux, 1996). Since the trailer 
serves exclusively for the replication to produce negative sense genome RNA while the leader 
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directs both transcription and replication, it can be assumed that the minimum sequence shared by 
the virus genome termini is the most important for the replication. Therefore, sequences 
downstream the shared area may be important for the transcription as suggested by Li and Pattnaik 
(1999) for vesicular stomatitis virus (VSV). The nucleotide substitutions occurring during cell 
culture passages for vaccine derivation can be located in any part of the genome. Those favouring 
specific modifications of the promoters can affect either the replication or mRNA transcription or 
both functions. Scanning mutagenesis analysis of the 3’ end of the genome of RPV carried out by 
Mioulet et al. (2001) did not distinguish the two functions since it was based on the measurement of 
the reporter CAT protein expression by the minigenome construct. This study identified nucleotides 
1, 3, 4, 10 and 19 as critical for the expression of the CAT protein. None of these nucleotides is 
concerned by the changes identified between the PPRV virulent strains and the vaccine in the work 
reported here. The same authors reported also the identification of residues in position 23-26 as 
critical. Precisely, for PPRV, RPV, MV and CDV, there is a pyrimidine Æ purine transversion at 
position 26 from the wild types (U or C) to the vaccine strains (A) (Fig. 4). Nucleotide 26 is 
downstream the sequence of the leader which complement with that of the trailer and it may be 
important for the transcription function of the leader promoter in its interaction with the RdRp or a 
cellular protein. It is interesting to note that for the SeV, two transversions UÆ A at positions 20 
and 24 in the leader sequence, outside the zone identified as critical for the replication/transcription 
of the viral genome, contribute to attenuate the virus for mice (Fuji et al., 2002). The transversion 
identified at the position 26 in the leader sequence of PPRV, RPV, MV and CDV may be one of the 
essential elements involved in the attenuation of morbilliviruses. As it can be seen in Fig. 4, there 
are some other nucleotide changes in the promoters sequences between virulent and vaccine strains 
of PPRV. The transition (C Æ U) at position 42 was only observed with PPRV. However, MV had 
a transversion (U Æ G ) at that position and for this virus it is believed that position 26 and 42 
pyrimidine-to-purine transversions belong to a nucleotide stretch between nt 17 and 42 that could 
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serve as contact site for a modified polymerase complex used for mRNA synthesis (Parks et al., 
2001). For PPRV, the conservation of a pyrimidine residue during the base 42 substitution limits 
probably the potential impact on the level of mRNA synthesis but may still contribute to an 
attenuated phenotype. Transitions at positions 5 and 12 were only identified in both PPRV and 
RPV. They occur within the highly conserved complementary hexamer motifs of GP and AGP 
starts. They affect residues identified as not critical by the scanning mutagenesis study of the RPV 
promoter but their change can reduce the reporter molecule production by about 60%. (Mioulet et 
al. 2001). Thus the transition at positions 5 and 12 may contribute also to the attenuated phenotype 
of the vaccine strain. The two other transitions of nucleotides 36 and 81 were only observed with 
PPRV. The pyrimidine U at position 36 of all PPRV virulent strains is unique among all other wild 
type and vaccine strains of morbilliviruses for which a conserved pyrimidine C is systematically 
found. Therefore, the transition U Æ C at that position gives the PPRV vaccine strain the 
morbillivirus conserved residue. Moreover, block mutation around that nucleotide has no effect in 
the promoter function of the RPV leader sequence (Mioulet et al., 2001). Also there is no evidence 
that the change in the position 81 has an impact on the PPRV virulence.  
In the AGP sequence (109 bp), there was only one unique nucleotide mutation specific to the 
vaccine strain at position 15842, 107 nucleotides from the 5’terminus of the genome (Fig. 4). The 
nucleotide in that position is variable although nucleotide G is found only in the vaccine strain.  
As demonstrated by Banyard et al. (2005) in the case of RPV, the virus genome promoters play a 
role in the pathogenicity of morbilliviruses. The 6 nucleotides changes observed at positions 
generally well conserved in the PPRV GP are likely attenuation candidates. With the advance of the 
reverse technology, it will be possible to generate strains with each individual mutation or group of 
mutations and evaluate their impact on the virus virulence. Among all the candidates, the most 
interesting is certainly the mutation observed at the position 26 because not only it is found in the 
genome of RPV, PPRV, MV and CDV vaccines strains but also it is in the area identified as 
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involved in the pathogenesis of SeV, another paramyxovirus (Fuji et al., 2002). Likely, any 
mutation in the promoters involved in the attenuation of PPRV may play in concert with other 
critical changes not only within the promoters but also in other virus genes as demonstrated with 
RPV. Indeed, as demonstrated Banyard et al., (2005) and  Baron et al. (2005) for RPV, the 
attenuation of morbillivirus may be a result of changes in different genes of the genome.  
Differences in virulence of PPR between goats and sheep reported in Africa were not supported by 
our sequence analysis of PPRV promoters. Also, specimen type did not play any role as there was 
100% homology between sequences derived from nasal swabs, lung and lymph nodes from the 
same goat or sheep (data not shown). In contrast, within a same geographic region like Israel, some 
nucleotide changes may occur in a short period. Interestingly, mutations were observed between 
1999 and 2000 in both GP and AGP sequences of goat as well as sheep strains, while the sequences 
are conserved after 2000 (data not shown). None of these viruses had been passaged on cell culture, 
which could have introduced genetic variability. It is however not clear what triggered these 
nucleotide changes.  
Use of the GP and AGP sequences of PPRV strains to determine the phylogenetic 
relationship 
Despite the overall high conservation of PPRV promoters, some variations were seen in parts of 
their sequence (Fig. 3). Phylogenetic analysis of tandemly linked GP and AGP (Fig. 5a) of PPR 
field strains from different areas and of the vaccine strain (Nig 75 vac) showed that these variations 
could lead to a geographic clustering of the strains. Earlier, Shaila et al. (1996), and then Dhar et al. 
(2002) demonstrated that isolates of PPRV could be grouped into four distinct lineages on the basis 
of partial sequence analysis of the fusion (F) protein gene. Relationship deduced from a method 
based on the principle of parsimony established that the promoter sequences were also lineage 
specific. Similar lineage specific base changes in the GP and AGP were also observed with 
rinderpest viruses (Banyard et al., 2005). This illustrates the possibility of using very short sequence 
  104
regions at the end of the virus genome for molecular typing of isolates, both for virulence and 
lineage discrimination. Lineage speciation was identical when using independently the GP or AGP 
sequences (data not shown). However, combination of the two allows to increase the bootstrap 
values and to strengthen the molecular typing of PPRV isolates next to other morbilliviruses. 
Furthermore, phylogenetic analysis of the GP-AGP tandem of Paramyxoviridae listed in Table 2, 
confirms that morbilliviruses form a unique cluster within the family (Fig. 5b). Although having 
unique features that clearly distinguish them from other paramyxoviruses, Henipa and Tupaia 
viruses are significantly closer to morbilliviruses than to any other virus genera (bootstrap values 
higher than 80%). The same observation was obtained when grouping the viruses through full-
genome sequences (Lwamba et al, 2005). The closer relationship observed among the genomic 
termini of these viruses could be supported by the slightly better identity of the N gene between 
Hendra and Morbillivirus (Yu et al., 1998) and of the L gene between Henipa, Tupaia and 
Morbillivirus (Harcourt et al, 2001). In particular, the polymerase contains a multifunctional G-rich 
motif in the domain VI that is identical in all these virsues. This phylogenetic proximity observed 
by independent sequence analysis of the viral promoters and the N and L proteins, may result from 
the physical constraints applied to the viral ribonucleoprotein (RNP) in which these three 
components have to be intimately linked to form a functional complex. Thus, one can imagine that 
co-evolution of these interacting molecules is necessary to maintain a functional RNP and a viable 
virus. Although the bootstrapping was not significant, further Paramyxoviridae discrimination was 
still possible and in agreement with the classification obtained using the full-genomes (Lwamba et 
al, 2005). The low bootstrap values are resulting from the promoter sequence shortness used for 
molecular discrimination.  
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Table 1.  Samples processed for RT-PCR and further genome and antigenome promoters sequence 
analysis 
 
No. Identification Sequence 
coding 
Country of 
origin 
Animal 
species 
Specimen Cell culture, 
cell type and 
passage no. 
1 Ethiopia-1994 Ethio/94 Ethiopia Goat  Sheep 
fibroblast-3 
2 Nigeria75/1wildtype Nig75wt    Vero-1 
3 RP-RBOKvac-1986* - UK, Pirbright   RBT-1 
4 Israel-1998 Isrl/98 Israel Goat lung Not passaged 
5 Israel-1999 Isrl/99 Israel Sheep eye swab « 
6 Israel-2000a** Isrl/00a Israel Goat lung « 
7 Israel-2000b - Israel Goat lung « 
8 Israel-2000c Isrl/00c Israel Sheep eye swab « 
9 Israel-2000d - Israel Sheep lung « 
10 Israel-2000e - Israel Sheep eye swab « 
11 Israel-2000f - Israel Sheep intestine « 
12 Israel-2000g - Israel Sheep eye swab « 
13 Israel-2001a Irsl/01a Israel Sheep spleen « 
14 Israel-2001b Isrl/01b Israel Sheep lung « 
15 Israel-2001c - Israel Sheep lung « 
16 Israel-2001d - Israel Goat lung « 
17 Israel-2001e - Israel Sheep lymph 
node 
« 
18 Israel-2001f - Israel Goat lung « 
19 Israel-2002 - Israel Sheep eye swab « 
20 Israel-2003a Isrl/03a Israel Sheep eye swab « 
21 Israel-2003b - Israel Sheep eye swab « 
22 Israel-2003c - Israel Sheep eye swab « 
23 Israel-2003d - Israel Sheep lung « 
24 Cote d’Ivoire-1989 C’Ivo/89 Cote d’Ivoire goat- lung- Sheep-
fibroblast-3 
25 India-Calcutta-1995 Ind-C/95 India, Calcutta Goat lymph 
node 
Sheep-
fibroblast26 
26 India-Pradesh-1995 Ind-P/95 India, Pradesh Goat lung Sheep-
kidney15 
27 Tadjikistan-2005 Tadijk/05 Tadjikistan - - - 
  
 
* The rinderpest virus strain (RP-RBOKvac) used for RT-PCR control in this study was not 
sequenced (the sequence for this virus was collected from GenBank, see table 2). 
** letters at the end of the year indicate different localities of specimen collection. 
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Table 2.  Selected strains of Paramyxoviridae from Gene bank database for phylogenetic analysis of 
genome and antigenome promoter sequences  
 
No. Virus Sequence 
coding 
Accession 
No. 
Author Publication 
1 Nigeria75/1vac Nig75vac X74443 Berhé et al, 2005 NCBI 
2 PPRV Nigeria 75/1 
(wild type) 
Nig75/1* AJ879463 
AJ879467 
Dash and Barrett, 
2005 
NCBI 
3 PPRV Nigeria76/1 
(wild type) 
Nig76/1 AJ879466 
AJ879468 
Dash and Barrett, 
2005 
NCBI 
4 PPRV Oman-83 Oman/83 AJ879464 
AJ879469 
Dash and Barrett, 
2005 
NCBI 
5 PPRV GuineaB-91 Guin-B/91 AJ879465 
AJ879470 
Dash and Barrett, 
2005 
NCBI 
6 PPRV Turkey-2000 Turk/00 NC-006383 Bailey et al., 2005 Virus Res. 
7 Rinderpest virus RPV NC-006296 Baron et al., 1996 J.Gen.Virol. 
8 Measles virus MV NC-001498 Takeuchi et al., 2000 Virus Genes 
9 Dolphin morbillivirus DMV NC-005283 Rima et al., 2003 NCBI 
10 Bovine respiratory 
syncitial virus 
BRSV NC-001989 Buchholz et al., 1999 J. Virol. 
11 Bovine parainfluenza 
virus 
BPIV NC-002161 Bailly et al., 2000 Virus Genes 
12 Human respiratory 
syncitial virus 
HRSV NC-001781 Karron et al., 1997 Proc.Natl.Acad. 
Sci. USA 
13 Human parainfluenza 
virus 
HPIV NC-003461  Newman et al., 2002 Virus Genes 
14 Newcastle disease 
virus 
NDV NC-002617 Sellers and Seal, 2000 NCBI 
15 Avian paramyxovirus APMV NC-003043 Chang et al., 2001 NCBI 
16 Sendai virus Sendai NC-001552 Itoh et al., 1997 J.Gen.Virol. 
17 Mumps virus Mumps NC-002200 Okazaki et al., 1992 Virology 
18 Nipah virus Nipah NC-002728 Harcourt et al., 2001 Virology 
19 Hendra virus Hendra NC-001906 Wang et al., 2000 J.Virol. 
20 Tupaia virus Tupaia NC-002199 Tidona et al., 1999 Virology 
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Table 3.  Results of RT-PCR using target gene specific primers. All negative results were confirmed 
by repeated tests 
 
No. Identification Morbillivirus 
specific PCR 
PPR specific 
PCR 
Genome 
promoter 
specific PCR 
Antigenome 
promoter 
specific PCR 
1 Nigeria75/1vac + + + + 
2 Nigeria75/1 wt + + + + 
3 Ethiopia-1994 + + + + 
4 RP-RBOKvac-
1986 
+ - - - 
5 Israel-1998 + + + + 
6 Israel-1999 - + + + 
7 Israel-2000a - + + + 
8 Israel-2000b - + + + 
9 Israel-2000c - + + + 
10 Israel-2000d - + + + 
11 Israel-2001a - + + + 
12 Israel-2001b - + + + 
13 Israel-2003a + + + + 
14 Israel-2003b + + + + 
15 Israel-2003c - + + + 
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(a) 
 
 
 
(b) 
 
 
 
Fig. 1  Morbillivirus genome organisation. (a) Morbillivirus replication pathway. Full-length 
genome copies are made via replication intermediate strands of the minigenome. (b) Genes and 
promoters of Morbillivirus (from Parks et al, 2001): the protein coding regions (N, P, V, C, M, F, 
H, and L), noncoding intergenic regions and the leader and trailer regions along with specialized 
sequence motifs are shown. The genome promoter includes the leader sequence and the non coding 
regions N at the 3' end of the genomic RNA. The antigenome promoter includes the trailer sequence 
and the untranslated regions of the L gene at 5’ end. Gene start (GS) and gene end (GE), enclosing 
the intergenic trinucleotide motifs are also shown.  
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(a) 
 
 1          11         21         31         41         51 
MV UGGUUUGUUU CAACCCAUUC CUAUCAAGUU AGUUACUAGU AGAAGAUCAC GUGAAUCCUA 
RPV UGGUCUGUUU CGACCCAUUC CUAGCAAGAU AGUUACUAAC ACUAAAUCGU GUGAAUCCUA 
PPRV UGGUCUGUUU CGACCCAUUC CUAUCAAGAA UAUUACUGAU AUCUGACCGU UUGAAUCCUC 
DMV UGGUCUGUUU CGACCGAUCC CCAUCUUAUU GUCUAUUACU AUUUAAUAGU AUGAAUCCUA 
CDV UGGUCUGUUU CAACCGAUUC CUAUCUAUUU AAUAACUUAU AAAAUAAUUU UUGAAUCCCA 
  
 Promoter Region I Æ 
 
       61         71         81         91         101 
MV AGUUCUAGGA UAAUAGUCCC UGUUCUCGUC CUAAUCCCUA UAGGCUCUAC 
RPV AGUUCUAGGA UAGCUGACCU CGUCCGAAUC CCGUGUCCAA GAAAUUUUAC 
PPRV AUUUCUAGGA UGACAGCCCC UCUCCUCCUC CUCGUUCUAG AAACUGGUAC 
DMV AUUACUAGGA UAGUUAACCG UGUCCUAAAC CUAUUUCCAA GUGUCAGUAC 
CDV GUUACUAGGA UGGAAUCCCU UGUUCCAGUC CCAAGUCUGG AUGGUUAUAC 
 
        Promoter Region II Æ 
 
 
(b) 
 
 1          11         21         31         41         51 
MV AACCAACUUG AGGCCUUGGG AUUAGGACGG GAUCCACCAA UCCGUAAUAA ACGUUAUAUA 
RPV AAGACGUUGA CAGACGAAGG ACUAGGACUA GACCAGUUAU UUUGACAUCU UUAUUAUAUG 
PPRV AAGCGCUAUG UAGACGGGGG AAGAGGAGGC GGUACUCUGA GAUGACCGUU AGAUUUUCUA 
DMV AUUGAUUACU UCACCUGGGG ACGAGGACAG GAACAGUCUC ACUAUAGUCU AAUAUUAAUA 
CDV ---GUCCAAC CAGACCGAGG AUUGGGAGAA GAUAAGUAAC GAUAACUUAA -AUUAAUAUG 
PDV ---AUUCGAU UGGCCGGAGG AGGUGGGGGA GAAGACUAGA GACACGCUAU –UUUAAUCUG 
 
   Å Promoter Region II 
 
       61         71         80         90         100 
MV AUUUCUUUUG AA-ACUUUUA UGCUUCAAAG AUAAGGGUCG AAACAGACCA 
RPV AUUUCUUUUG AA-GUUUCUA CACUUCAAAG AUAGGGGUCG AAACAGACCA 
PPRV AUUUCUUUUG AU-GUAUAAC CUAUUCAUAG AUAAGGGUCG AAACAGACCA 
DMV AUUCUUUUUG UU-CUAAGCU AAAUUCAUGG AUAUGGGUCG AAACAGACCA 
CDV CUUUUUUUUG UUGCCAAUAA UUAUUCAAUA GUAUGGGUCG AAACAGACCA 
PDV AUUUUUUUUG UUGUCUUCAA UUAUUCAAAG ---------- ---------- 
 
                 Å Promoter Region I 
 
 
 
Fig. 2 Alignment of the genomic (a) and antigenomic (b) promoters of the members of the genus 
Morbillivirus. The boxes delineate the promoter region I, that includes the first 30 nucleotides and 
the promoter region II composed of the three sequential hexamer residues. Bold letters in grey 
boxes represent identical residues. The trinucleotide inter-cistronic sequences are underlined, while 
dashes represent gaps introduced during alignment. Underscores mean no sequence available for 
that position. Bold white letters in black boxes represent the critical residues that neutralise the GP 
promoter activity of RPV (Mioulet et al, 2001) and the AGP promoter activity of MV (Walpita, P, 
2004). Accession numbers for this figure are CDV (AY466011), DMV (NC_005283), RPV 
(Z30697), MV (K01711), PPRV (X74443). 
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   (a) 
 
 
 
 
   (b) 
 
 
   
 
Fig. 3  Agarose gel electrophoresis of PCR products. (a). amplification was carried out using 
universal primers; Lane 4 is RPV and others were PPRV strains: lane 6 is a negative control (b). 
amplification was carried out using PPR specific primers. Lane 4 is RPV and others were PPRV 
strains; lane 12 in 3B is a negative control. M. represents 100bp DNA ladder (Biolabs, USA). 
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(a) 
Nucleotide position   1                                                                                                                        108 
                                                                         A                                                                      G 
                          5       12               26         36     42  A                                         81                           GG 
                          ↓       ↓                ↓      G   ↓      ↓ U AGUG C GC        A                 G      ↓       A              GG    GG 
                                                          G       G    U AGUA C GC        A      C          G      U       A              G     GG 
PPRV(wt) (cons/X4)    UGGUUU GUUUCA ACCCAU UCCUAU CU AGAAUAUUAU UGAUAC CUGACC GUUUGA AUCCUC AUUUCU AGGAUG ACAGCC CCCCUC CUCCUC CUCGUU CUAGAA ACUAAU 
                         1      2      3                                                                            14    15     16 
Nig75/1* (wt)         ....C. .....A ...... ...... .A.... .....C .....U ...... ...... ...... ...... ...... ...... ..U.C. ...... ...... ...... ...GGU 
Nig75vac              ....C. .....G ...... ...... .A.... .....C .....U ...... ...... ...... ...... ...... ...... ..U.U. ...... ...... ...... ...GGU 
--------------------------------------------------------------------------------------------------------------------------------------------------- 
RPV (wt)                  U       A            AG CC          C      C        GUGUGA AUCCUA AGUUCU                 C U                          UUU 
RPV (vac)                 C       G            AG CA          C      C        GUGUGA AUCCUA AGUUCU                 C U                          UUU 
 
MV (wt)                   U       A                U          C      U                                             U U                          UCU 
MV (vac)                  U       A                A          C      G                                             U U                          UCU 
 
CDV (wt)                  C       A                U          C      A                                             U U                          UAU 
CDV (vac)                 C       A                A          C      A                                             U U                          UAU 
 
Morbillivirus (wt)  cons  U       A                U          C      -                                             U U                          U-U 
Morbillivirus (vac) cons  C       A                A          C      -                                             U U                          U-U 
 
 
(b) 
Nucleotide position        ↓15842                                                                                                                 15948 
 
                                                                      A A     C U    A 
                                                  A       U     U     A A     C U    A 
                           C  C    A       A      A       U     U     A A     C U    A C                         G 
                           C  CC  CA       A      A       U    CUA    A A     C U    A C                         GG 
                        U  A CCC  CA U     A      A   A   UC   CUAU  AA A     CAU    A C A                     C GG                                     
PPRV(wt) (cons/X4)      A AUCGAU AUGUAG ACGGGG GAAGAG GAGGCG GUACUC UGGGGU GACUGC UAGGUU UUCUAA UUUCUU UUGAUG UAUAAC CUAUUC AUAGAU AAGGGU CGAAAC AGACCA 
                                          16     15     14                                                                            3      2      1 
Nig75/1*                . .G..C. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... 
Nig75vac                . .G..C. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... 
------------------------------------------------------------------------------------------------------------------------------------------------------- 
RPV (wt)                   G 
RPV (vac)                  G 
 
MV (wt)                    C 
MV (vac)                   C 
 
CDV (wt)                   C 
CDV (vac)                  C 
 
  
Mutations
Mutations
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Fig. 4  Analysis of GP (a) and AGP (b) promoter sequences of PPRV strains and comparison with other morbilliviruses on some interesting positions 
(shown by number and vertical arrows). Consensus sequences of wild type PPRV are shown as nucleotide hexamers from the ends of GP and AGP, 
respectively. Above the consensus, are shown the nature and frequency of mutations that were found. Directly below the consensus, the sequence of 
the vaccine and wild type strain of PPRV Nigeria 75 are aligned (dots mean conservative residue compared to consensus sequence). Below the dash 
line, the nucleotides of RPV, MV and CDV morbilliviruses at the interesting positions are reported. For GP, consensus nucleotides at the interesting 
positions for vaccine and wild type strains of morbilliviruses are also indicated. Positions where vaccine and wild type strains differ are emphasized by 
grey boxes. Pale orange Boxes indicated the blocks found to be critic on RPV by Mioulet et al (2001). Coloured hexamers represent the GP and AGP 
promoter regions I and II that are essential for transcription and replication activity (Tapparel et al, 1998). Accession numbers used in this figure are 
PPRV (Table 2), RPV (vac: Z30697, wt: Z33635, AY775545), MV (vac: AF266286, AF266289, wt: AF266288, AB012948), CDV (vac: AF305419, 
AF378705, wt: AF164967, X74443 
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Fig. 5  Phylogenetic analysis of the genome and antigenome promoters, combined in tandem 
sequences. (a) Promoter sequences of PPR field and vaccine (Nig75vac) strains with two 
outgroups (MV and RPV) added in order to root the tree. The tree was constructed using 
maximum parsimony (Neighbor joining method, Saitou and Nei, 1987) following a 
CLUSTAL W alignment of the nucleotide sequences. The numbers indicate the bootstrap 
values after 1000 resamplings. Scale represents the degree of similarity. PPRV lineages were 
placed according to Shaila et al (1996). In the tree (b), the same procedure was applied on the 
corresponding promoter sequences of various Paramyxoviridae. All strains used in this 
analysis are described in Table 1 and 2, except PPRV, which is the strain Nig75vac. 
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Chapter 6 
 
General discussion 
 
 
6.1. Epidemiology of PPR in Ethiopia 
 
The observations made on pathogenicity traits of PPRV in the natural biological life cycle 
indicate that it is a rather complex and multifaceted phenomenon for such recently classified 
virus. Even though it is known to be a single viral strain in the Morbillivirus genus and 
closely related to the other five members of the group with their restricted host range 
specificity, PPR infects most ruminant animals with varying degree of clinical and 
pathological outcome. Both large and small ruminants are readily infected and there is 
efficient natural transmission in the field in the large ruminant population from infected small 
ruminants as detected by seroconversion. However, infections in this population are generally 
asymptomatic and cannot be transmitted to contact animals, as confirmed by animal 
experimentation. Determinant factors for difference in PPRV pathogenicity according to the 
concerned species are not yet known. The figure is even more complicated in goats and sheep 
because in certain regions of Africa, some goat breeds may have subclinical infection while 
others manifest severe clinical disease and death. In East Africa (Ethiopia), PPR caused high 
mortality in goats, while sheep in contact had not been affected (Roeder et al. 1994). In Asia 
and the Middle East both goats and sheep are evenly affected and the virus caused high 
mortality in both species of animals (Shaila et al., 1989). Pattern of disease incidence and 
severity depends on the immunity level in the population, duration of maternal antibody, 
occurrence of other bacterial or parasitic diseases, movement and gathering of large 
populations for grazing or marketing purposes, feed stress and seasonal and climatic changes. 
To clarify the situation prevailing in Ethiopia, a field observation was conducted. Livestock 
production is an integral part of the country's agricultural system. The different ecological 
zones allow the production of various species of livestock which represent a major national 
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resource. Small scale and pastoralist farming systems in Ethiopia constitute reserves for 
family emergency needs and food security. In addition, animal products give major export 
commodities of about 50 millions USD annually. Sheep and goats represent more than 30% of 
the domestic meat consumption. Pastoralists and semi-pastoralists sustain their culture, life 
style and pride on their livestock. Animal diseases affect productivity by 50 to 60% a year by 
reducing production potentials of the indigenous stock and restricting the introduction of more 
productive exotic breeds. PPR was confirmed in 1991 and outbreaks were seen in goats while 
sheep in the same area were not affected. In the present work, we showed that the antibody 
seroprevalence in camel, cattle and sheep confirmed natural transmission of infection in these 
animals without clinical disease. The level of virus circulation in sheep was similar to the one 
observed in goats which were suffering from the disease. The apparent absence of 
pathogenicity in sheep could result from a particular resistance of the local species and/or a 
loss of virulence of the Ethiopian PPRV strains for sheep. Low virulence outcome may result 
from a reduced capacity of the virus to infect cells or to replicate in these cells, resulting in a 
lower viral antigen distribution through different organs and tissues. Such characteristics may 
account for the milder clinical disease and lower mortality. Therefore, differences in virulence 
can be related to the virus load received by the animals, the efficiency of intercellular 
spreading inside the body and capacity to induce damages in infected cells. However, other 
factors which determine strain virulence remain essentially unknown and those identified so 
far have not been related to a single event. The capability of cells to be infected and support 
active virus replication has important implications on the pathogenesis and epidemiology of 
the disease. Therefore, we were interested to test the cell susceptibility of PPRV. 
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6.2. Monitoring of PPRV virulence in vitro in cell culture systems 
In light of the epidemiological observation in the field, where PPRV expressed different 
degrees of pathogenicity in different species of animals. Monitoring of PPRV in vitro, in cell 
culture systems was conducted to determine if active replication of PPR and rinderpest viruses 
occurred in the same cell lines and thus if virus antigen expression can vary according to the 
cell type. The relative capacity of the cell to support active replication of PPRV and rinderpest 
virus (RPV) was determined by flow cytometry analysis. This analysis used labelling with 
MAbs against N and H proteins. Thus, the use of these virus specific monoclonal antibodies 
enabled to detect differences in cell susceptibility of PPRV compared to RPV. Vero and 293T 
cells supported productive infection by both viruses. However, comparison of the infections 
showed that the kinetics of replication in Vero and 293T cells was different in terms of virus 
antigen expression. The production of virus antigen and infectious virus progeny at the earlier 
time points post infection was lower in infected Vero cells compared to 293T cells. These 
results suggested that replication in 293T cells was initially more efficient. However, at later 
stages during the infectious cycle, the infection of Vero cells became more productive. The 
reason for the early efficient infection of 293T cells compared to Vero may relate to the 
difference levels of cytoplasmic, particularly lysosomal, activity in the cell types or to 
differences in endocytic and phagocytic activities. Nevertheless, these differences did not 
prevent the virus from eventual spreading to all cells at 120 or 144 hours post infection. 
MOCL5 cells did not support replication of PPRV and RPV (data not shown). Although of 
ovine origin, these cells may lack a specific attachment protein or an intracellular host protein 
necessary for efficient replication. Our results showed that B95a marmoset lymphoblastoid 
cells supported RPV replication, but they did not sustain replication of PPRV. Further 
attempts to adapt the PPRV to B95a cell line by six blind serial passages failed. This is 
contradictory to the report of (Das et al., 2000) in which PPRV could be adapted to B95a cells 
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after five to six blind passages. Nonetheless, PPRV seems to behave differently from all 
morbilliviruses tested so far. RPV (Kobune et al., 1991), MV (Kobune et al., 1990) and 
canine distemper virus (Seki et al., 2003) replicate and can be isolated successfully in B95a 
cell line. It may be that these cells lack an efficient receptor for the attachment H 
hemagglutinin protein of PPRV or are deficient for an essential intracellular host protein 
necessary for efficient PPRV replication. Cellular receptors are one of the major determinants 
of the host range and tissue tropism of a virus (Wild et al., 1991, Tatsuo et al., 2001). MV 
uses CD46 receptor for Vero but SLAM for B95a (Takeuchui et al., 2002). The H 
(attachment) glycoproteins of morbilliviruses are divergent and this variation may play a role 
in host cell specificity (Blixenkrone-Müller et al., 1996). Therefore, we carried out an amino-
acid sequence analysis of the H protein of several cell-adapted vaccine strains and wild type 
strains of PPRV, RPV, measles virus (MV) and canine distemper virus (CDV). We observed 
that all critical residues identified so far on the H-MV protein for the interaction with the 
SLAM (CD150 receptor) were conserved in the H-PPRV. However, we could identify 27 
unique mutations on the H-PPRV at conserved positions for MV, RPV and CDV. In order to 
anticipate the potential effect of these mutations on the H structure and function, we decided 
to use the hypothetical model of Masse et al (2004) established on the H-MV on the H amino-
acid sequence of our H-PPRV. Surface modelling using this hypothetical 3D structural model 
confirmed one mutation as critical for interaction with the SLAM of B95a cells (Masse et al, 
2004). Thus, the hydrophobic non polar aliphatic residue V525 of H-MV was replaced by the 
hydrophobic non polar aliphatic I525. The model also detected two conformational 
differences between the H-MV and H-PPRV molecules. First, on top side, the surface of 
critical residues was slightly modified, may be as a consequence of the mutation V508 Æ 
I508. Second, the critical residue L526 on H-MV was replaced by amino-acids Y540 and 
I542. Whether these modifications may account for a defective interaction of the H-PPRV 
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with the B95a SLAM receptor will need further analysis, as the non-susceptibility of B95a 
cells to PPRV cannot be explained simply by sequence modification of the H protein.  
6.3. Sequence analysis of PPRV and other morbilliviruses  
Molecular basis for attenuation of the virus vaccine strain was sought with comparative 
sequence analysis of the genome and antigenome promoters (GP and AGP). Thus, GP and 
AGP of the peste des petits ruminants (PPR) virus, amplified from different pathological 
samples of sheep and goat origins, were sequenced and compared with corresponding 
sequences of PPR vaccine strain and other morbilliviruses. The promoters of morbilliviruses 
are composed of the leader plus the untranslated 3’ end of the N gene for the GP, the 5’ 
untranslated gene of the L gene plus the trailer for AGP. Both GP and AGP complement each 
other on about the first 16 nucleotides for each virus. The promoter region I is probably 
involved both in the encapsidation of the genome within the helical structure made by the N 
protein and in the interaction between the encapsidated genome and the RNA-dependant RNA 
polymerase (Tapparel et al, 1998). The conserved motif is thought to be attached to the three 
hexamers of the promoter region I of the helical nucleocapsid to form the polymerase binding 
site (Tapparel et al, 1998; Mioulet et al, 2001). The second essential element, promoter region 
II, is composed of a series of three hexamer motifs present at position 79-84, 85-90 and 91-96 
on the GP sequence. In addition to these two conserved promoter regions, a third conserved 
region is found at position 52-71 in GP and 59-71 on AGP. The sequence alignment generated 
for GP and AGP of the Morbillivirus genus revealed a high degree of conservation, and so, 
the first four nucleotides of the 3’ terminus, UGGU, are shared between all viruses. It is 
believed that these four nucleotides contain the landing site for the viral RNA dependent RNA 
polymerase. In the cycle of infection, the RNA dependant RNA polymerase of non-segmented 
negative viruses as morbilliviruses uses the GP to synthesize the messengers RNA and later 
full-length genome copies are made via replication intermediate strands of the genome from 
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both GP and AGP. Therefore, changes in these regions may have a significant effect on the 
rate of transcription of viral mRNA or full-length genome replication (Mioulet et al., 2001). 
To identify possible attenuation nucleotides in the promoters of PPRV, we have amplified and 
sequenced the GP and AGP of 12 virulent strains recovered from field samples and compared 
the data with those of the vaccine strain. This later is derived from the virulent Nigeria 75/1 
strain and is known to be highly attenuated for all animals into which it has been inoculated so 
far (Diallo et al., 1989b). PPRV in field samples was initially detected by a RT-PCR (Couacy-
Hymann et al. (2002). Virus specific RNA was detected in nasal and eye swabs, mouth and 
gum erosions. Specimens which were positive with the PPRV specific primers were then 
submitted to two other PCR tests to amplify both GP and AGP fragments. The amplified 
products were sequenced. The sequence analysis was first done by including also the 
sequences from 2 RPV, 2 MV, 2 CDV and that of the original strain PPRV 75/1 from which 
derives our vaccine strain, all being available from Genbank. Sequence alignment of the GP 
(107 base pairs) of virulent strains of PPRV and the vaccine strain revealed six unique 
nucleotide changes at positions 5, 12, 26, 36, 42 and 81 in the vaccine strain. Nucleotide 
changes on positions 5 and 12 could not be identified in our 12 field strains because they were 
included in the forward primer used for GP amplification. However, mutations at positions 
26, 36, 42 and 81 were all confirmed, thus strengthening their importance in link with the 
virulent/attenuated phenotype. The original virus Nigeria 75/1 wild type (Nig75/1*) and its 
derived vaccine strain (63 passages on cell culture) have only 2 nt changes in GP. Their AGP 
sequences are identical. In Nig75/1* one nucleotide change, on position 12 is related to the 
virulent genotype as expected, whereas the other at position 83 is specific of Nig75/1* since 
all other PPR strains and other morbilliviruses have the same residue at that position. 
Preliminary results of experimental works on live animals indicated that, although virulent, 
PPR Nigeria 75/1 wild type has a much lower virulence than other PPR strains (Couacy-
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Hymann, personal communication). This observation would be in agreement with the 
conservation of promoter sequences between this low virulent strain and its attenuated 
progeny. Mioulet al. (2001) reported residues in position 23-26 as critical. Precisely, for 
PPRV, RPV, MV and CDV, there is a pyrimidine Æ purine transversion at position 26 from 
the wild type to the vaccine strains (A). Nucleotide 26 is downstream the sequence of the 
leader which complement with that of the trailer and it may be important for the transcription 
function of the leader promoter in its interaction with the cellular protein. The transversion 
identified at the position 26 in the leader sequence of PPRV, RPV, MV and CDV may be one 
of the essential elements involved in the attenuation of morbilliviruses. The transition at 
position 42 was only observed with PPRV. However, MV had a transversion at that position 
and for this virus it is believed that position 26 and 42 pyrimidine-to-purine transversions 
belong to a nucleotide stretch between nt 17 and 42 that could serve as contact site for a 
modified polymerase complex used for mRNA synthesis (Parks et al., 2001). For PPRV, the 
conservation of a pyrimidine residue during the base 42 substitution limits probably the 
potential impact on the level of mRNA synthesis but may still contribute to an attenuated 
phenotype. Transitions at positions 5 and 12 were only identified in both PPRV and RPV. 
They occur within the highly conserved complementary hexamer motifs of GP and AGP 
starts. They affect residues identified as not critical by the scanning mutagenesis study of the 
RPV promoter but their change can reduce the reporter molecule production by about 60%. 
(Mioulet et al., 2001). Thus the transition at positions 5 and 12 may contribute also to the 
attenuated phenotype of the vaccine strain. The two other transitions of nucleotides 36 and 81 
were only observed with PPRV. The pyrimidine at position 36 of all PPRV virulent strains is 
unique among all other wild type and vaccine strains of morbilliviruses for which a conserved 
pyrimidine is systematically found. Therefore, the transition at that position gives the PPRV 
vaccine strain the same morbillivirus conserved residue. Moreover, block mutation around 
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that nucleotide has no effect in the promoter function of the RPV leader sequence (Mioulet et 
al., 2001). Also there is no evidence that the change in the position 81 has an impact on the 
PPRV virulence.  
In the AGP sequence (109 bp), there was only one unique nucleotide mutation specific to the 
vaccine strain at position 15842, 107 nucleotides from the 5’terminus of the genome (Fig. 4). 
The nucleotide in that position is variable although nucleotide G is found only in the vaccine 
strain.  
As demonstrated by Banyard et al. (2005) in the case of RPV, the virus genome promoters 
play a role in the pathogenicity of morbilliviruses. The 6 nucleotides changes observed at 
positions generally well conserved in the PPRV GP are likely attenuation candidates. Among 
all the candidates, the most interesting is certainly the mutation observed at the position 26 
because not only it is found in the genome of RPV, PPRV, MV and CDV vaccines strains but 
also it is in the area identified as involved in the pathogenesis of SeV, another paramyxovirus 
(Fuji et al., 2002). Differences in virulence of PPR between goats and sheep reported in 
Africa were not supported by our sequence analysis of PPRV promoters. Also, specimen type 
did not play any role as there was 100% homology between sequences derived from nasal 
swabs, lung and lymph nodes from the same goat or sheep (data not shown). In contrast, 
within a same geographic region like Israel, some nucleotide changes may occur in a short 
period. Interestingly, mutations were observed between 1999 and 2000 in both GP and AGP 
sequences of goat as well as sheep strains, while the sequences are conserved after 2000 (data 
not shown). None of these viruses had been passaged on cell culture, which could have 
introduced genetic variability. It is however not clear what triggered these nucleotide changes.  
Phylogenetic analysis of tandemly linked GP and AGP of PPR field strains from different 
areas and of the vaccine strain (Nig 75 vac) showed that these variations could lead to a 
geographic clustering of the strains. Earlier, Shaila et al. (1996), and then Dhar et al. (2002) 
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demonstrated that isolates of PPRV could be grouped into four distinct lineages on the basis 
of partial sequence analysis of the fusion (F) protein gene. Relationship deduced from a 
method based on the principle of parsimony established that the promoter sequences were also 
lineage specific. Similar lineage specific base changes in the GP and AGP were also observed 
with rinderpest viruses (Banyard et al., 2005). This illustrates the possibility of using very 
short sequence regions at the end of the virus genome for molecular typing of isolates, both 
for virulence and lineage discrimination. Lineage speciation was identical when using 
independently the GP or AGP sequences (data not shown). However, combination of the two 
allows to increase the bootstrap values and to strengthen the molecular typing of PPRV 
isolates next to other morbilliviruses. Furthermore, phylogenetic analysis of the GP-AGP 
tandem of Paramyxoviridae, confirms that morbilliviruses form a unique cluster within the 
family. Although having unique features that clearly distinguish them from other 
paramyxoviruses, Henipa and Tupaia viruses are significantly closer to morbilliviruses than to 
any other virus genera (bootstrap values higher than 80%). The same observation was 
obtained when grouping the viruses through full-genome sequences (Lwamba et al, 2005). 
In our work, the initial observation in Ethiopia of a difference in clinical expression after 
infection of different species by PPRV supported the hypothesis of variable strain virulence. 
To assess this possibility, we have investigated the cell susceptibility of PPRV and tried to 
identify the molecular basis for different cell host range and replication capacity of this virus 
comparatively to RPV and their implication for understanding the pathology and pathogenesis 
of PPRV infection. Sequence analysis was done on two important virus components, the 
attachment H protein and the virus promoters. We conclude that the virus has modified 
nucleotide sequences either in the H gene (responsible for attachment with cellular receptors) 
or its promoters (which are responsible for initiation of transcription and mRNA replication) 
virulence/attenuated phenotype. 
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Recommendations 
1. Epidemiology and Control: PPR is one of the most important diseases of small 
ruminants in Africa, where poor farmers with subsistence agriculture rely on these 
animals for their livelihood and food security. It appears that in Africa, goats are 
severely affected while sheep undergo a mild form of the disease. PPR is one of the 
most important economical diseases in Ethiopia, since it had been confirmed in goats 
in 1991. However, its circulation in other animals has never been described. In the 
present work, we showed that the antibody seroprevalence in camel, cattle, goat and 
sheep confirmed natural transmission in these animals without clinical disease. The 
apparent absence of pathogenicity in these animals may have been due to host 
resistance or loss of virulence of the virus strain in Ethiopia. The epidemiology of the 
disease is much more complex than previously thought with added differences in 
pathogenicity and virulence. 
Therefore, in our view PPR warrants due attention for control and future eradication. 
PPR can be effectively controlled by RPV vaccine, rinderpest eradication programmes 
have been launched in many countries and, Office International des Epizooties (OIE) 
recommends the cessation of vaccination of all the animals with RPV vaccine so that 
any residual foci of RPV could be identified. Under these circumstances, small 
ruminants could only be protected against PPR by using homologous attenuated 
vaccine. In addition, the successful use of an attenuated PPRV vaccine against RPV 
has been reported in goats, opening the possibility to use it as a differentiable vaccine 
for cattle. Indeed, after RP is eradicated in cattle, small ruminants may serve as a 
reservoir from which RPV could re-emerge. Since there is presently no test for 
distinguishing between vaccine and wild-type RPV, one cannot determine the origin 
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(vaccinal or natural infection) of antibodies in goats and sheep. The problem of 
differentiating between vaccine and wild-type PPRV may also be posed. This may be 
the stimulating force for developing marked vaccines for both rinderpest and PPR. 
Future vaccines should be able to incorporate marked vaccines to differentiate natural 
infection from vaccine induced antibodies.  
Therefore, control programmes of PPR should be supported by field data generated by 
rigorous epidemiological surveillance, risk analysis and geo-referenced mapping 
systems using GIS.  
2. Diagnostic tools: Both antigen detection and cELISAs have been effectively used in 
diagnosis and surveillance of PPR. Virus isolation has been used as a gold standard 
technique. Initial studies on the relationship among the morbilliviruses were done 
using classical serological tests (agar gel precipitation, complement fixation, 
hemagglutination and virus neutralization) and cross protection studies. Cross 
neutralization has been adopted as a means for differentiating between PPRV and 
RPV whose host ranges overlap in small ruminants. Serum raised against one virus 
neutralised the homologous virus at a higher titre than the heterologous one. A 
practical consequence of serologic cross reactivity between morbilliviruses is that 
diagnostic tests based on polyclonal antibody are incapable of distinguishing between 
PPRV and RPV. 
The capability of cells to be infected and support active virus replication has important 
implications on the pathogenesis of the disease. Morbilliviruses use SLAMs of their 
respective host species as cellular receptors. However, MV, CDV, and RPV strains 
could use SLAMs of nonhost species as receptors, albeit at reduced efficiencies. Thus, 
the finding that these three morbilliviruses use SLAMs as cellular receptors suggests 
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that the usage of SLAM as a receptor has been maintained from the ancestral virus, 
accounting for an essential part of the pathogenesis of morbillivirus infections. 
 Differences in sensitivity of cells to PPRV and RPV were observed using monoclonal 
antibody based analysis with the Facs scan flow cytometry.  Therefore, more works 
should be conducted on merits of this technique in terms of sensitivity, specificity and 
cost to use as a diagnostic tool in developing countries compared to classical virus 
neutralisation test. 
3. Molecular tools: Molecular basis for attenuation of the vaccine strain was sought by 
comparative sequence analysis of the genome and antigenome promoters. Thus, 
promoters of the peste des petits ruminants (PPR) virus, amplified from different 
pathological samples of sheep and goat origins, were sequenced and compared with 
corresponding sequences of PPR vaccine strain and other morbilliviruses. The 
promoters of morbilliviruses are composed of the leader sequence and the non coding 
regions of the 3’ end of the N gene, and the 5’ untranslated region of the L gene and the 
trailer sequences. Both genome and antigenome promoters complement each other on 
about the first 16 nucleotides for each virus. The promoters are involved in interaction 
between the genome and the RNA-dependant RNA polymerase for the initiation of 
transcription, encapsidation of the genome and mRNA synthesis. It is believed that 
promoters contain the binding site for the viral RNA dependent RNA polymerase. In the 
cycle of infection, the RNA dependant RNA polymerase of non-segmented negative 
viruses as morbilliviruses uses the promoters to synthesize the messengers RNA and 
later full-length genome copies are made via replication intermediate strands of the 
genome. Therefore, changes in these regions may have a significant effect on the rate of 
transcription of viral mRNA or full-length genome replication. 
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Sequence analysis of genome and antigenome promoter regions detected high 
similarities between field virus and vaccine strain. There had been vaccine strain 
specific nucleotide mutations. Whether these mutations are associated with virulence or 
attenuation needs further research. More striking observation from this work is that 
promoter regions correlated with lineage specific geographic and phylogenetic analysis 
previously conducted using the F gene. Therefore, relatively short sequences of 
promoters could be used for virulence and epidemiological studies of PPR 
phylogeography and molecular phylogenetic classification of viruses within 
Paramyxoviridae. 
4. More research: Virulence of a virus to a specific host is multifactorial. From virus 
point of view it is multigenic and is not related to a single event. Nucleotide mutations 
observed in the promoter regions have not been tested in cellular models and further in 
animal models. Therefore, further work is needed to establish the role of these mutations 
in virulence and pathogenicity of the virus. Full length genome sequences are available 
for MV, RPV, CDV, PPRV and the dolphin morbillivirus (DMV). These data have been 
used to establish reverse genetics, a technology critical for negative sense RNA virus 
research. Interaction between viral H protein and cellular receptors needs more work in 
light of current developments in reverse genetics and molecular modelling. This study 
will be helpful to better understand the virus-cell interaction and its receptor effects on 
viral  pathogenicity and epidemiology. 
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Annexe I  
Virus neutralisation protocol  
 
The test can be carried in tissue culture roller tubes as follows: 
i) inactivated sera are diluted in a two-fold dilution series and mixed with a stock of virus 
suspension containing approximately 103 TCID50/ml; 
ii) the virus/serum mixtures are incubated for 1 hour at 37°C; 
iii) 0.2 ml of the mixture are inoculated into each of five roller tubes, followed immediately 
by 1 ml of vero cell suspension in growth medium at a rate of 2x105 cells/ml; 
iv) the sloped tubes are incubated for 3 days at 37°C; 
v) the medium is replaced with maintenance medium and the plates are incubated for a further 
7 days. The virus challenge dose is acceptable if it falls between 101.8 and 102.8 TCID50/ml. 
Any detectable antibody at a dilution of 1/8 is considered to be positive.  
The serum neutralization has become more efficient and economical with the use of tissue 
culture microplates and micro-pipetting systems. Thus, using multichannel pipettor, the serum 
is diluted serially and the constant amount (103 TCID50) of virus is added and incubated at 
37°C for 1 h. Still using multichannel pipettors, a constant amount of cells (2x 104  cells/ml) is 
added to the virus serum mixture. The plate is incubated at 37°C in the 5% CO2  incubator. 
The plate is read under microscope for cytopathic effect (CPE) of the virus. Judgement of the 
results is based on positive and negative control wells. No CPE should be detected in the 
negative control wells. For the positive controls the record should be similar to ten fold 
dilutions of the virus. The serum titre is the last dilution for which the test serum neutralizes 
the virus. 
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Annexe II 
PCR Protocol 
PCR can be used to amplify the virus RNA in gum and lachrymal swabs transported in 
phosphate buffer containing penicillin, streptomycin and fungizone, whole blood and 
postmortem specimens. In brief, PCR can be carried out as follows: RNA is extracted using 
the rapid methods (Forsyth and Barrett, 1995, Couacy-Hymann et al., 2002) and was 
conducted in nine hundred µl of lysis solution (6 M guanidine isothiocyanate or 6 M of 
sodium iodide) and 100 µl of sample suspension were mixed in a 0.5ml tube. The tube is spun 
in a microfuge. The supernatant is discarded and the pellet washed and eluted in DEPC 
treated water. The RNA was stored in –70°C until used. The primers were derived from the 
nucleoprotein and phosphoprotein gene (Couacy-Hymann et al., 2002). The reverse 
transcription reaction (RT) was carried out in a 250 µl tube as follows: 7 µl of the extracted 
RNA (denatured at 65°C for 10 min) were mixed with 1 µl of DTT, 1µl of random primer 
pdN6 and 5 µl of cDNA synthesis bulk (First strand cDNA synthesis kit) and the mixture was 
incubated at 37°C for 1 h. Three microliters of the RT product were used as template for the 
PCR. In a 250 µl thin wall tube, the cDNA was mixed with the following reagents: 5 µl of 
dNTP mixture (200 mM for each dNTP), 5 µl of 10X Taq buffer, 1µl of forward and reverse 
primers mixture (100 pmol/µl for each primer), 34 µl of water and 1 µl of Taq polymerase 
(1.25 U/µl). Once all the reagents were mixed, the tube was placed into the PCR machine. 
The amplification was carried out according to the following programme: initial heating step 
95°C for 5 min followed by 35 cycles of denaturation at 94°C for 30 sec, annealing at 55°C 
for 30 sec and the extension at 72°C for 2 min. (Fig. 1-12). Five µl of PCR products were 
analysed by electrophoresis on a gel (1.5% Nusieve agarose in Tris-borate-EDTA buffer, 
pH8.3). The gel was stained with ethidium bromide and visualized by UV fluorescence for the 
presence of DNA bands of the expected size and are photographed. 
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Résumé
La peste des petits ruminants (PPR) est une maladie infectieuse, contagieuse des petits 
ruminants domestiques ou sauvages. Elle se caractérise par une hyperthermie élevée 
(autour de 41°C), du jetage, des écoulements oculaires, une stomatite nécrosante, de la 
diarrhée profuse et généralement une forte mortalité. En Afrique, elle peut avoir différentes 
incidences cliniques sur les moutons ou les chèvres, depuis l'infection subclinique jusqu'à 
une infection aiguë létale. En Ethiopie, la PPR clinique est rarement décrite et l'étude de la 
circulation virale était jusqu'à présent peu développée. Dans ce travail, nous montrons la 
présence d'anticorps contre le virus de la PPR sur un grand nombre de moutons, chèvres, 
vaches et chameaux éthiopiens et nous confirmons la transmission naturelle du virus PPR 
chez ces animaux sans manifestation clinique détectable. Cette absence apparente de 
pathogénicité peut être liée à une résistance génétique particulière des races de petits 
ruminants présentes en Ethiopie ou à une variation de la virulence des souches de virus 
PPR. Afin d'étudier ce dernier point, nous avons entrepris des études in vitro sur des 
souches isolées en Ethiopie et dans différents pays en comparaison avec une souche 
vaccinale obtenue par atténuation par passages en série sur culture cellulaire et d'autres 
souches de morbillivirus.
Dans un premier temps, nous avons testé la capacité du virus PPR à infecter différents 
systèmes cellulaires.  Nous établissons que les cellules VERO (fibroblastes de rein de 
singe) et 293T (cellules épithéliales de rein humain) permettent la réplication du virus PPR 
comme  celle  du  virus  de  la  peste  bovine.  En  revanche,  les  cellules  B95a  (cellules 
lymphoblastoïdes B de singe) ne multiplient que le virus de la peste bovine. La capacité 
d'une  cellule  à  supporter  la  réplication  du  virus  est  de  nature  à  influer  son  pouvoir 
pathogène et l'épidémiologie de la maladie. La différence de sensibilité des cellules au 
virus PPR peut être lié à l'affinité de la glycoprotéine d'enveloppe virale H pour son ou ses 
récepteurs cellulaires utilisés notamment par le virus de la peste bovine. Pour aborder 
cette question, nous avons entrepris des comparaisons de séquences au niveau de la 
protéine H du virus PPR, en lien avec ce qui a été déjà décrit sur d'autres morbillivirus.
Pour compléter cette étude sur  la virulence,  nous avons séquencé les promoteurs de 
plusieurs souches de virus PPR et conduit une analyse des mutations pouvant jouer un 
rôle dans l'atténuation. En effet,  les promoteurs viraux des morbillivirus déterminent la 
transcription des ARNm viraux et la réplication du génome viral : la modification de leur 
séquence  peut  donc  affecter  leur  efficacité  et  influer  sur  la  virulence  de  la  souche 
concernée. Nous observons 7 mutations sur les promoteurs de la souche vaccinale du 
virus PPR en comparaison avec les autres souches virulentes. Certaines mutations sont 
retrouvées sur les autres morbillivirus, d'autres sont spécifiques du virus PPR. De cette 
approche moléculaire,  nous déduisons également  l'intérêt  d'utiliser  les  séquences des 
promoteurs du virus, relativement très variables par rapport au reste du génome, pour 
mener des études de phylogéographie et de comparaison entre paramyxovirus.
Le  document  de  thèse  a  été  organisé  en  6  chapitres.  Le  premier  concerne  l'histoire 
naturelle de la PPR avec la description du virus, du génome, de l'épidémiologie, de la 
transmission, des symptômes, de la pathologie,  de l'immunologie,  du diagnostic,  de la 
lutte  contre  la  maladie  et  des  aspects  économiques  en  Afrique  sub-saharienne.  Le 
deuxième  chapitre  traite  de  la  biologie  comparative  du  virus  PPR  avec  les  autres 
morbillivirus.  Le  troisième  chapitre  concerne  les  travaux  d'épidémiologie  de  la  PPR 
effectués en Ethiopie. Le quatrième volet de ce travail reprend les études sur la spécificité 
cellulaire du virus PPR et la comparaison des séquences sur la protéine H. Le cinquième 
chapitre expose les analyses de séquence des promoteurs génomique et antigénomique 
du  virus  PPR.  Enfin,  la  dernière  partie  comprend  une  discussion  générale  et  des 
perspectives.
Mots-clés :  Ethiopie,  épidémiologie,  Morbillivirus,  pest  bovine,  phylogéographie,  PPR, 
promoteurs, virulence
